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 In eukaryotes, DNA is packaged by histone proteins to form nucleosomes – the 
fundamental unit of chromatin.  Aside from their structural role in DNA compaction, 
histones are dynamic regulators of DNA accessibility and, hence, are important for 
DNA-templated processes including transcription and DNA repair.  To regulate 
chromatin architecture, histones are covalently modified with numerous post-
translational modifications (PTMs), e.g., methylation, acetylation, phosphorylation and 
monoubiquitylation.  Histone PTMs function by either directly altering chromatin 
structure or serving as binding sites for effector proteins that mediate downstream 
functions.  Because histone PTMs regulate many cellular processes, their specific 
deposition and removal throughout the genome are highly regulated.  Accordingly, 
dysregulation of histone PTMs can result in human diseases such as cancer.  One PTM 
that is carefully regulated and whose disruption results in disease is monoubiquitylation 
of lysine 123 on histone H2B (H2BK123ub1).  The work in this dissertation focuses on 
understanding how H2BK123ub1 is regulated and functions with an emphasis on its role 
in transcription.  These studies were performed using the highly tractable model 
organism Saccharomyces cerevisiae.  Here, two novel forms of H2BK123ub1 regulation 
are identified.  First, H2BK123ub1 was found to be regulated by a region of histone H2A 
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in a form of trans-histone regulation.  This finding led to identification of a second form 
of regulation, which couples H2BK123ub1 catalysis to the stability of the responsible 
modifying enzyme Bre1.  Lastly the functional role of H2BK123ub1 in transcription is 
expanded by connecting Bre1 stability to the regulation of gene silencing and by the 
finding that a histone PTM downstream of H2BK123ub1 facilitates interactions between 
histones and the transcriptional machinery.  Altogether, the work in this dissertation 
expands our knowledge of the role and regulation of H2BK123ub1.  These findings will 
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CHAPTER 1 INTRODUCTION1 
The human body displays an amazing diversity of structures and functions.  
Heart cells beat in unison to keep blood flowing through arteries, capillaries and veins.  
A layer of skin cells protects our insides from the surrounding environment.  A vast 
network of neurons communicates via electrical pulses to allow us to process and 
respond to stimuli.  The body is also highly resistant to change and has a stunning 
ability to adapt, which is evident in our immune system where a multitude specialized 
cells sense and fight off infection.  Given the incredible specification and adaptability of 
cells within the human body described in these few examples, it is remarkable that 
every cell originates from just a single cell and, hence, shares the same set of 
instructions – the genome.   
Over the past decades, efforts including and stemming from the Human Genome 
Project have helped clarify the basis of cellular diversity by demonstrating that the 
genome contains a massive amount of information in the form of genes.  These genes 
not only encode the basic functions required for each cell such as metabolism and the 
ability to divide, but also include the information required for specialized functions.  
Given that every cell shares the same genes, several primary questions still remain.  To 
begin, how does the any given cell select and utilize the necessary set of genes for a 
                                            
1 Portions of this chapter were adapted from Wozniak GG, Strahl BD. 2014. Hitting the 
'Mark': Interpreting Lysine Methylation in the Context of Active Transcription. Biochim 
Biophys Acta. doi: 10.1016/j.bbagrm.2014.03.002. 
 
  2 
given function?  At the same time, how does a cell ensure that other genes, which may 
be detrimental in the given cellular context, are not inappropriately activated?  Lastly, 
how is the pattern of gene activation and repression recapitulated after each cell division 
and even between parent and offspring?  These questions form the basis of the field of 
epigenetics, which seeks to understand how the genome is utilized and regulated in 
order to uncover the mechanisms of establishment, alteration and maintenance of 
cellular diversity.  The basic components of epigenetics and its advances in 
understanding gene regulation will be discussed here in further detail. 
 
Chromatin Structure and Function 
In the eukaryotic cell DNA does not exist on its own, but instead exists in a 
compacted structure called chromatin.  The main, repeating, functional until of 
chromatin is called the nucleosome, which consists of 147 base pairs of DNA wrapped 
around a octameric protein complex made up of two copies of each of the four core 
histone proteins H2A, H2B, H3 and H4 (Luger et al. 1997; Kornberg and Lorch 1999).  
The histone proteins are small (~100-130 amino acid) and positively charged, which 
allows them to bind to the negatively charged DNA.  Structurally, histones consist of 
unstructured N- and C-terminal tails and a globular central domain (Luger et al. 1997).  
As discussed in detail below, the histone tails play a prominent role in chromatin 
regulation.  Once formed into nucleosomes, the histones facilitate the compaction of 
DNA into a structure referred to as the 30-nm fiber (Horn and Peterson 2002).  Then, 
with the help of the non-core histone H1 and other proteins like cohesin and condensin, 
the DNA is further condensed into the poorly defined higher order structures observed in 
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the fully compacted mitotic chromosome (Kornberg and Lorch 1999; Horn and Peterson 
2002; Hagstrom and Meyer 2003).   
Functionally, chromatin serves multiple purposes.  First, it acts to compact and 
protect the DNA from damage (e.g. breaks and recombination) and ensure the faithful 
passage from mother to daughter during cell division.  Second, and in addition to its 
general compaction and protective function, chromatin acts as plastic barrier to the 
underlying DNA sequence (Li and Reinberg 2011; Voss and Hager 2014).  It is this 
function that plays a primary role in specifying cellular identity, as the cell is able to 
manipulate chromatin structure to make different regions of the genome more or less 
accessible to the machinery of myriad DNA-template processes.   
As a result of this manipulation, chromatin generally exists in two general states: 
euchromatin and heterochromatin (Li et al. 2007; Trojer and Reinberg 2007).  The two 
states, originally distinguished by staining intensity as observed using cytological 
techniques, represent accessible and inaccessible regions of the genome, respectively.  
Euchromatin encompasses gene-rich and transcriptionally active loci.  Depending on 
the activity at a given locus, euchromatin displays a range of compaction that also 
includes the complete removal of histones as observed at the most highly transcribed 
genes.  Heterochromatin displays more variability and, hence, is further divided into two 
subtypes called constitutive and facultative (Trojer and Reinberg 2007).  Constitutive 
heterochromatin is always repressed and mainly exists at specific chromosome features 
including telomeres, centromeres and at repetitive DNA elements such as transposons.  
Facultative heterochromatin consists of repressed genomic loci that may also exist as 
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euchromatin in other cellular contexts such as during development on in response to 
stimuli. 
The ability of chromatin state to alter over the course of development and in 
response to stimuli is an important component of cellular specification and adaptation.  
As a result, the transition between states is heavily regulated and involves a multitude of 
components.  Described below are the mechanisms by which the chromatin state is 
demarcated, altered and maintained.   
 
DNA-Based Determinants 
Aside from encoding genes and accompanied regulatory elements, DNA 
sequence itself can contribute to the structure and function of chromatin.  One way this 
can occur is by promoting or preventing histone binding to modulate nucleosome 
formation.  For instance, sequences rich in the bases adenine and thymine (AT-rich) will 
not form nucleosomes as readily as those with guanine and cytosine (Segal et al. 2006; 
Kaplan et al. 2009).  Consistently, AT-rich DNA is often found at promoter regions of 
genes where DNA accessibility is a hallmark feature.  Given that DNA sequence is 
static, unlike chromatin states, the extent to which it contributes to nucleosome 
formation, however, has not been fully determined.       
DNA also contributes to chromatin through the binding of transcription factors 
(Figure 1.1).  These proteins are capable of binding DNA with or without specificity and 
either harbor the activity to directly modify chromatin structure or recruit other proteins to 
carry out the same task (Rothbart and Strahl 2014).  Transcription factors often display 
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specific expression patterns such that they are only found in specific cell types or under 
certain environmental conditions.  The carefully regulated expression of these factors in 
addition to the specificity of binding across the genome plays an important role in 
dictating gene expression or repression in differing cellular contexts.       
Adding another dimension to DNA is its ability to be modified.  DNA can be 
methylated on the carbon 5 position of cytosine (5mC) by enzymes called DNA 
methyltransferases (Jones 2012).  DNA methylation is also dynamic and can be 
removed, generating intermediate modifications including hydroxymethyl-, formyl- and 
carboxycytosine, which are ultimately repaired to cytosine.  Canonically, 5mC is 
associated with gene repression and is partly thought to function by preventing the 
binding of transcription factors, which would otherwise alter chromatin accessibility 
(Jones 2012).   Additionally, certain proteins contain domains that are capable of 
recognizing and binding 5mC and its derivatives (Bartke et al. 2010; Spruijt et al. 2013).  
Many of these proteins are found in complexes that function in gene repression such as 
histone deacetylases and chromatin remodelers, both of which alter chromatin structure 
and are discussed below.  Lastly, the ability of DNA methylation to promote or prevent 
transcription factor binding helps explain, in part, why transcription factors are not found 
at every possible binding site across the genome.  Taken together, both DNA sequence 
and its modifications can impinge on chromatin.    
 
Histone Variants 
As described above, histones constitute the main structural element of chromatin, 
however, every histone across the genome is not the same (Figure 1.1).  Owing to the 
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fact that chromatin structure must be altered to govern DNA accessibility, histone 
proteins display considerable variability across the genome.  Thus, by altering the 
histones associated with DNA, the cell can maintain the structure of chromatin and at 
the same time modulate the functional output of a given genomic region.  
One way histones can be altered is through the use of histone variants.  With the 
exception of histone H4, alternate versions exist for the core histones (Maze et al. 
2014).  Overall, the structures of the variants remain similar to that of the core histones, 
but can differ in both amino acid sequence and length.  The inclusion of histone variants 
into nucleosomes can have varying affects on chromatin structure and can either act to 
stabilize or destabilize nucleosomes.  One of the most conserved histone variants is the 
H2A variant H2A.Z, which is found in organisms ranging from yeast to human 
(Zlatanova and Thakar 2008).  This variant, in particular, has been well studied with 
regard to its function.  It is thought to destabilize nucleosomes and, interestingly, has 
been proposed to play a role in maintaining the memory of recent transcription at 
multiple genomic loci (Brickner et al. 2007; Zlatanova and Thakar 2008).  Consistently, 
H2A.Z is typically found incorporated in the nucleosomes flanking the transcription start 
sites of genes (Zlatanova and Thakar 2008).  Part of its destabilizing function may arise 
from its sequence differences from H2A, which include the alteration of a region 
important for inter-nucleosomal interactions.  Another highly conserved variant called 
CENP-A replaces canonical H3 exclusively at centromeres and plays an important role 
in kinetochore formation (Black and Cleveland 2011; Maze et al. 2014).  Therefore, the 
replacement of core-histones with variants can introduce variability in chromatin.     
  7 
 
Histone Modifications 
In addition to the use of histone variants in demarcating chromatin, histone 
proteins (canonical and variant) can be modified with a large number of post-
translational modifications (PTMs, Figure 1.1).  These include acetylation, methylation, 
phosphorylation, ubiquitylation and sumoylation as well as less characterized and 
defined modifications including ADP-ribosylation, citrullination, and glycosylation 
(Peterson and Laniel 2004; Kouzarides 2007; Bannister and Kouzarides 2011; Tan et 
al. 2011).  Through the use of more sensitive mass spectrometry techniques, the 
number and types of modifications known continues to grow (Pesavento et al. 2004; 
Young et al. 2010).  Histone PTMs primarily occur on the unstructured N- and C-
terminal tails of the histone proteins where accessible and modifiable amino acid 
residues are enriched, however, a number of functionally significant modifications also 
occur within the globular domain (Luger et al. 1997; Kouzarides 2007; Bannister and 
Kouzarides 2011; Tan et al. 2011).   
Functionally, histone PTMs can alter chromatin structure both directly and 
indirectly.  The direct affect on chromatin structure mostly arises through alterations of 
amino acid charge.  The histone tails are enriched in positively charged residues such 
as lysine and arginine, which may interact with the negatively charged DNA to create a 
repressed chromatin structure (Kornberg and Lorch 1999).  Lysine acetylation, for 
example, can neutralize the positive charge, which is one reason it is considered a 
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modification associated with DNA accessibility (Kouzarides 2007).  Histone 
phosphorylation (negative charge) may play a similar role.   
It is thought, however, that the primary role by which histone PTMs affect 
chromatin structure is through their role in facilitating interactions with proteins and/or 
protein complexes that have the ability to directly alter chromatin (Kouzarides 2007; 
Bannister and Kouzarides 2011; Rothbart and Strahl 2014; Wozniak and Strahl 2014) 
(Figure 1.1 and 1.2).  A number of protein domains (so-called “reader” domains) have 
been identified that recognize histone PTMs.  Moreover, additional domains exist that 
are unable to bind histones when a given PTM is present (Figure 1.2A).  Thus, like DNA 
methylation, histone modifications can help recruit proteins to chromatin, while at the 
same time oppose those that may otherwise play an aberrant role in chromatin.     
Histone PTMs typically do not occur independently, but instead exist in distinct 
patterns that are thought to serve specific functions across the genome (Ruthenburg et 
al. 2007; Taverna et al. 2007; Young et al. 2010; Bannister and Kouzarides 2011; 
Musselman et al. 2012).  This idea is the basis of the “histone code” hypothesis (Strahl 
and Allis 2000; Jenuwein and Allis 2001).  Towards this idea, it has been observed that 
a number of proteins associated with chromatin contain more than one domain capable 
of recognizing histones (Jacobson et al. 2000; Vermeulen et al. 2007; Ruthenburg et al. 
2011).  It is thought that these proteins are able to “read” a particular chromatin state as 
dictated by the histone PTM pattern to faithfully perform its function only in specified 
genomic contexts.  A notable example of this is a subunit of the NURF chromatin 
remodeling complex called BPTF, which is capable of simultaneously recognizing 
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trimethylation of lysine 4 on histone H3 (H3K4me3) and acetylation of lysine 16 on 
histone H4 (H4K16ac) through the PHD (plant homeodomain) finger and bromodomain, 
respectively (Ruthenburg et al. 2011).  As described above, DNA methylation can also 
contribute to transcription factor binding specificity.  It is now clear that the combination 
of histone modifications and DNA methylation can function together to dictate factor 
binding across the genome (Bartke et al. 2010; van Nuland et al. 2013).  Consistently 
several proteins have been identified that can simultaneously recognize histone 
modifications and DNA methylation.  One of these proteins is UHRF1, which is capable 
of binding methylation of lysine 9 on histone H3 and hemimethylated DNA (Arita et al. 
2008; Rothbart et al. 2012a) (Figure 1.3A).  Thus, multiple components exist to create 
the distinct chromatin patterns observed across cell types. 
 
Mechanisms of Chromatin Alteration 
As described above, chromatin states are demarcated by a number of structural 
features.  However, when the cell accesses a previously repressed region of chromatin 
or represses an active region, a number of enzymatic processes must function together 
to alter chromatin structure.  A general overview of these activities follows.   
    
Histone Modifying Enzymes 
Histone modifications act as landmarks of specific chromatin states and serve to 
recruit proteins capable of physically remodeling chromatin (Kouzarides 2007; Bannister 
and Kouzarides 2011; Rothbart and Strahl 2014; Wozniak and Strahl 2014) (Figure 1.2).  
Thus, altering histone modifications is an important step in the transition between 
  10 
chromatin states.  Histone modifications are governed by a wide array of enzymes and 
enzyme complexes, which typically display high specificity for a given histone residue.  
Histone modifying enzymes can also be separated into two types: “writers” and 
“erasers” (Gardner et al. 2011).  These two enzyme classes catalyze either addition or 
removal of PTMs, respectively (Figure 1.2C).  It is important to note that the recruitment 
of “writers” and “erasers” is not always mutually exclusive.  Co-recruitment of both 
enzyme types is an important part in altering PTM patterns across the genome.  
Moreover, a competition between “writing” and “erasing” activities ensures a fine 
balance of histone PTMs and thus keeps chromatin accessibility properly regulated 
(Katan-Khaykovich and Struhl 2002; Black et al. 2012).     
Recruitment of histone modifying enzymes occurs either alone or as part larger 
protein complexes.  As with transcription factors, both DNA and histone recognition play 
an important role in enzyme recruitment (Rothbart and Strahl 2014).  The enzymes 
utilize conserved domains that are able to bind specific histone modifications and/or 
DNA to catalyze modifications only in a defined chromatin context.  As an interestingly 
extension of this concept, some histone modifiers are able to bind the modification that 
they catalyze, which may promote propagation of a modification across a specified 
genomic locus (Shi et al. 2007b; Milne et al. 2010; Eberl et al. 2013) (Figure 1.2D).   
 
Chromatin Remodelers 
Once a chromatin state is demarcated, it can be altered to change accessibility to 
the underlying DNA.  The most basic mechanism by which chromatin structure is altered 
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is through the use of ATP-dependent chromatin remodelers (Clapier and Cairns 2009; 
Narlikar et al. 2013).  Numerous proteins and protein complexes have been identified 
with chromatin remodeling activity, which includes the ability to deposit, slide and/or 
evict nucleosomes from chromatin (Figure 1.1).  In addition, some of these complexes, 
for example the SWR complex in budding yeast, are able to facilitate the incorporation 
of variant histones into chromatin (Mizuguchi et al. 2004).  Four general families of 
chromatin remodelers have been identified, which include SWI/SNF, ISWI, CHD and 
INO80 (Clapier and Cairns 2009; Narlikar et al. 2013).  Each of these families contains 
multi-subunit complexes with a central ATPase catalytic subunit.  While certain subunits 
and complex architectures are shared within a family, the activities of the specific 
complexes on chromatin can vary.  For example, most complexes of the ISWI family 
function by maintaining the equal spacing of nucleosomes on DNA, however, the NURF 
complex can promote random spacing (Clapier and Cairns 2009). 
Chromatin remodelers play a role in all DNA-templated processes including 
transcription, DNA replication and DNA repair.  Although, the mechanisms by which 
chromatin remodeling activity is specified at different regions of the genome or how 
complexes are recruited to chromatin is, largely, still not understood.  It is apparent that 
both histone and DNA modifications play an important role (Figure 1.2A).  Interestingly, 
and as described above, chromatin-remodeling complexes often contain multiple 
chromatin and DNA binding domains that may increase the specificity of binding across 
the genome (Kasten et al. 2004; Ferreira et al. 2007; Ruthenburg et al. 2011).  
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Alternatively, the modifications may stimulate or attenuate the activity of the complexes 
that have already been recruited to chromatin. 
 
Histone Chaperones 
Working in concert with chromatin remodelers are proteins called histone 
chaperones (Avvakumov et al. 2011; Burgess and Zhang 2013).  These proteins have 
the capability of binding free histones and facilitating their deposition and removal 
across the genome (Figure 1.1).  Free histones can have a detrimental effect in the cell 
by binding non-specifically with the DNA template, thus histone chaperones help 
maintain the highly regulated process of histone incorporation and removal across the 
genome and throughout the cell cycle.  One phase of the cell cycle where chaperones 
are especially important is during S-phase where a large pool of histones is generated 
for incorporation into the replicated strand of DNA.  A cascade of histone chaperones 
including Asf1, CAF-1, and Rtt106 help facilitate this process.  Histone chaperones also 
regulate replication-independent histone deposition such as during transcription where 
histones are removed and deposited during the passage of RNA polymerase (Li et al. 
2007; Avvakumov et al. 2011). 
While a number of histone chaperones have been described, each of them 
performs distinct functions.  Many show specificity for either H3/H4 (Asf1) or H2A/H2B 
(Nap1), but some exist that can bind both (FACT) (Avvakumov et al. 2011; Burgess and 
Zhang 2013).  Moreover, other chaperones are capable of binding histone variants such 
as H3.3 (Daxx and HIRA) or H2A.Z (Chz1) (Luk et al. 2007; Elsaesser and Allis 2010).  
Chaperones that bind the same histone can also display specificity for certain genomic 
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loci, as is the case for HIRA and Daxx, which associate with euchromatin and 
heterochromatin, respectively (Goldberg et al. 2010).  This specificity can be contributed 
by a number of factors including recognition of specific histone modifications on the 
bound histone or through the association with distinct complexes such as chromatin 
remodelers (Clapier and Cairns 2009; Avvakumov et al. 2011).    
 
General Mechanisms of Transcription 
Chromatin ultimately impinges on all DNA-templated processes, but has been 
most well studied in the process of transcription (Berger 2007; Li et al. 2007; Rando and 
Winston 2012).  This role is especially evident in the process of cellular specification 
where chromatin regulates large-scale, genome-wide changes in gene expression.  
Prior to exploring the role and regulation of chromatin in transcription, basic 
mechanisms and selected players of transcription will be discussed. 
 
The Transcription Cycle 
Transcription is defined by a number of highly regulated steps, which entail 
recruitment of RNA polymerase II (RNAPII) to genes and ultimately, the production of a 
fully processed and functional RNA molecule.  The first phase of transcription is referred 
to as initiation and takes place at regions upstream of the transcription start site (TSS) 
called promoters (Figure 1.4).  During initiation general and gene-specific transcription 
factors facilitate the recruitment and binding of RNAPII to the promoter to form the pre-
initiation complex (Nikolov and Burley 1997; Shandilya and Roberts 2012).  In addition 
to the promoter, sequences found both up- and downstream called enhancers interact 
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with other gene-specific transcription factors to promote initiation (Calo and Wysocka 
2013).  Once initiation is completed, RNAPII begins transcribing DNA into RNA and 
initial processing events occur such as the addition of the 7-methylguanosine cap on the 
5’ end of the RNA molecule.  In higher organisms such as Drosophila melanogaster and 
humans, RNAPII may associate with the NELF (negative elongation factor) complex 
leading to transcriptional pausing just downstream of the TSS (Adelman and Lis 2012).  
This promoter proximal pausing, is thought to allow rapid induction of stress response 
genes in response to external stimuli by bypassing initiation.  Either directly after 
initiation or after pause release by P-TEFb (positive transcription elongation factor), 
transcription progresses into the elongation phase where RNAPII continues along the 
length of the gene transcribing in a processive manner (Fuchs et al. 2009; Kwak and Lis 
2013).  During elongation RNA splicing occurs in a co-transcriptional fashion.  Finally, 
elongation continues until a termination sequence is reached and the nascent RNA is 
processed with the potential 3’ polyadenylation for its export from the nucleus.   
 
C-Terminal Domain (CTD) Phosphorylation 
The transcription cycle is highly coordinated to ensure faithful production and 
processing of the RNA molecule.  An important player in coordinating the steps of 
transcription is RNAPII itself, and in particular the C-terminal domain (CTD) (Fuchs et al. 
2009; Heidemann et al. 2013).  The CTD is unique in that it contains multiple copies (26 
in S. cerevisiae, 52 in H. sapiens) of a highly conserved heptapeptide repeat 
(YSPTSPS).  The CTD is thought to function in transcription by serving as a binding 
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platform for a multitude of proteins capable of facilitating distinct transcription-associated 
events (Hsin and Manley 2012).  Adding specificity to these binding events is the ability 
of the CTD repeats to be altered by modifications, which include phosphorylation of 
tyrosine 1, serine 2, threonine 4, serine 5 and serine 7 (Hsin and Manley 2012; 
Heidemann et al. 2013).  Interestingly, each modification is only found on the CTD when 
RNAPII is at a specified region of a gene.  For example, the CTD is phosphorylated at 
serine 5 when RNAPII is in the promoter and 5’ end of the gene, while serine 2 is 
phosphorylated when RNAPII is in the gene body (Figure 1.4).  Additionally several 
modifications can co-exist on the CTD as is the case for serine 5 and serine 2 
phosphorylation in the middle of genes.  The modifications are also dynamic and 
cyclical as evidenced by the fact that serine 5 of the CTD becomes dephosphorylated at 
the 3’ end of genes.   At the end of transcription all modifications are removed allowing 
RNAPII to restart the transcription cycle.   
This cycle of CTD modifications plays an important role in co-transcriptional 
processing and does so by recruiting proteins (Fuchs et al. 2009; Hsin and Manley 
2012).  It is now evident that a number of proteins are capable of binding the CTD and 
akin to histone binding proteins, recognize specific modification states.  Importantly, the 
CTD modification cycle must be carefully regulated to ensure proper control of gene 
expression.  Changes in the modification states can lead to defects in transcription 
length or frequency as well as improper processing that can have adverse effects for the 
cell as a whole.   
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The Polymerase-Associated Factor (PAF) Complex 
As described above, the CTD can serve as a binding site for numerous proteins.  
Some of the first proteins identified to associate with the CTD constitute a protein 
complex called the Polymerase-Associated Factor (PAF) complex (Shi et al. 1996; 
Wade et al. 1996; Jaehning 2010).  The PAF complex is a five subunit complex 
consisting of the namesake protein Paf1 as well as Cdc73, Ctr9, Leo1 and Rtf1.  Human 
PAF complex contains an additional subunit called Ski8 (Zhu et al. 2005).  Functionally, 
the PAF complex plays diverse roles during transcription, but mainly functions in 
promoting transcription elongation and 3’ end processing of select small RNAs 
(Jaehning 2010).  Accordingly, the complex appears to associate with RNAPII during 
initiation and continue throughout the 3’ ends of genes (Figure 1.4).  The PAF complex 
mediates its functions by serving as a platform for protein recruitment.  Interestingly, a 
number of these proteins are able to alter chromatin structure as described below.  The 
complex also stimulates phosphorylation of serine 2 of the RNAPII CTD, which may 
explain its role in mediating the later phases of transcription (Fuchs et al. 2012).  The 
role of the PAF complex in regulating chromatin is discussed further below.          
 
Chromatin and Transcription 
Chromatin plays a large role in transcription by regulating access to specific 
regions of the genome.  As described above, numerous mechanisms exist in the 
regulation of chromatin structure.  Discussed here are mechanisms of chromatin 
regulation during transcription with a particular emphasis on active transcription.   
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Chromatin Remodeling During Transcription 
Transcription does not take place on a “naked” DNA template, but in the context 
of a compacted chromatin environment.  Thus, chromatin acts as a significant physical 
barrier to the recruitment and binding of transcription factors as well as the passage of 
RNAPII.  In order for transcription to occur, the barrier must be overcome by remodeling 
the chromatin.  This process begins at promoter regions where DNA sequences 
required for transcription factor binding can be masked by the nucleosomes.  Through 
interplay of transcription factors and chromatin remodelers, the promoter sequence can 
be unmasked leading to the creation of a nucleosome free regions (NFR) and formation 
of a transcriptionally competent initiation complex.  One well-studied chromatin 
remodeler in this process, which may display gene-specific function, is the SWI/SNF 
complex (Yudkovsky et al. 1999; Clapier and Cairns 2009).   
Once RNAPII transitions into the elongation phase, a distinct set of activities 
comes into play to allow passage of RNAPII across the gene.  These activities include 
the coordinated removal and deposition of nucleosomes.  While RNAPII is capable of 
dislodging histones from DNA on its own, chromatin remodelers assist in this function.  
Several chromatin remodelers function in this context especially those of the SWI/SNF, 
ISWI and CHD families like the RSC complex and CHD1 (Clapier and Cairns 2009; 
Narlikar et al. 2013).  As described above the remodelers can play multiple roles 
including nucleosome sliding and eviction, although it is unclear how these activities are 
recruited to distinct loci to perform the specified function.  Histone modifications may 
play a role, as is the case for CHD1 and RSC (Figure 1.2A).  CHD1 in humans is able to 
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bind histone H3 methylated at lysine 4 and RSC is able to associate with H3 acetylated 
at lysine 14 (Kasten et al. 2004; Flanagan et al. 2005; Sims et al. 2005).  Other 
complexes, namely the PAF complex can also facilitate recruitment since the subunit 
Rtf1 can interact with CHD1 (Simic et al. 2003).     
While remodelers slide nucleosomes and regulate occupancy, mechanisms are 
also in place to ensure that histones are not lost from the gene bodies.  This is the 
function of histone chaperones.  Two important histone chaperones associated with 
transcription are the FACT complex and Spt6 (Hartzog et al. 1998; Orphanides et al. 
1999).  The FACT complex has been shown to bind all histones whereas Spt6 binds H3 
and H4.  As with CHD1, the PAF complex appears to play an important role in the 
recruitment of both chaperones (Squazzo et al. 2002; Dronamraju and Strahl 2014).     
Loss of histone chaperones and chromatin remodelers lead to altered DNA 
accessibility in gene bodies, which can negatively affect transcription.  Increased 
accessibility can increase the rate of DNA damage or recombination.  Additionally many 
genes contain sequences that mimic promoters called “cryptic” promoters.  The failure 
to restore nucleosome structure following the passage of RNAPII can expose these 
“cryptic” promoters and promote transcription (Cheung et al. 2008).  Some of these 
“cryptic” transcripts can be translated into protein, but the process of “cryptic” 
transcription itself can decrease the transcriptional efficiency of the upstream promoter 
by titrating away the transcription machinery.  Thus, regulation of chromatin architecture 
by remodelers and chaperones is important for maintaining the correct patterns of gene 
expression.               
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Histone Acetylation 
The activity and localization of chromatin remodelers and chaperones is highly 
regulated during transcription.  This regulation is mediated, in part, through histone 
PTMs.  Three types of modifications that have been most well defined in transcription 
are acetylation, methylation, and monoubiquitylation.  One of the first histone 
modifications linked to transcription is acetylation, which is found on a number of 
residues on each of the histones.  Generally histone acetylation is associated with 
active transcription (Kouzarides 2007; Bannister and Kouzarides 2011).  This is based 
on that fact that acetylation can neutralize the positive charge of lysine residues on 
histones to prevent DNA and internucleosomal interactions, thus promoting chromatin 
accessibility.  Acetylation also functions by recruiting proteins such as the general 
transcription factor TFIID and the RSC chromatin-remodeling complex - both of which 
have domains called bromodomains that are capable of binding acetylated lysine 
(Jacobson et al. 2000; Kasten et al. 2004) (Figure 1.3B).   
A number of histone acetyltransferases (HATs) function on chromatin.   The 
HATs show specificity for each of the core histones and can function either at promoters 
or in the gene body.  One of the most well studied HATs is Gcn5, which is capable of 
acetylating lysine residues on the H3 N-terminal tail (Kuo et al. 1996; Grant et al. 1997).  
Gcn5 exists as part of a complex called SAGA, which functions at promoters to facilitate 
chromatin remodeling and transcription initiation (Grant et al. 1997).  Opposing the 
activity of the HATs are the histone deacetylases (HDACs).  These enzymes remove 
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acetylation and play an important role in reducing chromatin accessibility.  
Paradoxically, HDACs can actually have a positive affect on transcription, by preventing 
the use of “cryptic” promoters, which as described above, can exist in gene bodies 
(Carrozza et al. 2005; Keogh et al. 2005; Li et al. 2009).  HDACs reduce the 
accessibility of “cryptic” promoters to increase transcription efficiency.  One such HDAC 
in budding yeast is Rpd3, which associates with RNAPII and histones during 
transcription elongation and suppress new transcription from “cryptic” promoters 
(Carrozza et al. 2005; Keogh et al. 2005; Li et al. 2009). 
 
Histone Methylation 
Another modification associated with transcription is histone methylation.  Unlike 
acetylation, which is mainly associated with active transcription, methylation can play 
positive or negative roles based on the residue being modified (Bannister and 
Kouzarides 2011; Black et al. 2012).  Active transcription is associated with methylation 
of lysine 4, 36 and 79 on histone H3, whereas repression involves methylation of lysine 
9 and 27 on histone H3 and lysine 20 on histone H4.  Arginine methylation is also 
associated with transcription, but interestingly, methylation of a single residue can play 
opposite roles in transcription depending on how it is methylated (symmetric or 
asymmetric) (Kouzarides 2007; Bannister and Kouzarides 2011).  Methylation functions 
during transcription, as described above by either recruitment or repulsion of proteins 
involved in transcriptional activation or repression (Kouzarides 2007; Bannister and 
Kouzarides 2011; Wozniak and Strahl 2014) (Figure 1.2).  While a number of 
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transcription-associated proteins have been identified to bind histone methylation, future 
work will be needed to uncover the full extent of reader proteins.  One novel reader 
protein is further explored in Appendix A.      
 
Histone H3 Lysine 4 Methylation 
One modification that has been well studied with regards to its function in 
chromatin recruitment is methylation of lysine 4 on histone H3 (H3K4me).  In budding 
yeast, where much work has been performed on elucidating the role of chromatin in 
transcription, a single SET domain-containing histone methyltransferase, Set1, 
mediates H3K4 methylation as part of the COMPASS complex.  In humans SET1A, 
SET1B and the mixed lineage leukemia proteins MLL1-4 perform the same function, 
albeit in an apparent context-dependent manner (Shilatifard 2012).   
Up to three methyl moieties can be added to a single lysine and it is thought that 
the number of moieties contributes to unique cellular function (Black et al. 2012).  
Trimethylation of H3K4 (H3K4me3) has been strongly linked to the process of 
transcription initiation and is most highly enriched at the nucleosome just downstream of 
the NFR centered at the TSS of actively transcribed genes (Strahl et al. 1999; Santos-
Rosa et al. 2002; Schubeler et al. 2004; Bernstein et al. 2005; Pokholok et al. 2005) 
(Figure 1.5).  Consistent with promoter localization, H3K4me3 requires S5ph of the CTD 
of RNAPII as well as the PAF complex (Ng et al. 2003b).  Interestingly, and in contrast 
to H3K4me3, monomethylation (H3K4me1) is a modification associated with enhancer 
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elements (Calo and Wysocka 2013) (Figure 1.5).  The role and regulation of this 
methylation state, however, has not been as fully investigated.   
Of all the histone modifications H3K4me has been most well studied in its ability 
to recruit proteins to chromatin.  For example, H3K4me3 can recruit proteins associated 
with RNAPII such as the general transcription factor TFIID (Vermeulen et al. 2007) 
(Figure 1.4B).  Interestingly a direct connection to RNAPII has not yet been explored 
and is the focus of the work in Appendix A.  It can also recruit accessory factors in 
transcription such as the chromatin remodeler CHD1 (Flanagan et al. 2005; Sims et al. 
2005).  Lastly, it can also recruit the complex that catalyzes H3K4me3, COMPASS, as a 
means to propagate the modification (Shi et al. 2007b; Milne et al. 2010; Eberl et al. 
2013) (Figure 1.2D).  At the same time H3K4 methylation can promoter active chromatin 
by preventing the binding of repressive proteins like BHC80 (a member of the LSD1 
H3K4 demethylase complex) and the DNA methyltransferase DNMT3A/B (Lan et al. 
2007; Ooi et al. 2007; Zhang et al. 2010) (Figure 1.2B).   
 
Histone H3 Lysine 36 Methylation  
As opposed to H3K4 methylation, methylation of lysine 36 of histone H3 (H3K36) 
is prevalent in gene bodies (Pokholok et al. 2005; Rao et al. 2005) (Figure 1.5).  In 
budding yeast, a single histone methyltransferase, Set2, catalyzes all three methylation 
states (Strahl et al. 2002; Wagner and Carpenter 2012).  In metazoans, several 
enzymes can methylate H3K36 including, but not limited to NSD1-3 and SETD2.  As 
with H3K4 methylation, H3K36 methylation requires the PAF complex, but given its 
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presence in gene bodies, is dependent on serine 2 phosphorylation of the RNAPII CTD 
(Li et al. 2003; Kizer et al. 2005; Nordick et al. 2008).   
The predominant function of H3K36 methylation is preventing “cryptic” 
transcription.  This occurs mainly by recruiting the Rpd3 HDAC complex described 
above.  At the same time H3K36 methylation can recruit an ISWI-family chromatin 
remodeling complex (Isw1b) as well as restrict histone turnover by preventing the 
binding of the histone chaperone Asf1 (Maltby et al. 2012; Smolle et al. 2012).  These 
activities combined help maintain a relatively closed chromatin environment in gene 
bodies to increase overall transcriptional efficiency.  It is important to note, however, that 
H3K36 methylation can also recruit the HATs NuA3 in yeast and MOF in complex 
organisms, suggesting that the role of H3K36 methylation in transcription is multifaceted 
(Shi et al. 2007b; Vezzoli et al. 2010).    
 
Histone H3 Lysine 79 Methylation  
Like H3K36 methylation, methylation of lysine 79 of histone H3 (H3K79) is also 
found in gene bodies, but its function is less well-defined (Figure 1.5).  This modification 
is catalyzed by one enzyme called Dot1 in budding yeast and Dot1L in metazoans 
(Feng et al. 2002; Lacoste et al. 2002; Ng et al. 2002a; van Leeuwen et al. 2002).  
Displaying further similarity to H3K4 and H3K36 methylation, H3K79 methylation 
requires the PAF complex, but a direct connection with RNAPII has not been fully 
determined (Krogan et al. 2003a).  Functionally, H3K79 methylation appears to play a 
primary role in preventing the binding of repressive proteins that would otherwise 
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negatively regulate transcription.  The primary protein complex involved is the Silent 
Information Regulator (SIR) complex, which contains the HDAC Sir2 (Norris and Boeke 
2010).  Sir2 deacetylates lysine 16 of histone H4 (H4K16ac) and this is an important 
step in chromatin compaction and heterochromatin compaction.  The Sir3 subunit of the 
SIR complex is not able to bind nucleosomes when H3K79 is methylated (Altaf et al. 
2007; Onishi et al. 2007).  Loss of H3K79 methylation in euchromatin regions leads to 
the spreading of silencing proteins into active gene regions leading to repression (Ng et 
al. 2002a; van Leeuwen et al. 2002).  Conversely, increased H3K79 methylation 
reduces heterochromatin formation.  To date, no protein has been identified to 
recognize and bind methylated H3K79.     
 
Histone Monoubiquitylation 
As opposed to small chemical modifications such as acetylation and methylation, 
histones can also be modified by the covalent addition of proteins (Komander and Rape 
2012).  The primary protein that can be attached to histones is ubiquitin, which is an 8.5 
kDa protein that plays an important role in numerous cellular processes both in the 
nucleus and the cytosol.  Ubiquitin is added to lysine residues via an isopeptide linkage, 
which links the C-terminal glycine residue to the epsilon amino group of the target 
lysine.  This process is mediated by the concerted effort of three enzyme classes called 
ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2) and ubiquitin 
ligases (E3).  Ubiquitin is activated for conjugation in an ATP-dependent manner by the 
E1 and then transferred to the active site of the E2.  Then, in conjunction with the E3, 
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ubiquitin is transferred to the substrate.  Interestingly the diversity of proteins involved 
increases with each step.  Accordingly, less than ten E1 enzymes exist, whereas 
hundreds of E3 enzymes have been identified.  This observation is likely due to the fact 
that the E3 provides substrate specificity.  Lastly, multiple E3 enzymes can associate 
with each E2, thus increasing the utility of E2 enzymes.   
Since ubiquitin itself also contains lysine residues, chains of ubiquitin can be 
formed (polyubiquitylation) (Komander and Rape 2012).  Certain types of polyubiquitin 
chains can direct the modified proteins to degradation via the proteasome.  In contrast 
to polyubiquitylation, histones are typically modified with one ubiquitin molecule 
(monoubiquitylation) and this is thought to serve as signaling molecule in chromatin 
(Weake and Workman 2008; Chandrasekharan et al. 2010b).  Monoubiquitylation of 
histones is thought to function by two means.  The first is that given its size relative to 
the histones, it may directly impinge on chromatin structure by altering the ability of 
chromatin to compact.  The second function is similar to that of other histone 
modifications in that it can act to recruit proteins to chromatin.  Two primary sites of 
histone monoubiquitylation exist on the C-terminal tails of histone H2A and histone H2B 
(Weake and Workman 2008).  Interestingly, modification of these two sites have 
opposite effects on transcription with H2A monoubiquitylation generally playing a 
repressive role and H2B monoubiquitylation playing a role in activation.   
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Histone H2B Monoubiquitylation 
Monoubiquitylation of histone H2B occurs on lysine 123 (H2BK123ub1) in 
budding yeast, and is a highly conserved modification (Robzyk et al. 2000).  The 
modification is catalyzed in yeast by the concerted effort of the E2 ubiquitin-conjugating 
enzyme Rad6 and the E3 ubiquitin ligase Bre1 (Robzyk et al. 2000; Hwang et al. 2003; 
Wood et al. 2003a).  H2BK123ub1 is also a very dynamic histone modification and this 
is due, in part, to the presence of deubiquitylating enzymes that can cleave the 
modification from histones.  In yeast, these enzymes are Ubp8 and Ubp10 (Henry et al. 
2003; Emre et al. 2005).  As described above, monoubiquitylation of H2B is associated 
with active transcription and is predominantly found in gene bodies, but may exist 
transiently at promoters (Henry et al. 2003; Kao et al. 2004; Xiao et al. 2005; Pavri et al. 
2006; Fleming et al. 2008; Chandrasekharan et al. 2009; Chandrasekharan et al. 
2010b) (Figure 1.5).  Accordingly, and consistent with active histone methylation, 
H2BK123ub1 is dependent on the PAF complex (specifically the Rtf1 subunit) and 
serine 5 phosphorylation of the RNAPII CTD (Ng et al. 2003a; Wood et al. 2003b; Xiao 
et al. 2005).  
H2BK123ub1 is thought to function by multiple mechanisms in transcription.  One 
mechanism ubiquitin may function in chromatin is by altering chromatin structure.  
H2BK123ub1 does appear to affect chromatin architecture, but the ultimate affect has 
not been fully resolved.  First, in vitro studies have shown that H2BK123ub1 hinders 
chromatin compaction to maintain an open chromatin environment (Fierz et al. 2011).  
At the same time it has also been suggested to increase nucleosome stability (Fleming 
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et al. 2008; Chandrasekharan et al. 2009).  The latter effect may be due to the interplay 
between H2BK123ub1 and the histone chaperone complex FACT.    
H2BK123ub1 also facilitates the function of other proteins involved in 
transcription.  For example, H2BK123ub1 has been shown to increase the recruitment 
of the chromatin remodeler SWI/SNF and, as stated above, the FACT complex (Fleming 
et al. 2008; Shema-Yaacoby et al. 2013).  H2BK123ub1 has also been implicated in a 
unique phenomenon of ‘cross-talk’ called trans-histone regulation whereby one histone 
modification can stimulate the modification of another histone (Bannister and 
Kouzarides 2011).  Ubiquitylation of histone H2B stimulates methylation of both lysine 4 
and lysine 79 on histone H3 (Briggs et al. 2002; Dover et al. 2002; Ng et al. 2002b; Sun 
and Allis 2002).  The mechanisms of this trans-histone regulation, however, have not 
been fully determined.  Moreover the extent of trans-histone regulation in chromatin is 
not entirely known.     
Similarly to H3K79 methylation, H2BK123ub1 is a carefully regulated modification 
and can impinge on the spreading of heterochromatic modifications into euchromatin 
regions.  Therefore, too much or too little H2BK123ub1 can have adverse affects for the 
cell (Briggs et al. 2002; Emre et al. 2005).  To avoid this, the cell carefully regulates the 
levels of H2BK123ub1, in part and as stated above, by the opposing activities of the 
ubiquitylating and deubiquitylating enzymes.  In agreement, both activities are found to 
overlap across the genome (Schulze et al. 2011).  In order for productive H2BK123ub1 
to occur, however, the equilibrium needs to shift in a particular direction.  Understanding 
how this occurs would provide important insight for the regulation of H2BK123ub1 
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genome-wide and how this balance is maintained or altered during changing cellular 
conditions or in disease. 
 
Description of Work Included in Dissertation 
Work over the past decades has demonstrated the existence and functional 
significance of histone modifications.  Furthermore, it is clear that aberrant histone 
modification can trigger defects in chromatin structure and function and lead to disease 
such as cancer (Sharma et al. 2010; Bannister and Kouzarides 2011).  Thus, histone 
modifications must be carefully regulated.  The work in this dissertation focuses on one 
particular histone modification, monoubiquitylation of histone H2B (H2BK123ub1).  This 
modification is of interest due its diverse functions in chromatin and the fact that it is 
both dynamically and carefully regulated.  Moreover, it has been demonstrated that H2B 
ubiquitylation is altered in the context of disease (Shema et al. 2008; Blank et al. 2012; 
Chernikova et al. 2012; Wang et al. 2013).  Interestingly, both the loss of gain of the 
modification genome-wide can contribute to disease.  To better understand this 
modification, I initially focused on identifying novel regulators of this histone 
modification, which is discussed in Chapter 2.  Then in an effort to understand the 
dynamics of histone H2B ubiquitylation, I identified a unique mechanism that keeps the 
modification in check.  This work, which is presented in Chapter 3, also demonstrates a 
functional role for H2B ubiquitylation in transcription.  As described above H2B 
ubiquitylation can partly function in transcription by regulating histone methylation.  In 
Appendix A I present evidence connecting this downstream methylation directly to 
RNAPII and thus further make a connection between H2B ubiquitylation and 
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transcription. Finally, the work from these studies is put into the larger context of 
chromatin regulation in Chapter 4.  Overall, the studies presented here provide new 




        
  







Figure 1.1 Components of Chromatin Regulation 
 
Numerous proteins and complexes play a role in regulating chromatin structure and 
function.  Transcription factors (light purple) associated with RNA Polymerase II 
(RNAPII) and DNA (black) can also recruit histone modifiers (red) such as 
methyltransferases and ubiquitin ligases to chemically modify histones (blue).  Histone 
modifications (orange) can either directly alter chromatin structure or recruit proteins 
with so-called reader domains (green) that recognize the modification.  Many types of 
chromatin-associated proteins contain reader domains including chromatin remodeler 
proteins (green) that can deposit, remove or slide nucleosomes.  Working in concert 
with the chromatin remodelers are histone chaperones (gray) that bind free histones 
and/or facilitate the incorporation of histone variants (light blue).  In addition to histone 
modifications, DNA can be methylated (white circles), which also impinges on chromatin 


















Figure 1.2 Types of Histone Modification Binding 
 
Histone modifications regulate the association of proteins and protein complexes with 
chromatin.  (A) Modifications can recruit proteins that can directly remodel chromatin or 
(B) repel the binding of proteins.  (C) Histone modifying enzymes that add or remove 
histone modifications can also be recruited by other modifications.  (D) Histone 
modifying enzymes can bind the modification that they catalyze as a potential 

















Figure 1.3 Multivalent Chromatin Binding 
 
Shown are examples of an individual protein (A) or protein complex (B) that can 
simultaneously recognize histones and DNA.  Both histones and DNA can be modified 
thus establishing a “code” that dictates protein binding across the genome.   





















Figure 1.4 The Transcription Cycle 
 
Transcription by RNA Polymerase II (RNAPII) proceeds in a cyclical fashion.  RNAPII 
associates with factors such as the Polymerase Associated Factor (PAF) complex 
throughout the cycle to facilitate multiple steps.  RNAPII is also modified on its repetitive 
C-terminal domain (CTD) with different modifications coinciding with distinct steps.  
Shown are the patterns of serine 2 and serine 5 phosphorylation on the CTD repeat.  
Pausing after initiation is an important step in metazoan transcription and is regulated by 
the opposing functions of the negative elongation factor (NELF) complex and the 


























Figure 1.5 Patterns of Transcription-Associated Histone Modifications 
 
Histone modifications exist in distinct patterns in and around actively transcribed genes. 
Shown is a representative model of a gene region with corresponding enrichment of 
selected modifications. Modification enrichment reflects patterns observed in mammals. 
The +1 nucleosome is displayed in red at the transcription start site (arrow), which is 
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CHAPTER 2 IDENTIFICATION OF THE HISTONE H2A REPRESSION DOMAIN 
AS A REGULATOR OF H2B UBIQUITYLATION AND TRANSCRIPTION 
ELONGATION IN YEAST2 
 
Overview 
Histone ‘cross-talk’ represents a fundamental mechanism by which histone post-
translational modifications (PTMs) regulate the structure and function of chromatin.  
Here we show in the budding yeast Saccharomyces cerevisiae that a H2A N-terminal 
region referred to as the H2A repression (HAR) domain is important for trimethylation of 
H3K79 (H3K79me3).  Consistent with a recently published report, we also find that the 
HAR domain regulates monoubiquitylation of H2BK123 (H2BK123ub1) which, as we 
show for H3K79me3, is a regulatory pathway observed across multiple genetic 
backgrounds.  In contrast, we found that the regulation of H3K4 trimethylation by the 
HAR domain is context dependent regarding genetic background.  We further show that 
the HAR domain promotes H3K79me3 by maintaining wild-type levels of H2BK123ub1, 
but this mechanism is independent of recruitment of the H2B ubiquitylation machinery to 
chromatin.  Finally, we provide genetic evidence that the HAR domain contributes to 
telomeric silencing and the process of transcription elongation – consistent with the 
established role of H2BK123ub1 in these processes.  In sum, these data highlight a 
                                            
2 Portions of this chapter were adapted from Wozniak GG, Strahl BD. 2014. Catalysis-
dependent stabilization of Bre1 fine-tunes histone H2B ubiquitylation to regulate gene 
transcription. Genes Dev. 28:1647-1652 
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‘cross-talk’ pathway involving the H2A tail that governs H2B ubiquitylation and H3 
methylation in the process of transcriptional regulation.     
 
Introduction 
Histone post-translational modifications (PTMs) play an important role in the 
regulation of chromatin structure and function, and occur primarily on the unstructured 
N- and C-terminal tails of the histones (Kouzarides 2007; Zentner and Henikoff 2013).  
A wide number of histone PTMs exists, and they include acetylation, methylation, 
phosphorylation and ubiquitylation.  Histone PTMs can alter chromatin structure, at least 
in part, through the recruitment or occlusion of effector proteins that can carry out 
chromatin remodeling or further modification (Kouzarides 2007; Zentner and Henikoff 
2013).  On the histone tails, PTMs further exist in unique combinations, which add a fine 
level of control in the coordination of DNA-templated processes including transcription, 
replication and DNA repair (Strahl and Allis 2000; Kouzarides 2007).  
 Due to their importance for chromatin structure and function, histone PTMs are 
highly regulated.  Regulation of histone modifications has been observed at both the 
level of the modifying enzymes and that of the histones themselves.  The modifying 
enzymes can be regulated through their association with protein complexes that 
mediate recruitment to chromatin or by PTMs that can activate or inhibit enzymatic 
activity (Smith and Shilatifard 2010; Black et al. 2012).  At the histone level, PTMs can 
regulate one another both in cis and trans (Kouzarides 2007).  The first and well-
characterized example of a trans-histone pathway involves the directed regulation of 
methylation at lysines 4 and 79 on histone H3 (H3K4 and H3K79) by monoubiquitylation 
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of histone H2B at lysine 123 (H2BK123ub1) (Briggs et al. 2002; Dover et al. 2002; Ng et 
al. 2002b; Sun and Allis 2002; Nakanishi et al. 2009).  While the mechanism of how this 
occurs is still under investigation, it is known that this regulatory pathway is important for 
transcription (both at the levels of initiation and elongation) as well as DNA repair and 
replication (Henry et al. 2003; Kao et al. 2004; Xiao et al. 2005; Game et al. 2006; Pavri 
et al. 2006; Fleming et al. 2008; Chandrasekharan et al. 2010b; Schulze et al. 2011; 
Trujillo and Osley 2012). 
 Despite a wealth of studies investigating the prevalence and functional 
importance of histone PTMs, a thorough investigation to examine the extent to which 
the histone tails participate in trans-histone regulation of other histone PTMs remains to 
be performed.  Moreover, it remains to be determined what the functional significance of 
trans-histone regulation may be.  In the current study, we systematically examined the 
role of the individual histone N-terminal tails in trans-histone regulation of histone 
methylation and ubiquitylation.  We found that the N-terminal tail of histone H2A, 
specifically a region in the H2A tail known as the HAR domain, acts as a trans-histone 
regulator of H3K79 methylation and H2BK123ub1.  Our results with the regulation of 
H2BK123ub1 are consistent with a recently published report (Zheng et al. 2010); 
however, we find that the reported regulation of H3K4 methylation is yeast strain 
specific.  We also find that the HAR domain regulates H3K79 methylation through 
H2BK123ub1, but does not regulate the recruitment of the ubiquitylation machinery to 
chromatin.  Lastly, we show the functional importance of this regulation by establishing 
a role of the HAR domain in the process of transcription elongation.              
  38 
 
Materials and Methods  
Yeast Strains and Plasmids   
The strains used in this study are listed in Table 2.1.  Strains with wild-type (WT) 
or N-terminal tail truncations of histones (Figure 2.1) were obtained from C.D. Allis and 
have been described previously (Ahn et al. 2005).  W303-derived WT and truncated 
H2A strains (Figure 2.2A) were obtained from M. Parra and have been described 
previously (Parra et al. 2006; Parra and Wyrick 2007).  WT and mutant histone plasmids 
were introduced into FY406 and derivatives (Figure 2.2B, 2.4 and 2.5C, obtained from 
F. Winston (Hirschhorn et al. 1995)) using standard transformation and shuffling 
protocols.  YZS276-derived strains (Figure 2.3, obtained from Z.W. Sun (Sun and Allis 
2002; Chandrasekharan et al. 2009)) were generated by transforming YZS276 and 
YZS606 with pSAB6 (CEN URA3 HTA1-HTB1, obtained from F. Winston (Hirschhorn et 
al. 1995)) followed by two rounds of selection on synthetic media lacking uracil to 
promote loss of the HIS3-containing plasmid pZS145.  The newly created histone 
shuffle strains (YGW063 and YGW066) were then transformed with pZS145 (obtained 
from Z.W. Sun (Sun and Allis 2002)) and mutant derivatives and shuffled as described 
above.  Strains to assess telomeric silencing defects (Figure 2.5) were obtained from 
Z.W. Sun and have been described previously (Sun and Allis 2002).   
Gene disruptions were performed using high efficiency transformation of a PCR 
product amplified from either genomic DNA of the gene of interest, which had already 
been replaced by KanMx (Open Biosystems) or from the NatNT2 plasmid pFA6a-
natNT2.  Endogenous tagging of Rad6 with triple hemagglutinin (3HA) was performed 
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using plasmids and procedures previously described (Janke et al. 2004).  Gene 
disruption and tagging were verified by both PCR and immunoblotting. 
The plasmids pZS145 (CEN HIS3 HTA1-Flag-HTB1) and pZS146 (CEN HIS3 
HTA1-Flag-htb1-K123R) were obtained from Z.W. Sun (Sun and Allis 2002).  The 
plasmids pEG101 (CEN HIS3 hta1 ∆1-20 Flag-HTB1), pEG102 (CEN HIS3 hta1 ∆1-16 
Flag-HTB1) and pEG103 (CEN HIS3 hta1 ∆16-20 Flag-HTB1) were derived from 
pZS145 using the QuikChange II Site-Directed Mutagenesis kit (Agilent).  All mutant 
plasmids were verified by DNA sequencing. 
 
Yeast Whole Cell Extracts and Western Blot Analysis   
Yeast were grown in rich media  (YPD) at 30˚C from a starting OD600 or 0.25 to 
mid-log phase (OD600 ~1.0).  Five OD600 units were collected by centrifugation and used 
for preparation of whole cell extracts as previously described (Fuchs et al. 2012).  For 
western blot analysis 5-10 µl of whole cell extract was separated by 15% SDS-PAGE.  
Gels were transferred to PVDF using a semi-dry apparatus (Hoefer) for 90 minutes at 
45 mA and dried in methanol.  Dried membranes were then rehydrated in methanol, 
washed briefly with TBS with 0.1% Tween-20 (TBST) and incubated for 30 minutes with 
gentle shaking in TBST containing 5% non-fat dry milk.  Primary antibodies were diluted 
in TBST containing 2.5% non-fat dry milk and incubated overnight at 4˚C.  Western blots 
were visualized using HRP-conjugated antibodies and ECL Plus chemiluminescence 
(GE Healthcare).   
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 The following primary antibodies and dilutions were used: H3K79me3 (Abcam, 
ab2651) 1:2500, H3K79m2 (Active Motif, 39143) 1:2500, H3K79me1 (Active Motif, 
39145) 1:2000, H3K4me3 (Active Motif, 39159) 1:2000, H3K4me2 (Millipore, 07-030) 
1:2500, H3K4me1 (Millipore, 07-436) 1:1000, H3K36me3 (Abcam, ab9050) 1:1000, 
H3K36me2 (Active Motif, 39255) 1:1000, H3K36me1 (Abcam, ab9048) 1:1000, 
H2BK123ub1 (Cell Signaling Technology, 5546) 1:2000, H2A (Active Motif, 39235) 
1:5000, H2B (Active Motif, 39237) 1:2500, H4 (Millipore, 05-858) 1:1000, H3 
(EpiCypher, 13-0001; 1:1000) 1:2000, HA (Covance, MMS-101R) 1:1000, G6PDH 
(Sigma, A9521) 1:100,000. 
 
Yeast Chromatin Fractionation   
Chromatin fractionation was performed using a combination of previously 
described methods (Donovan et al. 1997; Keogh et al. 2006).  Cells were grown in YPD 
from a starting OD600 of 0.25 to mid log phase (OD600 ~1.0).  Forty OD600 units of cells 
were harvested by centrifugation, resuspended in 10 ml of sterile water.  Following 
another round of centrifugation, cells were resuspended in 10 ml SB buffer (1 M 
Sorbitol, 20 mM Tris pH 7.4) then collected by centrifugation.  The buffer was then 
aspirated and cell pellets were stored at -80˚C overnight.  The cell pellets were then 
thawed on ice, resuspended in 1.5 ml PSB buffer (20 mM Tris pH 7.4, 2 mM EDTA, 100 
mM NaCl, 10 mM 2-mercaptoethanol) and transferred to a 2 ml microcentrifuge tube.  
Cells were allowed to mix for 10 minutes at room temperature on a rotating shaker.  The 
cells were then pelleted by a flash spin in a microcentrifuge and the buffer was 
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aspirated.  Cell pellets were then washed briefly in 1.5 ml SB buffer then quickly 
centrifuged as in the previous step.  The cell pellet was then resuspended completely in 
1 ml SB buffer followed by the addition of 125 µl of 10 mg/ml Zymolyase 20T 
(Seikagaku Biobusiness) prepared fresh in SB buffer.  Tubes were then allowed to mix 
at room temperature for 30-60 minutes on a rotating shaker.  Spheroplasting progress 
was assessed by addition of 10 µl of cells to 1 ml 1% SDS and vortexing followed by 
measuring the OD600 of the liquid.  Once OD600 measurement decreased by more than 
80% the starting value, spheroplasting was stopped by the addition of ice-cold SB 
buffer.  Spheroplasts were pelleted at 2000 rpm for 5 minutes at 4˚C in a chilled 
microcentrifuge.  The buffer was removed and the pellet was gently resuspended in 1 ml 
LB buffer (0.4 M Sorbitol, 150 mM potassium acetate, 2 mM magnesium acetate, 20 
mM PIPES-KOH pH 6.8, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml aprotinin, 1 mM 
PMSF) and pelleted as in the previous step.  The LB buffer wash step was repeated 
once more.  To lyse the cells, the pellet was then gently resuspended in 250 µl LB buffer 
with 1% Triton X-100, transferred to a 1.5 ml microcentrifuge tube and allowed to sit on 
ice for 10 minutes with occasional gentle mixing.  Following lysis, 125 µl was removed 
for the whole cell extract (WCE) and the remainder was centrifuged at 5000 xg for 15 
minutes at 4˚C.  The supernatant was collected as the “soluble” fraction.  The 
“chromatin” pellet was then washed once by resuspension in 125 µl of LB buffer with 
1% Triton X-100 and spun as in the previous step.  The supernatant was then discarded 
and the “chromatin” pellet was resuspended in 125 µl of LB buffer with 1% Triton X-100.  
All samples were normalized to total protein content of whole cell extract as determined 
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using Bradford reagent (Bio-Rad).  Normalized whole cell extract and volume 
equivalents of “soluble” and “chromatin” fractions were boiled in 1x SDS loading buffer, 
separated by 15% SDS-PAGE and analyzed by standard immunoblot procedures.  
 
Phenotypic Spotting Assays   
Five-fold serial dilutions of saturated overnight yeast cultures were plated on YPD 
or synthetic complete dropout media with or without indicated drugs.  Cells were plated 
at a starting OD600 of 0.5 on appropriate media and imaged after 2-4 days of growth at 
30˚ C.  For growth on 6-azauracil, drug was used at a final concentration of 200 µg/ml.  
 
Results 
The Histone H2A N-terminal Tail Regulates H3K79 Methylation and H2BK123 
Ubiquitylation.   
The N-terminal tail domains of histones play important roles in chromatin 
structure and function, which is regulated, in part, through trans-tail regulation of histone 
modifications (Kouzarides 2007).  One well-characterized example is the regulation of 
H3K4me and H3K79me by H2BK123ub1.  Additional examples include the regulation of 
H3K36 methylation (H3K36me) by surface core residues in H2A and H4, and the 
regulation of H3K79me by the basic patch found in the H4 N-terminal domain (Altaf et 
al. 2007; Fingerman et al. 2007; Du and Briggs 2010). Given these observations, we 
asked whether other trans-tail regulatory pathways might also exist, and whether they 
might have important roles in chromatin function. To explore this possibility, we 
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screened yeast strains containing or lacking the N-terminal tail domains from H3, H4, 
H2A and H2B for their histone methylation and H2B ubiquitylation status.   
We first set out to recapitulate several recent trans-tail findings in regards to the 
loss of the H4, H3 and H2A N-terminal tails.  In agreement with previous reports (Altaf et 
al. 2007; Fingerman et al. 2007), we found that loss of the H4 tail domain resulted in a 
complete abolishment of H3K79 methylation (Figure 2.1).  In contrast, however, we 
were unable to observe the reported loss of H3K4me3 in the absence of the H2A tail, as 
was recently reported (Zheng et al. 2010).  Interestingly, our studies have uncovered a 
basis for this discrepancy (see below).   Furthermore, we were also unable to observe 
significant decreases in H3K36 methylation in the loss of the H3 tail domain, as was 
reported (Psathas et al. 2009).     
In addition to confirming the role of the H4 tail in regulating H3K79 methylation, 
we found H3K79 methylation to be regulated further by other histone tails.  Surprisingly, 
we found that loss of the H2A tail had decreased levels of H3K79me3 and increased 
H3K79me2 and H3K79me1 (Figure 2.1).  Loss of the H3 tail had the opposite affect 
showing increased levels of H3K79me3 with a corresponding decrease in both 
H3K79me2 and H3K79me1.   Given the role of H2BK123ub1 in regulating H3K79 
methylation, we also screened the strains for this modification.  We found that loss of 
the H2A tail resulted in decreased H2BK123ub1, consistent with a recently published 
report (Zheng et al. 2010).  Taken together, our results reveal the H2A tail as a regulator 
of H3K79 methylation and H2BK123ub1.   
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The HAR Domain of H2A Regulates H3K79 Methylation and H2BK123 
Ubiquitylation Independent of Genetic Background.   
Given our finding that the H2A tail regulates H3K79 methylation and 
H2BK123ub1, we next wanted to determine which residues of the H2A tail are involved.  
We addressed this question using yeast strains harboring truncated versions of H2A.  
As shown in Figure 2.2A, loss of the entire N-terminal tail resulted in decreased 
H3K79me3 and H2BK123ub1 whereas loss of residues 4-16 had WT levels.  In 
contrast, truncations lacking residues 16-20, a region of histone H2A known as the H2A 
repression (HAR) domain (Parra and Wyrick 2007), closely mimicked the methylation 
and ubiquitylation decrease observed in the absence of the entire tail, suggesting that 
the HAR domain is important for regulating both H3K79 methylation and H2BK123 
ubiquitylation.  We also validated these findings in another strain background and found 
similar results (Figure 2.2B).  The results confirm that the HAR domain of histone H2A 
regulate H3K79 methylation and H2BK123 ubiquitylation in a manner that is 
independent of strain background. 
 
The Regulation of H3K4me3 by Histone H2A is Dependent on Genetic Background.   
The unique opportunity to examine multiple H2A truncation strains and 
backgrounds to identify the region responsible for affecting H3K79me also allowed us to 
further examine the discrepancy between our observations and those of others 
pertaining to the proposed role of the HAR domain in regulating H3K4me3.  As 
mentioned, a recent report suggested that HAR domain regulates H3K4me3 (Zheng et 
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al. 2010), which is in contrast to the results from our screen (Figure 2.1).  Using the 
originally published strains of that study, we were indeed able to recapitulate the 
previously reported findings (Figure 2.2A).  We then independently addressed this 
questions in a third strain background and found that, as we observed in our screen, 
H3K4me3 was not affected by loss of the HAR domain (Figure 2.2B).  Taken together, 
these results indicate that regulation of H3K4me3 by the HAR domain is not universal 
as is the regulation of H3K79me3, but instead dependent on the strain background.      
 
The HAR Domain Promotes H3K79 Methylation Through Maintenance of H2BK123 
Ubiquitylation.   
Given the fact that H2BK123ub1 regulates H3K79 methylation in a trans-tail 
manner, we next asked whether the regulation of H3K79me3 by the HAR domain was 
dependent on the regulation of H2BK123ub1.  In support of this possibility, analysis of 
the crystal structure of the nucleosome revealed that the HAR domain is located next to 
H2BK123 (Figure 2.3A).  To address this question we hypothesized that increasing the 
amount of H2BK123ub1 in the HAR domain mutant strain would rescue the decrease in 
H3K79me3.  We answered this question by introducing the HAR domain deletion into 
strains with or without the H2BK123-specific deubiquitylases Ubp8 and Ubp10.  As 
reported previously, we found that the combined loss of Ubp8 and Ubp10 resulted in a 
dramatic increase in the amount of both H2BK123ub1 and H3K79me3 in cells (Figure 
2.3B) (Gardner et al. 2005).  In the absence of the HAR domain, we also observed a 
dramatic increase in both H2BK123ub1 and H3K79me3, albeit less than what is 
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observed in the strain with WT H2A. These data indicate that the ability of the HAR 
domain to regulate H3K79me3 likely occurs through H2BK123ub1.  Moreover, the HAR 
domain is likely involved in the catalysis of H2BK123ub1. 
 
Loss of the HAR Domain Does Not Alter Recruitment of the Histone Ubiquitylation 
Machinery to Chromatin.   
The observation that loss of the H2BK123 deubiquitylating enzymes could not 
fully rescue the levels of H2BK123ub1 in the absence of the HAR domain (Figure 2.3B) 
suggested a problem with the ability to ubiquitylate histones.  One question we next 
addressed is whether the histone ubiquitin ligase machinery consisting of Rad6 and 
Bre1 was still recruited to chromatin globally in the absence of the HAR domain.  To 
address this question, we used a technique to fractionate cells into an insoluble 
chromatin-containing fraction and a soluble non-chromatin associated fraction, which 
has been used previously to assess association of factors with chromatin (Donovan et 
al. 1997; Keogh et al. 2006).  Using an endogenously epitope tagged Rad6, we 
measured the chromatin association of the ubiquitylation machinery in either the 
presence or absence of the HAR domain.  As opposed to loss of Bre1, which is required 
for Rad6 to associate with chromatin (Wood et al. 2003a; Kao et al. 2004), loss of the 
HAR domain did not affect the chromatin association of Rad6 (Figure 2.4).  These 
results are consistent with previous results showing that the HAR domain was not 
required for Rad6 association with the GAL locus (Zheng et al. 2010).  We conclude that 
the HAR domain is not required for the global association of the histone ubiquitylation 
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machinery with chromatin, but instead is likely important for catalysis of the 
ubiquitylation reaction.   
 
The HAR Domain is Important for Telomeric Silencing and is linked with 
Transcription Elongation.   
H2BK123ub1 has been implicated in numerous chromatin related processes 
including telomeric gene silencing and transcription elongation (Sun and Allis 2002; Xiao 
et al. 2005; Pavri et al. 2006; Fleming et al. 2008; Schulze et al. 2011).  Since the HAR 
domain regulates H2BK123ub1, we hypothesized that it also plays a role in both 
telomeric silencing and transcription elongation.  To determine if the HAR domain plays 
a role in telomeric silencing we made use of a common reporter strain containing the 
URA3 gene integrated in the subtelomeric region of the left arm of chromosome VII (Sun 
and Allis 2002).  We introduced different H2A tail truncations into this strain and plated 
cells on media containing 5-fluoroorotic acid (5-FOA) to measure phenotypes (Figure 
2.5A).  Serving as a control, loss of the silencing protein Sir2, which is vital for telomeric 
silencing results in a severe growth defect on 5-FOA.  Compared to WT, we found that 
deletion of the entire H2A tail or just the HAR domain, but not residues 1-16 resulted in 
a growth defect on 5-FOA indicating an inability to silence the reporter gene (Figure 
2.5A). 
 Loss of H2BK123ub1 also results in sensitivity to the drug 6-azauracil (Xiao et al. 
2005), which has been used previously to study proteins involved in the transcription 
elongation process.  Using the H2A tail truncation strains, we also find that loss of the 
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HAR domain, but not residues 1-16 results in sensitivity to 6-azauracil (Figure 2.5B).  
The observed sensitivity of the HAR domain deletion is not as strong as observed for 
loss of H2BK123ub1 consistent with the reduced levels, but not complete loss of 
H2BK123ub1 in HAR domain deletions.  To further determine if the HAR domain plays a 
role in transcription elongation we assayed for genetic interactions between the HAR 
domain and several factors known to be involved in elongation.  We focused on three 
proteins previously identified to genetically interact with H2BK123ub1: Rbp9, Elp3 and 
Spt4 (Xiao et al. 2005).  As reported and recapitulated here, we found that loss of 
H2BK123ub1 using a lysine to arginine point mutation results in synthetic sickness with 
the genes encoding Rbp9, Elp3 and Spt4 (Figure 2.5C).  Consistent with the ability of 
the HAR domain to regulate H2BK123ub1 we find that the loss of the HAR domain 
displays synthetic sickness when combined with either loss of Elp3 or Spt4.  
Surprisingly, and in contrast to the loss of H2BK123ub1, we found that loss of the HAR 
domain was able to dramatically rescue the growth defect observed for strains lacking 
Rpb9.  The results from our genetic analyses suggest that similar to H2BK123ub1, the 
HAR domain plays a role in telomeric silencing and transcription elongation – a result 
that is likely manifested at the level of the HAR domain to regulate H2BK12ub1 and 
H3K79me3 in a trans-tail fashion.  
 
Discussion 
In the present study we uncover a role for the HAR domain of histone H2A in 
regulating both H3K79me3 and H2BK123ub1.  We find that this regulation occurs 
across multiple strain backgrounds, and that there is strain background dependence for 
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the regulation of H3K4me3.  We also show that the regulation of H3K79me3 by the HAR 
domain occurs through regulation of H2BK123ub1, but that the HAR domain is 
dispensable for recruitment of the ubiquitylation machinery to chromatin.  Lastly we 
identify a novel role for the HAR domain in both telomeric silencing and transcription 
elongation. 
Our results showing that the HAR domain regulates H2BK123ub1 are consistent 
with a recently published report (Zheng et al. 2010).  This report also found that in the 
absence of the HAR domain, Rad6 recruitment to the GAL locus is not altered.  Here we 
confirm and expand upon this finding and show that loss of the HAR domain does not 
affect global association of the ubiquitylation machinery with chromatin (Figure 2.4).  
These data provide further support that the HAR domain plays a role in regulating the 
activity of the ubiquitin ligase on chromatin.  It is therefore interesting to speculate on 
how the HAR domain contributes to H2BK123ub1.  Notably, the HAR domain is situated 
close to lysine 123 in H2B, forming a nucleosomal surface that likely contributes to 
either catalytic domain recognition and/or enzymatic function.  Future work will be 
required to explore the role of the HAR domain in H2BK123ub1 function. 
The previous report investigating the HAR domain also showed that it regulates 
H3K4me3.  While we were able to recapitulate this result using the published strains we 
found that the regulation of H3K4me3 is strain dependent.  In contrast, the HAR domain 
universally regulates H3K79me3 and H2BK123ub1.  The mechanism by which 
H3K4me3 is differentially regulated in different strain backgrounds by the HAR domain 
remains unclear. 
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Our observation that the HAR domain affects H2BK123ub1 and H3K79me3 
without H3K4me3 is especially interesting considering that the trans-histone regulatory 
pathway involving H2BK123ub1 is typically thought to involve both H3K4 and H3K79 
methylation.  Several recent observations, however, have begun to separate the 
regulation of each of these methylation states by H2BK123ub1.  For example loss of 
Bur2, a component of a transcription-associated kinase complex in yeast, results in 
decreased H2BK123ub1 and H3K4me3, but not H3K79me3 (Laribee et al. 2005).  
Moreover during myogenic differentiation in mammals there is an observed decrease of 
H2BK123ub1 and H3K79 methylation, but not H3K4 methylation (Vethantham et al. 
2012).  Adding to this set of examples, the results presented here provide the first 
evidence for a specific mutation that in some instances affects H2BK123ub1 and H3K79 
methylation, but not H3K4 methylation.   
In addition to identifying a unique role in trans-histone regulation of histone 
PTMs, we discovered an additional functional role for the HAR domain in the process of 
transcription elongation.  Consistent with the known role of H2BK123ub1 in transcription 
elongation and the observation that the HAR domain regulates H2BK123ub1 we found 
that the HAR domain exhibits genetic interactions with known elongation factors.  
Several of these interactions mimic those observed with H2BK123ub1, however this 
was not always the case.  We were surprised by the genetic interaction between the 
HAR domain and Rpb9, where loss of the HAR domain was able to rescue the slow 
growth phenotype observed in the absence of Rpb9.  This result is the opposite of that 
observed for the combined loss of H2BK123ub1 and Rpb9, which display synthetic 
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sickness.  This result suggests that the role for the HAR domain in transcription 
elongation may be multifaceted.  Given that the HAR domain is present throughout all of 
chromatin (unlike H2BK123ub1) it is possible that it may play multiple roles depending 
on the chromatin context and act as a binding platform for proteins with diverse 
functions.  In line with this view is the observation in both fission yeast and humans that 
the condensin complex can bind the HAR domain (Tada et al. 2011).  Future studies will 
need to address the full collection of proteins that interact with the HAR domain to 
further elucidate the unique functions of this domain. 
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Tables 
Table 2.1 Yeast Strains and Genotypes 
Strain Genotype Source 
JHY311 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1-
hhf1∆::KAN hhf2-hht2∆::NAT hta1-htb1∆::HPH 
hta2-htb2∆::NAT pQQ18 (CEN LEU2 HTA1 HTB1 
HHT2 HHF2) 
(Ahn et al. 2005) 
JHY293 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1-
hhf1∆::KAN hhf2-hht2∆::NAT hta1-htb1∆::HPH 
hta2-htb2∆::NAT pJH53 (CEN LEU2 hta1 ∆1-20 
HTB1 HHT2 HHF2) 
(Ahn et al. 2005) 
JHY297 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1-
hhf1∆::KAN hhf2-hht2∆::NAT hta1-htb1∆::HPH 
hta2-htb2∆::NAT pJH49 (CEN LEU2 HTA1 htb1 ∆1-
32 HHT2 HHF2) 
(Ahn et al. 2005) 
JHY307 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1-
hhf1∆::KAN hhf2-hht2∆::NAT hta1-htb1∆::HPH 
hta2-htb2∆::NAT pJH57 (CEN LEU2 HTA1 HTB1 
hht2 ∆1-30 HHF2) 
(Ahn et al. 2005) 
JHY315 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1-
hhf1∆::KAN hhf2-hht2∆::NAT hta1-htb1∆::HPH 
hta2-htb2∆::NAT pJH45 (CEN LEU2 HTA1 HTB1 
HHT2 hhf2 ∆1-27) 
(Ahn et al. 2005) 
PY014 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP002 (CEN6 TRP1 HTA1 HTB1) 
(Parra et al. 2006) 
PY015 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2  
pMP012 (CEN6 TRP1 hta1 ∆4-20 HTB1) 
(Parra and Wyrick 
2007) 
PY050 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP072 (CEN6 TRP1 hta1 ∆4-16 HTB1) 
(Parra and Wyrick 
2007) 
PY051 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP073 (CEN6 TRP1 hta1 ∆4-12 HTB1) 
(Parra and Wyrick 
2007) 
PY052 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP074 (CEN6 TRP1 hta1 ∆4-8 HTB1) 
(Parra and Wyrick 
2007) 
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PY053 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP075 (CEN6 TRP1 hta1 ∆8-20 HTB1)  
(Parra and Wyrick 
2007) 
PY054 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP076 (CEN6 TRP1 hta1 ∆12-20 HTB1)  
(Parra and Wyrick 
2007) 
PY055 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 hta1-htb1∆::HIS3 hta2-htb2∆::LEU2 
pMP077 (CEN6 TRP1 hta1 ∆16-20 HTB1) 
(Parra and Wyrick 
2007) 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Open Biosystems 
YGW116 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 dot1∆::NAT This study 
FY406 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pSAB6 (CEN URA3 HTA1-HTB1) 
(Hirschhorn et al. 
1995) 
YGW062 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
dot1∆::NAT pSAB6 (CEN URA3 HTA1-HTB1) 
This study 
YGW067 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
dot1∆::NAT pZS145 (CEN HIS3 HTA1-Flag-HTB1) 
This study 
YGW072 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pZS145 (CEN HIS3 HTA1-Flag-HTB1) 
This study 
YGW073 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pZS146 (CEN HIS3 HTA1-Flag-htb1-K123R) 
This study 
YGW074 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pEG101 (CEN HIS3 hta1 ∆1-20 Flag-HTB1) 
This study 
YGW075 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pEG102 (CEN HIS3 hta1 ∆1-16 Flag-HTB1) 
This study 
YGW076 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pEG103 (CEN HIS3 hta1 ∆16-20 Flag-HTB1) 
This study 
YZS276 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
(Sun and Allis 
2002) 
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pZS145 (CEN HIS3 HTA1-Flag-HTB1)  
YGW063 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pSAB6 (CEN URA3 HTA1-HTB1)  
This study 
YGW136 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pZS145 (CEN HIS3 HTA1-Flag-HTB1)  
This study 
YGW137 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pEG103 (CEN HIS3 hta1 ∆16-20 Flag-HTB1)  
This study 
YGW138 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pZS146 (CEN HIS3 HTA1-Flag-htb1-K123R) 
This study 
YZS606 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
ubp8∆::KanMX6 ubp10∆::NatMX4 pZS145 (CEN 
HIS3 HTA1-Flag-HTB1)  
(Chandrasekharan 
et al. 2009) 
YGW066 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
ubp8∆::KanMX6 ubp10∆::NatMX4 pSAB6 (CEN 
URA3 HTA1-HTB1)  
This study 
YGW139 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
ubp8∆::KanMX6 ubp10∆::NatMX4 pZS145 (CEN 
HIS3 HTA1-Flag-HTB1)  
This study 
YGW140 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
ubp8∆::KanMX6 ubp10∆::NatMX4 pEG103 (CEN 
HIS3 hta1 ∆16-20 Flag-HTB1)  
This study 
YGW141 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
ubp8∆::KanMX6 ubp10∆::NatMX4 pEG103 pZS146 
(CEN HIS3 HTA1-Flag-htb1-K123R) 
This study 
YGW162 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 RAD6-
3HA::KanMX pZS145 (CEN HIS3 HTA1-Flag-HTB1) 
This study 
YGW163 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 RAD6-
This study 
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3HA::KanMX pEG103 (CEN HIS3 hta1 ∆16-20 
Flag-HTB1)  
YGW132 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
bre1∆::NAT RAD6-3HA::KanMX pZS145 (CEN 
HIS3 HTA1-Flag-HTB1) 
This study 
YZS272 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
pZS144 (CEN TRP1 HTA1-Flag-HTB1)  
(Sun and Allis 
2002) 
YZS273 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
pZS145 (CEN HIS3 HTA1-Flag-HTB1)  
(Sun and Allis 
2002) 
YZS274 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
pZS146 (CEN HIS3 HTA1-Flag-htb1-K123R) 
(Sun and Allis 
2002) 
YZS275 MATa leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
sir2∆::TRP1 pZS145 (CEN HIS3 HTA1-Flag-HTB1)  
(Sun and Allis 
2002) 
YEG186 MATa  leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
pEG101 (CEN HIS3 hta1 ∆1-20 Flag-HTB1) 
This study 
YEG187 MATa  leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
pEG102 (CEN HIS3 hta1 ∆1-16 Flag-HTB1) 
This study 
YEG188 MATa  leu2-3,112 his3-11,15 trp1-1 ura3-1 ade2-1 
can1-100 hta1-htb1∆::LEU2 hta2-htb2∆ URA3-TEL 
pEG103 (CEN HIS3 hta1 ∆16-20 Flag-HTB1) 
This study 
YGW131 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
elp3∆::KanMX  pSAB6 (CEN URA3 HTA1-HTB1) 
This study 
YGW142 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
rbp9∆::KanMX pSAB6 (CEN URA3 HTA1-HTB1) 
This study 
YGW143 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
spt4∆::KanMX pSAB6 (CEN URA3 HTA1-HTB1) 
This study 
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Figures 
                                       
Figure 2.1 The H2A N-terminal Tail Regulates H3K79 Methylation and H2B 
Ubiquitylation 
 
Shown is a screen of histone methylation and ubiquitylation states in wild-type (WT) and 
mutant strains lacking the N-terminal tails of each of the core histones (H2A∆N = ∆1-20, 
H2B∆N = ∆1-32, H3∆N = ∆1-30 and H4∆N = ∆1-27).  Whole cell extracts (WCE) 
prepared from each strain were resolved by 15% SDS-PAGE and transferred to PVDF 
prior to immunoblotting with antibodies to the indicated histones or histone 
modifications.  It should be noted that the H4 antibody recognizes an epitope in the N-
terminal region, explaining the lack of signal in the H4 tail mutant strain.    














Figure 2.2 The H2A Repression (HAR) Domain is Important for the Regulation 
of H3K79me3 and H2BK123ub1 
 
(A) WCE prepared from W303-derived WT and H2A N-terminal tail truncation mutants 
(left) were used for immunoblot analysis with antibodies to the indicated histones or 
histone modifications.  Antibody specificity to the indicated histone modification was 
demonstrated in parallel using WCE prepared from BY4741-derived WT, dot1∆ and 
bre1∆ strains (right).  (B) S288C-derived WT and mutant strains were subjected to 
Immunoblot analysis as described in (A).  The H2BK123R strain contains an arginine 
instead of lysine at position 123 of histone H2B rendering the site non-ubiquitylated.   
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Figure 2.3 The HAR Domain Regulates the Catalysis of H2BK123ub1 
 
(A) The HAR domain (cyan) is located next to H2BK123 (magenta) on the surface of the 
nucleosome (Protein Data Bank [PDB] ID: 1ID3).  (B) WT and histone mutant plasmids 
were shuffled into UBP8 UBP10 and ubp8∆ubp10∆ strains and subjected to immunoblot 
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Figure 2.4 The HAR Domain is not required for the Global Recruitment of 
Rad6 
 
Indicated WT and mutant strains, with or without endogenously triple HA epitope-tagged 
Rad6 (Rad6-3HA), were spheroplasted and subjected to detergent lysis to generate 
whole cell extract (WCE).  The WCE was then lightly centrifuged to separate it into a 
soluble non-chromatin associated fraction (Soluble) and insoluble chromatin associated 
fraction (Chromatin).  Samples of WCE along with both the soluble and chromatin 
fractions were subjected to SDS-PAGE and immunoblot analysis with antibodies to the 
indicated histones, histone modifications and G6PDH as a cytoplasmic control.     
 
  
HA (long exposure) 
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Figure 2.5 The HAR Domain Plays a Role in Telomeric Silencing and 
Transcription Elongation 
 
(A) Loss of the HAR domain causes defects in telomeric silencing.  Plasmids carrying 
WT and indicated H2A N-terminal tail mutations were introduced into a telomeric 
silencing reporter strain.  The strains make use of the URA3 gene inserted into the sub-
telomeric region on the left arm of chromosome VII.  Each strain was replica plated in 
five-fold serial dilutions from left to right on rich media (YPD) and media containing 5-
fluoroorotic acid (5-FOA).  (B) The HAR domain is important for cell growth under 
conditions of stressed transcription.  WT and histone mutant strains carrying an empty 
URA3-containing vector (pRS316) were plated as five-fold serial dilutions on SC-URA 
plates with or without 200 µg/ml 6-azauracil (6-AU).  (C) The HAR domain genetically 
interacts with transcription elongation factors.  Indicated WT or histone mutant plasmids 
were shuffled into WT or elongation factor mutant (rpb9∆, elp3∆ and spt4∆) 





















spt4∆ rpb9∆ WT 
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CHAPTER 3 CATALYSIS-DEPENDENT STABILIZATION OF BRE1 FINE-TUNES 
HISTONE H2B UBIQUITYLATION TO REGULATE GENE TRANSCRIPTION3 
 
Overview 
Monoubiquitylation of histone H2B on lysine 123 (H2BK123ub1) plays a 
multifaceted role in diverse DNA-templated processes, yet the mechanistic details by 
which this modification is regulated are not fully elucidated.  Here we show in yeast that 
H2BK123ub1 is regulated in part through the protein stability of the E3 ubiquitin ligase, 
Bre1.  We find that Bre1 stability is controlled by the Rtf1 subunit of the polymerase 
associated factor (PAF) complex and through the ability of Bre1 to catalyze 
H2BK123ub1.  Using a domain in Rtf1 that stabilizes Bre1, we show that inappropriate 
Bre1 levels lead to defects in gene regulation.  Collectively, these data uncover a novel 
quality control mechanism used by the cell to maintain proper Bre1 and H2BK123ub1 
levels, thereby ensuring proper control of gene expression.     
 
Introduction 
Histone post-translational modifications (PTMs) play essential roles in the 
regulation of chromatin structure and function (Kouzarides 2007; Zentner and Henikoff 
2013).  One such histone PTM that has been well studied as a regulator of multiple 
                                            
3 Portions of this chapter were adapted from Wozniak GG, Strahl BD. 2014. Catalysis-
dependent stabilization of Bre1 fine-tunes histone H2B ubiquitylation to regulate gene 
transcription. Genes Dev. 28:1647-1652 
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DNA-templated processes is monoubiquitylation of histone H2B, which occurs at lysine 
123 (H2BK123ub1) in the budding yeast Saccharomyces cerevisiae (Robzyk et al. 
2000). This PTM functions in the context of transcriptional regulation (both initiation and 
elongation) (Henry et al. 2003; Kao et al. 2004; Xiao et al. 2005; Pavri et al. 2006; 
Fleming et al. 2008; Chandrasekharan et al. 2009; Chandrasekharan et al. 2010b), but 
has also been linked to other processes including DNA replication (Rizzardi et al. 2012; 
Trujillo and Osley 2012), repair (Game and Chernikova 2009) and kinetochore function 
(Latham et al. 2011). 
H2BK123ub1 functions in chromatin by several means.  First, this mark 
physically alters chromatin compaction and nucleosome stability (Fleming et al. 2008; 
Chandrasekharan et al. 2009; Fierz et al. 2011).  Another function of H2BK123ub1 is to 
promote histone H3 methylation at lysines 4 (H3K4me) and 79 (H3K79me) in a 
mechanism of histone ‘cross-talk’ referred to as trans-histone regulation (Briggs et al. 
2002; Dover et al. 2002; Ng et al. 2002b; Sun and Allis 2002).  H3K4me and H3K79me, 
in conjunction with H2BK123ub1, serve as markers of euchromatin and act to facilitate 
transcription factors recruitment and prevent the binding of silencing factors (Wozniak 
and Strahl 2014).  Accordingly, loss of these PTMs leads to aberrant gene regulation.   
In yeast, H2BK123ub1 is catalyzed by the concerted efforts of the ubiquitin-
conjugating enzyme (E2) Rad6 and the RING finger domain-containing ubiquitin ligase 
(E3) Bre1 (Robzyk et al. 2000; Hwang et al. 2003; Wood et al. 2003a).  Similar to other 
E3 ligases, Bre1 serves as the substrate recognition module for the complex and is 
important for the recruitment of Rad6 to chromatin (Wood et al. 2003a).  Studies have 
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also found that the polymerase associated factor (PAF) complex associates with Rad6 
and facilitates its recruitment to gene bodies (Ng et al. 2003a; Wood et al. 2003b; Xiao 
et al. 2005).  Although the mechanistic underpinnings of this recruitment are not entirely 
clear, it is known that the Rtf1 subunit of the PAF complex plays a major role (Wood et 
al. 2003b; Xiao et al. 2005).  In addition to Bre1 recruitment and catalysis, H2BK123ub1 
levels are also controlled by the deubiquitylases Ubp8 and Ubp10 (Henry et al. 2003; 
Emre et al. 2005). Loss of Ubp8 or Ubp10 leads to similar phenotypes as the loss of 
H2BK123ub1, indicating that the levels of this PTM are carefully regulated in the cell.   
In this report, we find that H2BK123ub1 is regulated through the control of Bre1 
protein stability.  Surprisingly, Bre1 stability is primarily controlled through its catalytic 
activity, in addition to its association with the PAF complex that is likely responsible for 
its recruitment to chromatin.  By taking advantage of a region in Rtf1 of the PAF 
complex that can stabilize Bre1, we find that inappropriate stabilization of Bre1 under 
normal conditions leads to defects in gene regulation.  Our results suggest a ‘rheostat’ 
control mechanism for H2BK123ub1 that contributes to proper transcriptional control.  
 
Methods 
Yeast Strains and Plasmids   
Strains and plasmids used in this study are listed in Tables 3.1 and 3.2.  Gene 
disruptions and endogenous overexpression were performed as previously described 
(Janke et al. 2004) and verified by both PCR and immunoblotting. 
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Yeast Whole Cell Extracts and Western Blot Analysis   
Yeast were grown in YPD or synthetic complete dropout (SC) media at 30˚C to mid-log 
phase and extracts were prepared as previously described (Mehta et al. 2010).  
Western blots were performed as described previously (Fuchs et al. 2012).  The 
following primary antibodies and dilutions were used: H3K79me3 (Abcam, ab2651) 
1:2500, H2BK123ub1 (Cell Signaling Technology, 5546) 1:2000, H2A (Active Motif, 
39235) 1:5000, H2B (Active Motif, 39237) 1:2500, H3 (EpiCypher, 13-0001; 1:1000) 
1:2000, FLAG (Sigma) 1:5000, Myc Tag (Millipore, 05-724) 1:5000, G6PDH (Sigma, 
A9521) 1:100,000. 
 
Phenotypic Spotting Assays   
Five-fold serial dilutions of saturated overnight yeast cultures were plated on YPD or 
synthetic complete dropout media with or without indicated drugs.  Cells were plated at 
a starting OD600 of 0.5 on appropriate media and imaged after 2-4 days of growth at 30˚ 
C.   
 
RNA Isolation and RT-PCR   
RNA was prepared from 10 OD600 units of mid-log phase cells using hot acid phenol-
chloroform extraction followed by ethanol precipitation.  Crude RNA was DNaseI treated 
(Promega) then purified using an RNeasy Mini Kit (QIAGEN).  cDNA was synthesized 
using SuperScript II First Strand Synthesis System (Life Technologies) and diluted 1/10 
prior to amplification by PCR.  Primers are listed in Table 3.3.  Reactions were run on 
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2% agarose gels and visualized by UV with SYBR Safe DNA gel stain (Life 
Technologies).  Bands were quantified using ImageJ software.   
 
Chromatin Immunoprecipitation (ChIP)   
ChIP was performed as described previously (Jha and Strahl 2014) with some 
exceptions.  Sonication for each sample was performed for 20 minutes with alternating 
on/off cycles of 30 sec using a Bioruptor Standard (Diagenode).  Immunoprecipitation 
was performed overnight with 1 mg clarified, sonicated extract and 20 µl equilibrated 
FLAG M2 agarose (Sigma).  For PCR analysis 1 µl ChIP DNA and 0.25 µl of 1:4 diluted 
input DNA was used per reaction.  Reactions were run on 2% agarose gels and 
visualized by UV with SYBR Safe DNA gel stain (Life Technologies).  Bands were 
quantified using ImageJ software.  Relative IP was calculated as follows:  the intensity 
of the IP band for each sample was divided by the intensity of the corresponding input 
(IP/input).  IP/input for all samples were then normalized to the untagged sample, which 
was set at 1.  Statistical analysis was performed using an unpaired t-test.  P < 0.05 was 
considered significant.  Primer sequences are listed in Table 3.3.  
 
Results and Discussion 
The HAR domain regulates H2BK123ub1 by stabilizing Bre1   
As presented in Chapter 2, we identified a region of the histone H2A N-terminal 
tail comprising residues 16-20 (HAR domain), which is important for the regulation of 
H2BK123ub1.  We next sought to uncover the mechanism by which the HAR domain 
regulates H2BK123ub1.  Given the close physical proximity of the HAR domain to 
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H2BK123 on the nucleosomal surface (Figure 2.3A), we hypothesized that the HAR 
domain may play a role in the ubiquitylation reaction itself.  Thus, we investigated 
whether loss of the HAR domain had any effect on the E2 or E3 ubiquitin ligases Rad6 
and Bre1, respectively.  We previously found that loss of the HAR domain did not alter 
either total or bulk chromatin bound levels of Rad6 (Figure 2.4), but Bre1 was not 
previously investigated.  To assess Bre1 levels, we transformed bre1∆ strains either 
containing or lacking the HAR domain with a low copy plasmid expressing ADH1-driven, 
N-terminally FLAG-tagged Bre1.  Importantly, this expression construct restores 
H2BK123ub1 to WT levels in the bre1∆ strain and behaves similarly to a version 
containing the native BRE1 promoter (Figure 3.1A and Figure 3.2).  Surprisingly, the 
levels of Bre1 in the HAR deletion strain were reduced, matching the decrease in 
H2BK123ub1 (Figure 3.1A).  Moreover, this was not the result of decreased BRE1 
transcription as measured by RT-PCR (Figure 3.3), indicating that the HAR domain 
regulates Bre1 levels through a mechanism that is post-transcriptional.               
 
Bre1 stability is dependent on its ability to ubiquitylate H2BK123   
Given the possibility that the HAR domain might regulate Bre1 stability through its 
contribution to a nucleosomal surface required by Bre1 to catalyze H2BK123ub1, we 
next asked if the loss of H2BK123ub1 itself might also regulate Bre1 stability.  Strikingly, 
we found Bre1 proteins levels were nearly abolished in strains harboring a point 
mutation at H2BK123 (H2BK123R) (Figure 3.1B).  As with the loss of the HAR domain, 
the H2BK123R mutation did not affect BRE1 expression, suggesting that the regulation 
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occurs at the level of the protein stability (Figure 3.3).  Consistent with this, a 
cyclohexamide (CHX) pulse-chase analysis revealed that Bre1 is more rapidly turned 
over in the H2BK123R strain (Figure 3.1C, compare WT to H2BK123R at 30 minutes 
post CHX treatment).  Taken together, these data provide strong support that Bre1 in 
the HARΔ and H2BK123R strains is subject to post-transcriptional control.  We note that 
Bre1 regulation may not involve the proteasome since MG132 treatment failed to 
stabilize Bre1 (Figure 3.4).  This result is in agreement with another report showing 
MG132 decreases H2BK123ub1 levels (Mimnaugh et al. 1997). 
We next ascertained if mutations in the ubiquitylation machinery would also affect 
Bre1 stability.  We found that loss of Rad6, like the H2BK123R mutant, also decreased 
Bre1 levels (Figure 3.1B).  Moreover, both deletion of the catalytic RING finger domain 
of Bre1 (1-650) and a point mutation that disrupts its enzymatic function (H665A) (Wood 
et al. 2003a) destabilize Bre1 (Figure 3.1D).  Additionally, RING finger mutants of Bre1 
also had a destabilizing effect on the protein when expressed in the context of WT 
endogenous Bre1 indicating that destabilization is not merely the consequence of a 
global loss of histone ubiquitylation (Figure 3.1D).  Thus, the ability of Bre1 to 
ubiquitylate chromatin is important for its stability.     
 
The PAF complex contributes to Bre1 stability via a conserved domain in Rtf1   
Given that Bre1 stability is dependent on catalysis, we next sought to determine if 
other proteins that promote H2BK123ub1 also regulate Bre1 stability.  We focused on 
the PAF complex, which has been well studied as a regulator of H2BK123ub1 (Jaehning 
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2010).  As shown in Figure 3.5A, deletions of individual members of the complex have 
varying effects on H2BK123ub1 with the paf1∆ and rtf1∆ strains having the strongest 
effect.  Significantly, we found that the loss of H2BK123ub1 correlates with the loss of 
Bre1 levels in these mutant strains, thereby linking the PAF complex to Bre1 stability 
and H2BK123ub1.   
 Rtf1 is the only subunit of the PAF complex that is absolutely required for 
H2BK123ub1 (Ng et al. 2003a; Wood et al. 2003b; Xiao et al. 2005).  This appears to be 
mediated by a small conserved domain of Rtf1 called the histone modification domain 
(HMD), which is capable of facilitating H2BK123ub1 independently of the PAF complex 
(Piro et al. 2012).  Based on this finding, we hypothesized that the HMD promotes 
H2BK123ub1 by stabilizing Bre1.  To test this idea, we co-expressed Myc-tagged HMD 
fused to a nuclear localization sequence (NLS-Myc-HMD) and FLAG-Bre1 in the rtf1∆ 
strain.  In agreement with published data (Piro et al. 2012), we found that the HMD 
could restore H2BK123ub1 in the rtf1∆ strain (Figure 3.5B).  Moreover, we found that 
expression of the HMD could also rescue Bre1 levels, indicating a critical role for the 
HMD in stabilizing Bre1.  
To examine the functional relevance of HMD-mediated Bre1 stabilization, we 
investigated its role in telomeric silencing – a function linked to both Bre1 and Rtf1.  We 
made use of a telomeric silencing reporter strain, which has the URA3 gene inserted 
near the telomere of chromosome VII.  Loss of Rtf1 in this strain shows a severe growth 
defect when grown on media containing 5-FOA, indicating a loss of silencing (Figure 
3.5C).  In line with the finding that the HMD could rescue Bre1 levels and H2BK123ub1, 
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expression of the HMD was able to restore the silencing defect of the rtf1∆ strain (Figure 
3.5C).  These data demonstrate that the HMD plays an important role in gene silencing 
by stabilizing Bre1.   
 
Altering the balance of Bre1 leads to defects in gene regulation   
The ability of the HMD to stabilize Bre1 allowed us to use it as a tool to ask why 
Bre1 is under such careful regulation.  To address this question, we again utilized the 
telomeric silencing reporter strain used above.  In this strain we overexpressed Bre1 
from the highly expressed GPD promoter either alone or in combination with the HMD 
and measured growth on 5-FOA.  Overexpression of Bre1 alone did not result in any 
growth defect on 5-FOA (Figure 3.6A), consistent with inability of Bre1 overexpression 
to increase the levels of H2BK123ub1 (Figure 3.1D).  In contrast, we found that 
overexpression of the HMD resulted in reduced growth on 5-FOA and this effect was 
exacerbated when Bre1 was also overexpressed indicating loss of silencing of the 
URA3 reporter (Figure 3.6A).  In validation of the reporter strain, we also observed 
increased transcription of two naturally silenced subtelomeric genes (YFR057W 
(chromosome VI) and COS12 (chromosome VII)) with Bre1 stabilization indicating that 
aberrant levels of Bre1 impact transcription of normally silenced telomere-proximal 
genes  (Figure 3.6B).   
Lastly, we sought to determine if the observed changes in gene expression were 
the result of HMD-mediated binding of Bre1 at telomeres.  To determine this we 
performed chromatin immunoprecipitation (ChIP) to measure Bre1 binding to a 
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subtelomeric region of chromosome VI proximal to YFR057W where the HMD has been 
previously shown to bind (Piro et al. 2012).  In agreement with the upregulation of 
YFR057W, we found increased Bre1 binding in this region in the presence of the HMD 
(Figure 3.6C).  Taken together, these observations demonstrate that aberrant 
stabilization of Bre1 at telomeres leads to defects in gene silencing.  Given loss of Ubp8 
and Ubp10 also result in increased H2BK123ub1 levels at euchromatic and telomeric 
regions (Henry et al. 2003; Emre et al. 2005), the collective data support a model 
wherein the ubiquitylation machinery is present across the genome, but is kept in check 
by the opposing functions of RNAPII-dependent PAF recruitment and the 
deubiquitylating enzymes that reduce H2BK123ub1 – both of which would control Bre1 
stability and hence H2BK123ub1 levels genome-wide. 
 
Concluding Remarks 
In this study, we uncover a novel pathway of H2BK123ub1 regulation that involves the 
precise control of Bre1 protein stability.  Using mutants that disrupt i) the nucleosomal 
surface targeted by Bre1, ii) Bre1 catalytic activity, or iii) proteins that aid in Bre1 
catalysis (i.e., Rad6 and the PAF complex), we show that the ability to ubiquitylate H2B 
is critical for the stabilization of this E3 ligase.  By expressing a domain in Rtf1 that 
couples the PAF complex with Bre1 and leads to its stabilization, we show that aberrant 
Bre1 levels results in adverse consequences for gene silencing.  Taken together, these 
findings reveal a novel control mechanism for Bre1 that we suggest functions to fine-
tune the appropriate levels of H2BK123ub1 genome-wide. 
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In addition to the regulation of Bre1, another mechanism that acts to fine-tune the 
levels of H2BK123ub1 across the genome is the deubiquitylating enzymes Ubp8 and 
Ubp10.  A question remains as to why the cell would utilize two distinct mechanisms to 
control H2BK123ub1 levels.  Perhaps similar to histone acetylases and deacetylases, 
where the equilibrium of the “on” and “off” enzymes define the precise levels of histone 
acetylation at any given point across the genome, it may be that the level of 
H2BK123ub1 across the genome is similarly governed by the equilibrium of Rad6/Bre1 
and Ubp8/Ubp10.  Consistent with this idea, deletion of the heterochromatin-associated 
Ubp10 deubiquitylase results in increased levels of H2BK123ub1 in silenced regions of 
the genome (Emre et al. 2005).  This finding implies Bre1/Rad6 can localize to these 
regions but is prevented from functioning by the removal of H2BK123ub1.  Notably, we 
were unable to detect Bre1 at a subtelomeric region of chromosome VI under normal 
conditions (Figure 3.6C), suggesting that it may interact transiently with these regions.  
In contrast, within transcribed regions where Bre1 is stabilized by the PAF complex, the 
equilibrium shifts toward productive H2BK123ub1 (Figure 3.7A).  Thus, a possible 
surveillance mechanism comprising the deubiquitylating enzymes ensures loss of Bre1 
and erasure of H2BK123ub1 where it would otherwise drive inappropriate functions 
(Figure 3.7B).   
Our observations also provide insight into the regulation of H2BK123ub1 by the 
PAF complex.  Previous work has shown that Bre1 directly interacts with the PAF 
complex in vitro using purified recombinant proteins (Kim and Roeder 2009).  In 
addition, we have demonstrated that Rad6/Bre1 is associated with the PAF complex in 
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yeast (Xiao et al. 2005).  Given these observations, we propose that the PAF complex, 
through the HMD, stabilizes Bre1 in transcribed regions, which in turn promotes Rad6 
recruitment (Wood et al. 2003a) and H2BK123ub1 (Figure 3.7A).  It is not entirely clear 
how a potential interaction with Rtf1 could stabilize Bre1, but the interaction may either 
mask specific degradation sequences within Bre1 or aid in the recruitment of Bre1 to its 
nucleosomal substrate, which may be the actual stabilizing interaction.  
 One of the important mechanistic functions of H2BK123ub1, in addition to 
promoting nucleosomal disruption and stability during transcription elongation, is the 
regulation of histone methylation at H3K4 and H3K79 (Briggs et al. 2002; Dover et al. 
2002; Ng et al. 2002b; Sun and Allis 2002; Chandrasekharan et al. 2010b).  This form of 
histone ‘cross-talk’ has been the focus of numerous studies over the past decade, but 
the mechanism remains to be fully elucidated.  Two primary models exist, which 
suggest that H2BK123ub1 either acts as a wedge in chromatin to facilitate enzyme 
access (Fierz et al. 2011) or as a bridge to the histone methyltransferases (either 
directly (McGinty et al. 2008; Kim et al. 2013) or indirectly (Lee et al. 2007; Vitaliano-
Prunier et al. 2008)).  The indirect recruitment mechanism has been proposed to involve 
Cps35/Swd2, which is a subunit of the H3K4 methylating COMPASS complex and has 
been suggested to interact with the H3K79 methyltransferase Dot1 (Lee et al. 2007).  
Both these models share the common theme, however, that the ubiquitin moiety itself at 
H2BK123 mediates the ‘cross-talk’.  Intriguingly, our data demonstrate that the same 
mutations used to characterize H2BK123ub1-mediated ‘cross-talk’ also disrupt the 
stability of Bre1.  Thus, it will be intriguing to determine if any aspect of the trans-histone 
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pathway of H3K4 and H3K79 methylation might involve Bre1 itself independent of 
H2BK123ub1.  In support of this idea, Bre1 has been shown to interact with 
Cps35/Swd2 in vivo (Vitaliano-Prunier et al. 2008) and, intriguingly, mutations that 
disrupt H2BK123ub1 (and hence Bre1 stability) also disrupt the ability of Cps35/Swd2 to 
facilitate COMPASS-mediated H3K4 methylation (Lee et al. 2007; Vitaliano-Prunier et 
al. 2008).  Thus, Cps35/Swd2 may be a link between Bre1 and H3K4 methylation. 
Future studies will be required to revisit some of the basic assumptions of H2BK123ub1-
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Tables 
Table 3.1 Yeast Strains and Genotypes 
Strain Genotype Source 
FY406 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pSAB6 (CEN URA3 HTA1-HTB1) 
(Hirschhorn et al. 
1995) 
YGW067 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
dot1∆::NAT pZS145 (CEN HIS3 HTA1-Flag-
HTB1) 
This study 
YGW072 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pZS145 (CEN HIS3 HTA1-Flag-HTB1) 
This study 
YGW073 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pZS146 (CEN HIS3 HTA1-Flag-htb1-K123R) 
This study 
YGW076 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
pEG103 (CEN HIS3 hta1 ∆16-20 Flag-HTB1) 
This study 
YGW161 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
bre1∆::HPH pZS145 (CEN HIS3 HTA1-Flag-
HTB1) 
This study 
YGW169 MATa leu2∆1 ura3-52 lys2∆1 lys2-128δ his3∆200 
trp1∆63 hta1-htb1∆::LEU2 hta2-htb2∆::TRP1 
bre1∆::HPH pEG103 (CEN HIS3 hta1 ∆16-20 
Flag-HTB1) 
This study 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Open Biosystems 
YJJ662 MATa leu2∆1 his3∆200 ura3-52  (Shi et al. 1997) 
YJJ577 MATa leu2∆1 his3∆200 ura3-52 paf1∆::HIS3 (Shi et al. 1997) 
YJJ665 MATa leu2∆1 his3∆200 ura3-52 cdc73∆::HIS3 (Shi et al. 1997) 
YJJ1197 MATa leu2∆1 his3∆200 ura3-52 ctr9∆::KanMx (Nordick et al. 
2008) 
YJJ1336 MATa leu2∆1 his3∆200 ura3-52 leo1∆::KanMx (Nordick et al. 
2008) 
YJJ1303 MATa leu2∆1 his3∆200 ura3-52 rtf1∆::KanMx (Nordick et al. 
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2008) 
YCB647 MATa ura3-52 his3∆200 leu2∆1 trp1 ∆63 
lys2∆202  
(Brachmann et al. 
1995) 
YNL012 MATa ura3-52 his3∆200 leu2∆1 trp1 ∆63 
lys2∆202 rtf1∆::KanMx 
This study 
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Table 3.2 List of Plasmids 
Plasmid Features Source 
pZS145 CEN HIS3 HTA1-FLAG-HTB1 (Sun and Allis 2002) 
pZS146 CEN HIS3 HTA1-FLAG-htb1-K123R (Sun and Allis 2002) 
pEG101 CEN HIS3 hta1 ∆1-20 FLAG-HTB1 This study 
pEG102 CEN HIS3 hta1 ∆1-16 FLAG-HTB1 This study 
pEG103 CEN HIS3 hta1 ∆16-20 FLAG-HTB1 This study 
FLAG-Bre1 p416 
ADH 
CEN URA3 pADH1-FLAG-BRE1 This study 
FLAG-Bre1 






CEN URA3 pADH1-Myc-NLS-HMD This study 
Myc-NLS-HMD 
p415 ADH 
CEN LEU2 pADH1-Myc-NLS-HMD This study 
Myc-NLS-HMD 
pAD4M 
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Table 3.3 List of Primers 
Primer Sequence Application 
ACT1 F TCACCAACTGGGACGATATGG RT-PCR 
ACT1 R CAAGGACAAAACGGCTTGGA RT-PCR 
BRE1 F CAAGCAGAAGGCATCTCATCTA RT-PCR 
BRE1 R CATCGCTCGAGCCCTTATTT RT-PCR 
COS12 F TGGAATTCGCCAATACTGTTC RT-PCR 
COS12 R ACAAAGACGCTTGCGAAGAT RT-PCR 
YRF057W F CTAGTGTCTATAGTAAGTGCTCGG  RT-PCR 
YFR057W R CTCTAACATAACTTTGATCCTTACTCG  RT-PCR 
TEL-VI F GCGTAACAAAGCCATAATGCCTCC ChIP 
TEL-VI R CTCGTTAGGATCACGTTCGAATCC ChIP 
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Figures 
 
Figure 3.1 Bre1 Stability is Dependent on the Catalysis of H2BK123ub1 
 
(A) The HAR domain is important for the stability of Bre1.  Indicated mutant strains were 
transformed with empty vector or ADH1-driven FLAG-BRE1 and subjected to 
immunoblot analysis with indicated antibodies. G6PDH serves as a loading control.  
Increasing amounts of extract were loaded for each sample as indicated by solid black 
triangles.  (B) Catalysis of H2BK123ub1 is required for Bre1 stability.  Indicated strains 
were analyzed as in (A).  (C) Loss of H2BK123ub1 destabilizes Bre1.  WT and 
H2BK123R strains were treated with cyclohexamide (CHX) for the indicated amount of 
time.  Samples taken at each time point were analyzed by immunoblot analysis and 
Coomassie Brilliant Blue (CBB) staining.  Percentage of signal compared to 0 minute 
time point for each sample is indicated (% remaining).  (D) The RING finger domain of 
Bre1 is required for stability.  WT or bre1∆ strains expressing empty vector (-), full length 
(FL) FLAG-Bre1 or mutant derivatives lacking the RING finger domain (1-650) or 
harboring an inactivating point mutation (H665A) were analyzed by immunoblot 



































































    
 
Figure 3.2 Stability of Bre1 Expressed from its Native Promoter 
 
(A) Catalysis is important for the stability of natively expressed Bre1.  WT strains were 
transformed with empty vector or a constructs expressing WT or mutant 9xMyc-tagged 
Bre1 (Myc-BRE1) from its native promoter and subjected to immunoblot analysis with 
indicated antibodies. G6PDH serves as a loading control.  Increasing amounts of extract 
were loaded for each sample as indicated by solid black triangles.  (B) Rad6 and Rtf1 
are important for natively expressed Bre1.  Indicated WT and mutant strains expressing 


































Figure 3.3 Bre1 Transcript Levels are not affected by the Level of 
H2BK123ub1 
 
Reverse transcriptase (RT) PCR was performed using indicated strains with primers 
directed towards BRE1 or the housekeeping gene ACT1.  Reactions performed with or 


























                            
 
Figure 3.4 The Stability of Bre1 is not regulated by the Proteasome 
 
WT strains expressing FLAG-BRE1 were grown in presence of MG132 (75µM) or 
DMSO vehicle control for 4 hours prior to immunoblot analysis with indicated antibodies.  
Cells were grown in 0.004% SDS as previously described to increase drug permeability 
(Liu et al. 2007).  Increasing amounts of extract were loaded for each sample as 
indicated by solid black triangles.  Decreased levels of H2BK123ub1 were used as a 















Figure 3.5 The Histone Modification Domain (HMD) of Rtf1 Stabilizes Bre1 
 
(A)  The PAF complex regulates Bre1 stability.  Indicated strains transformed with 
empty vector or FLAG-BRE1 were subjected to immunoblot analysis.  Increasing 
amounts of extract were loaded for each sample as indicated by solid black triangles.  
Asterisk indicates a non-specific band.  (B) The HMD of Rtf1 stabilizes Bre1.  Indicated 
strains were transformed with FLAG-BRE1 and/or NLS-Myc-HMD (Myc-HMD, CEN) and 
subjected to immunoblot analysis as in (A).  (C) The HMD is sufficient for mediating the 
telomeric silencing function of Rtf1.  Empty vector or a plasmid expressing NLS-Myc-
HMD (HMD, 2µ) were transformed into WT or rtf1∆ telomeric silencing reporter strains 
harboring the URA3 gene inserted within a subtelomeric region of chromosome VII.  
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Figure 3.6 Aberrant Bre1 Stabilization Disrupts Gene Silencing 
 
(A) Stabilization of Bre1 causes defective silencing at telomeres.  Telomeric silencing 
strains that overexpressed Bre1 from the GPD promoter (GPD-BRE) and/or the HMD 
(2µ) were used and analyzed as in Fig. 3c.  (B) Stabilized Bre1 alters the expression of 
naturally silenced telomeric genes.  Reverse transcriptase (RT) PCR was performed 
with RNA isolated from strains expressing FLAG-BRE1 (CEN) and/or the HMD (2µ) with 
primers directed towards the subtelomeric genes YFR057W (chromosome VI), COS12 
(chromosome VII), BRE1 or the housekeeping gene ACT1.  Decreasing amounts of 
cDNA were used for each PCR as indicated by solid black triangles.  The expression of 
each target was normalized to ACT1 and the fold change versus WT was calculated 
and shown below each strain.  (C) The HMD recruits Bre1 to telomeres.  ChIP was 
performed with M2 FLAG agarose under each of the indicated conditions.  ChIP and 
input DNA were used as template for PCR reactions containing primers specific to a 
subtelomeric region of chromosome VI (TEL-VI).  Relative IP represents fold change 
enrichment versus untagged.  See Supplemental Methods for further details.  Data 
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Figure 3.7 Transcription-Coupled Stabilization of Bre1 Fine-Tunes H2B 
Ubiquitylation 
 
(A) We find that the Rtf1 subunit of the PAF complex is important for stabilizing Bre1 
and promoting H2BK123ub1.  Given the close association of the PAF complex with 
transcribing RNA Polymerase II (RNAPII) we propose that Rtf1, residues 16-20 of 
histone H2A and perhaps other proteins associated with the transcriptional apparatus 
interact with and stabilize Bre1 (indicated by solid black outline) to promote 
H2BK123ub1 in active regions of the genome.  (B) Once transcription is complete or in 
repressed regions, the absence of the transcriptional machinery leads to Bre1 instability 
(indicated by dashed outline).  Transient interactions of Bre1/Rad6 with chromatin in 
repressed regions catalyze short-lived H2BK123ub1 (dashed outline) that is rapidly 
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CHAPTER 4 CONCLUSIONS 
Ubiquitylation of histone H2B (H2BK123ub1) is a dynamic histone modification 
that plays important roles in many DNA-templated processes.  Consistent with its 
diverse functionality, alterations of this modification have been implicated in disease, 
underscoring the importance of understanding its regulation and function.  Over the past 
decades, much has been learned about H2BK123ub1 such as the proteins involved and 
downstream functions, but there are still important open questions as evidenced in the 
previous chapters.  It is clear that H2BK123ub1 is associated with euchromatin, but it 
remains to be determined how the ubiquitylation machinery recognizes its substrate to 
catalyze H2BK123ub1.  Additionally, despite the observation that H2BK123ub1 is 
dynamically regulated, it is unclear how this occurs.  How H2BK123ub1 mediates its 
affect in chromatin and fits into the larger picture of chromatin and cellular regulation 
also warrants further investigation.  The work presented in this dissertation does not 
provide all the answers, but adds important insights into each of these questions.  
These insights will be important for guiding future research on the role and regulation of 
H2BK123ub1.   
 
A Role for the HAR Domain in Catalysis of H2BK123ub1 
As presented in Chapter 1, a region of the histone H2A N-terminal tail called the 
HAR domain was identified to regulate and function analogously to H2BK123ub1.  It is 
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still not clear, however, how exactly the HAR domain participates in this regulation.  We 
and others have shown that it does not play a role in the recruitment of Rad6 to 
chromatin (Zheng et al. 2010).  Instead, loss of the HAR domain reduces the stability of 
Bre1.  As revealed in Chapter 2, Bre1 becomes unstable when it is unable to catalyze 
H2BK123ub1, indicating that the HAR domain regulates the catalysis of the 
modification.  This is idea is further bolstered by the observation that the HAR domain 
sits in close physical proximity to H2BK123 on the surface of the nucleosome.   
One possible mechanism for how this occurs is that Bre1 physically interacts with 
the HAR domain.  To test this question, in vitro binding experiments using purified 
recombinant Bre1 and nucleosomes will be required due to the issue of Bre1 stability in 
vivo.  An alternative possibility is that the HAR domain is important for the structural 
integrity of the nucleosomal surface surrounding H2BK123 and, thus, is important for 
accessibility of the lysine residue.  In support of this idea, replacement of the amino acid 
residues within the HAR domain with alanine does not dramatically affect H2BK123ub1 
(data not shown).  Alanine may be able to maintain the nucleosomal surface and this 
also indicates that the residues themselves do not necessarily matter.  Structural 
analysis of nucleosomes lacking the HAR domain may be required to fully test this 
possibility.   
Either of these possibilities will shed light on the interaction surface utilized by the 
histone ubiquitylation machinery.  Knowledge of such interactions could be useful to 
guide the design of small molecule chemical probes to disrupt H2BK123ub1 catalysis.  
Small molecules that disrupt the contribution of the HAR domain to H2BK123ub1 could 
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prove a useful in cancers, which are dependent on H2BK123ub1 (Wang et al. 2013).  
Loss of the HAR domain does not abrogate H2BK123ub1, which is also detrimental to 
cells, and thus, may restore H2BK123ub1 to normal levels in these cells.          
 
Functionality of the HAR Domain 
While it is unclear how the HAR facilitates H2BK123ub1, it is clear that it shares 
similar biological functions with H2BK123ub1.  With the two functions tested 
(transcription elongation and telomeric silencing) the HAR domain showed similar 
phenotypes with the notable exception of genetic interaction with Rpb9.  As suggested 
in Chapter 2, this may be the consequence of multiple functions for the HAR domain in 
chromatin.  Alternatively, reduction of H2BK123ub1 may lead to different phenotypes 
than complete loss.  This possibility could be tested using other mutations that reduce 
H2BK123ub1.   
It remains to be seen, however, whether the HAR domain plays a similar 
biological function in more complex organisms especially given the conservation of H2B 
ubiquitylation.   A comparison of histone H2A between organisms also reveals that the 
HAR domain is highly conserved (Parra and Wyrick 2007).  Until recently, this question 
could not be addressed due to the inability to completely mutate histones genes in a 
complex organism.  This has recently changed with histone replacement methods in the 
fruit fly Drosophila melanogaster (Gunesdogan et al. 2010; Pengelly et al. 2013).  With 
this technology it is now possible to test the effect of HAR domain mutation and/or the 
loss of H2B ubiquitylation on an organismal level. 
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 Mechanisms of Trans-Histone Regulation 
The regulation of H2BK123ub1 by the HAR domain represents a type of trans-
histone regulation whereby one histone influences the modifications on another. One of 
the most well-defined forms of trans-histone regulation involves the regulation of H3K4 
and H3K79 methylation by H2BK123ub1 (Briggs et al. 2002; Dover et al. 2002; Ng et al. 
2002b; Sun and Allis 2002; Chandrasekharan et al. 2010b; Pengelly et al. 2013).  
Consistent with this pathway, the HAR domain also regulates H3K4 and H3K79 
methylation in addition to H2BK123ub1.  Surprisingly, however, the regulation of H3K4 
appears to be dependent on genetic background.  Part of this observation may be 
explained by how H3K4 methylation is catalyzed.  It has been reported that the H3K4 
methyltransferase complex COMPASS can bind the H2B C-terminus independently of 
H2BK123ub1 (Chandrasekharan et al. 2010a).  As suggested above, loss of the HAR 
domain could create structural aberrations in or around the H2B C-terminus that would 
preclude binding of COMPASS and hence H3K4 methylation.   Why this would only be 
affected in one genetic background but not the other is still an open question.  An in 
depth DNA sequence and RNA expression comparison of the two backgrounds will 
likely be required to understand this phenomenon.   
 Despite the differences in H3K4 methylation with mutation of the HAR domain, 
the mechanism of trans-histone regulation of histone methylation by H2BK123ub1 is still 
poorly defined.  Two general hypotheses have been put forth, which state that either 
H2BK123ub1 promotes chromatin accessibility or acts as a binding site for the 
methylation enzymes (Chandrasekharan et al. 2010b).  Focusing on H3K79 
methylation, the enzyme responsible for this modification (Dot1) has been shown to bind 
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ubiquitin, but does not show altered binding to nucleosomes in the presence or absence 
of H2BK123ub1 (McGinty et al. 2008; Oh et al. 2010).  Remarkably, H2BK123ub1 
stimulates H3K79 methylation within the context of the same nucleosome in vitro, which 
suggests that ubiquitin may be functioning allosterically (McGinty et al. 2008).  It also 
suggests that other accessory factors may not be required for the trans-histone pathway 
as previously suggested (Lee et al. 2007).   
Not investigated in this context, however, was the effect of H2BK123ub1 on 
internucleosomal interactions.  Increased internucleosomal interaction in the absence of 
H2BK123ub1 could disrupt histone binding sites required for the activity of Dot1.  In 
agreement with this idea, unmodified mononucleosomes serve as better substrates for 
Dot1 than nucleosomal arrays (Fierz et al. 2011).  Moreover, addition of H2BK123ub1 to 
the arrays eliminates this difference.  One of these potential internucleosomal 
interaction involves the histone H4 N-terminal tail, which has been shown to stimulate 
Dot1 activity, but not contribute to overall nucleosome binding (Fingerman et al. 2007).  
Interestingly the H4 tail has also been proposed to mediate internucleosomal 
interactions with a region of histone H2A on a neighboring nucleosome (Luger et al. 
1997).  Thus a competition between Dot1 and the neighboring nucleosome for binding 
the H4 tail may govern H3K79 methylation.  Furthermore, H2BK123ub1 may block the 
internucleosomal interaction between H4 and H2A to help resolve the competition in 
favor of Dot1.  Future studies will be required to integrate the contribution of 
internucleosomal interactions into the trans-histone regulatory pathway. 
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Regulation of H2BK123ub1 via Bre1 Stability 
Initial work on the HAR domain led to the surprising finding that Bre1 stability is 
coupled to the catalysis of H2BK123ub1.  Moreover stability is linked to transcription via 
the PAF complex, thereby ensuring that H2BK123ub1 is only found at actively 
transcribed genes.  While this mechanism provides a framework for how H2BK123ub1 
can by dynamically regulated during transcription, some questions still remain.  It is still 
unknown how Bre1 is degraded and, moreover, what upstream signals trigger the 
degradation process.  Initial experiments indicated that, perhaps, Bre1 is not degraded 
by the proteasome owing to the fact that treatment with the proteasome inhibitor MG132 
decreased protein levels.  Upon further investigation it appears that this result may be 
the result of cellular stress induced by MG132, since other forms of cellular stress such 
as heat shock also reduced Bre1 levels – a point further explored below.  Interestingly, a 
recent study on the human homolog of Bre1 called RNF20 showed that it is degraded in 
a proteasome-dependent manner (Blank et al. 2012).  Therefore, the mechanism of 
Bre1 degradation in yeast will need to be revisited using other techniques that reduce 
the stress response such as genetic inactivation of the proteasome over short time 
courses.  Understanding the mode of degradation is important because it will help focus 
work to identify the players involved in degradation.   
Despite this gap in knowledge, a few candidate regulators of Bre1 have been 
identified.  One comes from the aforementioned study on RNF20, which found that a E3 
ubiquitin ligase called Smurf2 can polyubiquitylate RNF20 to target it for degradation 
(Blank et al. 2012).  Whether this is linked to transcription has not yet been explored.  
Intriguingly, however, is that a putative yeast homolog of Smurf2, Rsp5, has been 
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extensively linked to transcription and has been demonstrated to participate in the 
degradation of RNAPII (Huibregtse et al. 1997; Somesh et al. 2005).  This evidence, 
while circumstantial, puts Rsp5 at the right place and time to serve a regulator of Bre1 
stability and warrants further study.  Moreover, it will be interesting to see if the coupling 
of Bre1 stability to transcription is conserved in more complex organisms. 
Another unknown with regards to Bre1 stability is how degradation is signaled.  
Interestingly, as described above, Bre1 levels decrease in response to cellular stress.  It 
is not clear, however, which proteins or if a common set of stress response proteins are 
involved.  Moreover, several possibilities exist for the initiation of Bre1 degradation.   
Since Bre1 stability is coupled with transcription, it could be a more passive process 
whereby when a stalled or terminated RNAPII leaves the gene, Bre1 becomes more 
vulnerable to degradation.  Alternatively, transcriptional repressors recruited to genes 
during inactivation may also recruit the proteins that degrade Bre1.  Degradation of Bre1 
would lead to the loss of H2BK123ub1 and stalled transcription leading to complete 
gene inactivation.  In this scenario, Bre1 degradation would be an early event in gene 
repression. 
 
Purpose of Bre1 Degradation 
 As mentioned above, one reason Bre1 may be degraded is that it may be an 
early event in the process of gene inactivation to reduce H2BK123ub1.  Having Bre1 as 
a control point for transcriptional regulation could prove useful in the event of large, 
genome-wide changes in transcription.  A prime example of this is during the yeast 
stress response where many genes change their expression and, intriguingly, Bre1 
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levels are also altered.  Another surprising result is that Bre1 is still degraded in mutants 
where H2BK123 cannot be ubiquitylated (H2BK123R).  The degradation of Bre1 in this 
mutant may be the result of reduced global transcription, although this possibility is not 
likely since loss of the PAF complex, which plays a much larger role in transcription 
(Jaehning 2010), reduces Bre1 to a similar level at the H2BK123R mutant.  Bre1 
degradation in the H2BK123R mutant may, instead, suggest that Bre1 has additional 
ubiquitylation substrates or binding partners during transcription.  Thus Bre1 has to be 
degraded to prevent interaction with and, perhaps, ubiquitylation of the non-histone 
substrates.   
Currently, no other substrates of Bre1 have been identified, but intriguingly Bre1 
has been linked to the ubiquitylation status of other proteins.  One of these proteins is 
Swd2/Cps35, which is involved in both histone methylation and RNA 3’ processing.  
Swd2/Cps35 has been shown to be ubiquitylated and this is dependent on the presence 
of H2BK123ub1 in cells (Vitaliano-Prunier et al. 2008).  Because Bre1 levels are also 
dependent on H2BK123ub1, Swd2/Cps35 ubiquitylation may actually be dependent on 
Bre1.  Bre1 has also been shown to physically interact with the RNA processing factor 
Npl3 (Moehle et al. 2012).  Thus Bre1 may have additional roles outside of 
H2BK123ub1, which could explain its careful regulation.  Future studies including 
identification of binding partners using unbiased mass-spectrometry as well as 
identification of novel substrates using substrate labeling techniques (Zhuang et al. 
2013) will help identify the full spectrum of Bre1 function. 
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 A Role for Bre1 and H2BK123ub1 in Ubiquitin Homeostasis                                      
 H2B is just one of many ubiquitylation substrates in the cell, but given the large 
number of histones required to cover the genome, it may reflect one of the most 
substantial substrates.  In fact, about 25% of total cellular ubiquitin in human cells is 
associated with histones (Kaiser et al. 2011).  Important to note, the contribution of H2A 
and H2B ubiquitylation to this quantity has not been determined.  In budding yeast, 
however, only H2B is ubiquitylated.  Therefore, alterations in histone H2B ubiquitylation 
alone in yeast could affect the total cellular level of ubiquitin.  Moreover, histones could 
be a key player in the regulation of ubiquitin homeostasis by serving as an excess 
supply of ubiquitin.   
 Two studies support this idea.  The first found that treatment of cells with the 
proteasome inhibitor MG132 leads to an increase in polyubiquitylated proteins, 
consistent with the inability to degrade these proteins (Mimnaugh et al. 1997).  
Interestingly, however, they also found that the levels of histone ubiquitylation 
decreased.  The second study used microscopy techniques to more carefully assess 
ubiquitin levels in response to proteasome inhibition (Dantuma et al. 2006).  They found 
that the nuclear pool of ubiquitin decreases rapidly after treatment, while the cytosolic 
pool increases along with the amount of polyubiquitylated proteins.  They also provide 
evidence that the decrease in nuclear ubiquitin is not due to deubiquitylation of histones.  
Instead, the decrease is due to changes in the utilization of free ubiquitin.  Thus, there 
appears to be a competition between the histone ubiquitylation enzymes and the 
cytosolic ubiquitylation enzymes for the pool of free ubiquitin.  Under stress conditions, 
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where ubiquitin is required for protein degradation, the cytosolic pathway takes over and 
decreases the pool of ubiquitin available for histone ubiquitylation.   
How could the competition for free ubiquitin be resolved?  As illustrated in 
Chapter 3, treatment of cells with MG132 decreases the levels of Bre1.  Moreover, Bre1 
stability depends on its ability to ubiquitylate histones.  Therefore, Bre1 may act as a 
sensor of both cellular stress and free ubiquitin to modulate the cellular distribution of 
ubiquitin.  Coupling Bre1 stability to the stress response would not only regulate 
ubiquitin homeostasis, but also impinge on transcription and perhaps mediate the gene 
expression changes observed during this time.  Lastly, Bre1 serves as an ideal 
component of the histone ubiquitylation machinery to regulate owing to its exclusive 
nuclear function as opposed to its partner Rad6, which is involved in ubiquitylation of 
non-histone and potentially cytosolic proteins.  Future studies will be required to 
determine if H2BK123ub1 itself playes into ubiquitin homeostasis and identify how the 
stress response regulates Bre1 stability.   
 
Final Thoughts 
Bre1 and H2BK123ub1 play diverse roles in the cell and as evidenced here and 
elsewhere it is clear why this pathway is under such strict regulation.  Since Bre1 sits at 
a potential intersection between protein homeostasis and chromatin regulation, it 
represents a key player in the cell.  The dynamic regulation of Bre1 and H2BK123ub1 
allow for a rapid cellular response to stress that is stably maintained through other 
histone modifications.  Bre1 and H2BK123ub1 are likely also important players during 
cellular specification.  As discussed in Chapter 1, changes in genome utilization account 
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for the diversity of cellular states.  The transient nature of H2BK123ub1 may place it as 
an important regulator of cellular differentiation, by facilitating genomic plasticity.  It is, 
therefore, no surprise that disrupting the careful balance of H2BK123ub1 leads to 
diseases like cancer.  Given the diverse roles of H2BK123ub1 and Bre1, the human 
homologues of Bre1 (RNF20/40) could prove useful drug targets for the treatment of 
disease.  It is likely, however, that in order for such drugs to succeed the levels of 
H2BK123ub1 will need to be carefully monitored to restore and maintain the fine-tuned 
balance of the modification.   
In addition to the regulation of H2BK123ub1, much work is still needed to 
understand how it functions in chromatin.  Recent work identifying factors that associate 
with H2BK123ub1 has begun to shed light on the mechanism, but this is only half of the 
story.  Since H2BK123ub1 is an important regulator of histone methylation, future work 
will also need to identify how H3K4 and H3K79 methylation function in transcription.  
This will require, like for H2BK123ub1, the identification of effector proteins for each 
modification.  Our work on Bye1 in Appendix A adds another piece to the puzzle by 
linking H3K4 methylation directly to RNAPII.  These studies as well as others will help 
unveil the mechanisms of H2BK123ub1 function.     
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APPENDIX A STRUCTURES OF RNA POLYMERASE II COMPLEXES WITH THE 
CHROMATIN-BINDING PHF3/DIDO1 HOMOLOGUE BYE14 
 
Overview 
Bye1 is a nuclear protein with a domain resembling the central domain in the 
transcription elongation factor TFIIS. Here we show that Bye1 binds with its TFIIS-like 
domain (TLD) to RNA polymerase II (RNAPII), and report crystal structures of the Bye1 
TLD bound to RNAPII and three RNAPII-nucleic acid complexes. Like TFIIS, Bye1 binds 
to the RNAPII jaw and funnel, but in contrast to TFIIS it neither alters the conformation 
nor the in vitro functions of RNAPII. In vivo, Bye1 is recruited to chromatin via its TLD 
and occupies the 5’-region of active genes. A PHD domain in Bye1 binds histone H3 
tails with trimethylated K4, and this interaction is enhanced by the presence of 
additional marks for active transcription, but impaired by repressive marks. These data 
indicate that Bye1 is a novel type of chromatin transcription factor that tethers histones 
with active marks to transcribing RNAPII. Finally, we detect putative human homologues 
of Bye1, the proteins PHF3 and DIDO1, which were implicated in cancer. 
 
                                            
4 This chapter is based on Kinkelin K, Wozniak GG, Rothbart SB, Lidschreiber M, Strahl 
BD, Cramer P. 2013. Structures of RNA polymerase II complexes with Bye1, a 
chromatin-binding PHF3/DIDO homologue. Proceedings of the National Academy of 
Sciences of the United States of America 110: 15277-15282. 
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Introduction 
For transcription of eukaryotic protein-coding genes, RNA polymerase II (RNAPII) 
associates transiently with dozens of transcription factors. Different RNAPII-associated 
factors are required for transcription initiation, for RNA chain elongation through 
chromatin, for pre-mRNA processing, including 5’-capping, splicing, and 3’-processing 
of the nascent transcript, and for transcription termination (Perales and Bentley 2009; 
Hahn and Young 2011; Mischo and Proudfoot 2013). In order to understand how these 
factors cooperate with RNAPII and achieve their functions, structural information on 
RNAPII in complex with transcription factors is required. Thus far, X-ray crystallographic 
structural information on such complexes is limited to two transcription factors, the 
initiation factor TFIIB (Bushnell et al. 2004; Kostrewa et al. 2009; Liu et al. 2010; 
Sainsbury et al. 2013), and the elongation factor TFIIS (Kettenberger et al. 2003; 
Kettenberger et al. 2004; Wang et al. 2009; Cheung and Cramer 2011). TFIIS contains 
three domains, a mobile N-terminal domain, a central domain that binds directly to the 
RNAPII jaw and funnel domains, and a C-terminal zinc ribbon domain that inserts into 
the polymerase pore (or secondary channel) and reaches the RNAPII active site 
(Kettenberger et al. 2003), to stimulate cleavage of backtracked RNA during 
transcriptional proofreading and arrest (Wind and Reines 2000). 
In the yeast Saccharomyces cerevisiae, there is only a single protein that 
contains a domain that is distantly homologous to the central, RNAPII-associated 
domain of TFIIS. This protein, Bye1, has been identified as a multi-copy suppressor of 
Ess1 (Wu et al. 2000), a peptidyl-prolyl cis-trans isomerase that is involved in proline 
isomerization of the C-terminal domain (CTD) of RNAPII (Hani et al. 1995; Morris et al. 
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1999). In Bye1, the central TFIIS-like domain (TLD, residues 232-365), is flanked by an 
N-terminal PHD domain (residues 74-134) and a C-terminal SPOC domain (residues 
447-547, Figure A.1A). PHD domains are mostly found in proteins involved in 
chromatin-mediated gene regulation (Aasland et al. 1995). Consistent with this, the 
Bye1 PHD domain binds to a histone H3 tail peptide containing trimethylated lysine 4 
(H3K4me3) (Shi et al. 2007a). The function of SPOC domains in yeast is unclear, but in 
higher eukaryotes SPOC domains are implicated in developmental signaling (Ariyoshi 
and Schwabe 2003). Bye1 localizes to the nucleus (Kumar et al. 2000), consistent with 
harboring putative nuclear localization signals in the N-terminal protein region. Based on 
yeast genetics, it was suggested that Bye1 plays an inhibitory role during transcription 
elongation (Wu et al. 2003). It is unknown whether Bye1 binds to RNAPII directly, and 
what the consequences of such binding are for polymerase structure and function. 
Here we show that Bye1 binds directly to the core of RNAPII and report four 
crystal structures of different RNAPII functional complexes bound by Bye1. The 
structures reveal similarities and differences to the RNAPII-TFIIS complex. Together 
with functional data our results indicate that Bye1 binds to early RNAPII elongation 
complexes at the beginning of transcribed regions of active genes without changing 
polymerase structure or function. The polymerase interaction recruits Bye1 to 
chromatin, where it tethers promoter-proximal RNAPII at early stages of elongation to 
actively transcribed chromatin via a second, direct contact to histone H3 tails with 
modification marks for active transcription. 
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Materials and Methods 
Protein Preparation  
Saccharomyces cerevisiae 12-subunit RNAPII was prepared as described (Sydow et al. 
2009).  Full-length Bye1 was cloned into pOPINF with an N-terminal hexahistidine tag 
and expressed in E. coli BL21 (DE3) (Novagen). The culture was grown in LB medium 
at 37 °C until an OD600  of 0.9 was reached, induced with 0.25 mM IPTG, and grown for 
18 h at 20 °C. Cells were collected by centrifugation and flash-frozen. Protein was 
purified by nickel affinity, anion exchange and size-exclusion chromatography. Cells 
were lysed by sonication in buffer A (20 mM Tris pH 7.5, 100 mM NaCl, 10 μM ZnCl2, 
10% (v/v) glycerol, 5 mM dithiothreitol (DTT), supplemented with 20 mM imidazole, 1 
u/µl DNase (Fermentas) and 1× protease inhibitors (100× stock: 1.42 mg leupeptin, 
6.85 mg pepstatin A, 850 mg PMSF, 1,650 mg benzamidine in 50 ml ethanol)). After 
centrifugation at 16,000g for 20 min, the cleared lysate was applied to a pre-equilibrated 
(buffer A) Ni-NTA agarose column (Qiagen). The column was washed with 10 column 
volumes of buffer A containing 20 mM imidazole before step-wise elution of the protein 
with buffer A containing 50/100/200 mM imidazole. Fractions containing Bye1 were 
pooled and applied to a MonoQ 10/100 GL column (GE healthcare) equilibrated in buffer 
A. The protein was eluted with a linear gradient from 100 mM to 1 M NaCl (buffer B. 
20 mM Tris pH 7.5, 1 M NaCl, 10 μM ZnCl2, 10% (v/v) glycerol, 5 mM DTT). To remove 
any minor contaminants a final size exclusion step using a Superdex 200 10/300 GL 
column (GE Healthcare) in 20 mM Tris pH 7.5, 100 mM NaCl, 10 μM ZnCl2, 10% (v/v) 
glycerol, 5 mM DTT was carried out. SeMet-substituted Bye1 was grown in 2 L 
SelenoMet Base, 100 ml nutrient mix (Molecular Dimensions), 80 mg Selenomethionine 
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(Acros Organics) at 37 °C until absorbance at 600 nm of 0.6. 0.5 mM IPTG, 50 mg 
Selenomethionine, 100 mg Lysine, Threonine, Phenylalanine (Sigma-Aldrich), 50 mg 
Leucin, Isoleucin, Valin (Sigma-Aldrich) was added per 2 liter culture and the culture 
was grown for a further 18 h at 20 °C. Protein was purified as above. Bye1 TLD 
(residues 225-370) was expressed as a larger variant (residues 69-370) containing a 
protease cleavage site at the N-terminal border of the TLD, cloned into pOPINI with an 
N-terminal hexahistidine tag. The protein was expressed and purified as above except 
that buffers did not contain glycerol and the protein was eluted from the Ni-NTA column 
with 200 mM imidazole. After ion exchange purification, 300 µg precision protease was 
added and cleavage was carried out overnight at 4°C. To separate the cleavage 
products, the protein was applied to a pre-equilibrated (buffer A) Ni-NTA column. Bye1 
TLD could be collected in the flow-through fraction and was then applied to size-
exclusion chromatography using a Superdex 75 10/300 GL column. 
 
Surface Plasmon Resonance 
Approximately 2500 resonance units of yeast RNAPII were immobilized in 
immobilization buffer (Na-Acetate, pH 5) on the surface of a biosensor CM5 chip 
(Biacore) using the amine coupling kit (Biacore) (Löfås 1990; Johnsson et al. 1991). 
Recombinant Bye1 full-length was injected for 60 sec at 10 µl/min in running buffer 
(5 mM HEPES (pH 7.25 at 20 °C), 40 mM (NH4)2SO4, 10 µM ZnCl2, 5 mM DTT, 0.005% 
P20) at different concentrations (19 nM to 20 µM). The complex was allowed to 
dissociate for 5 min between injections. Affinity was measured for three independent 
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dilution series. Raw data were corrected for the bulk signal from buffer and by identical 
injection through a flow cell in which no RNAPII was immobilized. Data were analyzed 
with BIAevaluation software (Biacore). 
 
Crystallization and X-ray Structure Determination 
Complexes of RNAPII and Bye1 were formed by incubating RNAPII with a ten-fold 
molar amount of Bye1 at 4°C overnight. For the elongation complex (EC) and the 
arrested complex (AC), purified RNAPII (3.5 mg ml−1) was mixed with a two-fold molar 
excess of template (EC template see (Cheung et al. 2011), AC template see (Cheung 
and Cramer 2011)) prepared as described (Kettenberger et al. 2004), 8 mM magnesium 
chloride and 2 mM CTP (AC), and incubated for 1 h (EC) or 2 h (AC) at 20 °C before 
crystallization by vapor diffusion with 5-7% PEG 6000, 200 mM ammonium acetate, 
300 mM sodium acetate, 50 mM HEPES pH 7.0 and 5 mM TCEP as reservoir solution. 
Crystals were grown for 5–10 days, cryo-protected in mother solution supplemented with 
22% glycerol and containing 4 μM tailed template and 2 mM CTP, 8 mM magnesium 
chloride (AC), followed by overnight incubation at 8 °C before harvesting and freezing in 
liquid nitrogen. Bye1 TLD or SeMet substituted Bye1 was added to the cryo-protectant 
at 1 mg ml−1 and crystals were incubated overnight at 8 °C. For complexes containing 
AMPCPP, RNAPII was co-crystallized with nucleic acids in the presence of 8 mM 
magnesium chloride and was soaked with 2 mM AMPCPP in all cryo protectant 
solutions. For co-crystallization of RNAPII and Bye1 full-length, purified RNAPII (3.5 mg 
ml -1) was mixed with a tenfold molar excess of recombinant Bye1 and incubated over 
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night at 4°C before crystallization by vapor diffusion with 750 mM tri-Na-citrate and 100 
mM HEPES pH 7.5 as reservoir solution. Crystals were grown for 13 days, cryo-
protected in 22% glycerol, followed by one hour incubation before harvesting and flash-
freezing in liquid nitrogen. Diffraction data were collected at 100 K at beamline X06SA of 
the Swiss Light Source. Data were collected at 0.91887 Å, the K-absorption peak of 
bromine and 0.9797 Å, the K-absorption peak of selenium. Structures were solved with 
molecular replacement using BUSTER (Bricogne et al. 2012) and the structure of 12-
subunit RNAPII (1WCM) as search model. Refinement was performed using iterative 




Strains used in yeast chromatin fractionation were derived from W303. Plasmids 
containing HA-tagged, full-length Bye1, Bye1 ∆PHD (∆1-177) and Bye1 ∆TLD (∆177-
354) (obtained from S.D. Hanes, (Wu et al. 2003)) were transformed into wild-type 
yeast. Chromatin fractionation was performed as described in Chapter 2.   
 
Histone Peptide Microarrays 
Full-length Bye1 (residues 1-594) and Bye1 PHD (residues 47-134) were expressed as 
GST-fusions from exponentially growing (OD600 ~0.6) BL21 RIL cells by overnight 
induction with 0.4 mM IPTG at 16°C. Cells were lysed by sonication in cold 1x PBS pH 
7.6 containing 1 mM (PHD) or 5 mM (full-length) DTT, 1 mM PMSF, 1 mM ZnSO4, and 
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10% glycerol (full-length only). Proteins were captured on GST-Bind Resin (Novagen) 
and eluted in buffer containing 50 mM Tris-HCl pH 8.0 and 10 mM glutathione. Proteins 
were dialyzed into buffer containing 20 mM Tris-HCl pH 8.0, 150 mM NaCl, and 1 mM 
DTT prior to microarray hybridization. Peptide synthesis and validation, microarray 
fabrication, effector protein hybridization and detection, and data analysis were 
performed essentially as described (Rothbart et al. 2012b) with the following 
modification. Each peptide was spotted in triplicate eight times per array. Triplicate 
spots were averaged and treated as a single value for subsequent statistical analysis. 
 
Synthetic Lethality Screen 
Strains used to validate candidates from the synthetic lethality screens were derived 
from BY4741. Synthetic genetic array analysis was performed as described previously 
(Tong et al. 2001; Tong et al. 2004). Briefly, strain BY5563 bye1Δ was crossed to the 
complete knockout library of nonessential genes (Giaever et al. 2002). After sporulation 
and selection for the respective double knockout, the latter was screened for viability. 
The screen was performed on a Beckman-Coulter Biomek FX. 
 
In Vitro Transcription Assay 
Nuclear extracts of BY4741 and bye1Δ were prepared from 3L of yeast culture as 
described (24,25).  Activator-dependent in vitro transcription assays were carried out 
using 150 ng of recombinant full-length Gcn4 (26) and addition of recombinant Bye1. 
The transcript was detected by primer extension using the 5′-Cy5-labelled 
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oligonucleotide 5′-TTCACCAGTGAGACGGGCAAC-3’ (24). The resulting gel was 
scanned on a typhoon scanner FLA9400 and data was analyzed with ImageQuant 
Software (GE Healthcare). 
 
RNA Extension Assay 
RNA extension assays were carried out as described (27). All samples were incubated 
ON at 4°C prior to addition of NTPs to allow complex formation of RNAPII and Bye1. 
 
Results 
Bye1 Interacts with RNAPII  
To test whether RNAPII binds directly to Bye1 in vitro, we incubated pure yeast 
RNAPII with recombinant Bye1 and subjected the sample to size-exclusion 
chromatography (Materials and Methods). A stable and apparently stoichiometric 
RNAPII-Bye1 complex was obtained (Figure A.1B). To characterize the RNAPII-Bye1 
interaction, we used surface plasmon resonance. We immobilized RNAPII on a Biacore 
sensor chip by amine coupling (Löfås 1990; Johnsson et al. 1991) and determined Bye1 
association and dissociation rates ka and kd, respectively. The ratio of these rates 
provided a dissociation constant of KD=3.8 ± 2.2 µM. 
 
Structure of Bye1-bound RNAPII Elongation Complex 
Co-crystallization of RNAPII with full-length Bye1 yielded crystals diffracting to 
4.8 Å resolution. Structure solution by molecular replacement with free RNAPII 
(Armache et al. 2005) revealed strong positive difference density for the Bye1 TLD on 
  105 
the Rpb1 surface, but no density for the two other Bye1 domains. To obtain better 
diffraction, the Bye1 TLD was expressed in isolation and soaked into preformed RNAPII 
elongation complex crystals containing a DNA-RNA scaffold. Diffraction data to 3.15 Å 
resolution were obtained (Table A.1). Phasing with the RNAPII structure (Armache et al. 
2005) revealed positive difference density at the same location observed with full-length 
Bye1 (Figure A.1C, D). The Bye1 TLD structure was built with the aid of sequence 
markers obtained with selenomethionine-labeled protein, and the complex structure was 
refined to a free R-factor of 20.7% (Table A.1).  
 
Bye1 Binds the Polymerase Jaw 
The Bye1 TLD fold comprises an N-terminal three-helix bundle (helices α1-α3) 
followed by two short helices (α4, α5) that link to an extended C-terminal helix α6 
(Figure A.1E). This fold resembles that of TFIIS domain II (helices α1-α6) (Kettenberger 
et al. 2003), and helix α6 corresponding to the TFIIS linker between domains II and III 
(Figure A.2A). The Bye1 TLD binds the Rpb1 jaw domain at the location where TFIIS 
domain II binds the polymerase (Figure A.3). Despite an overall similarity in the 
interactions of Bye1 and TFIIS with RNAPII, the detailed contacts differ. The Bye1 helix 
α3 binds the loop ß30-ß31 and helix α40 of the Rpb1 jaw domain and induces ordering 
of loop α40-ß29. Helix α6 extends from the jaw into the RNAPII funnel, contacting the 
Rpb1 loops α20-α21 and ß29-α41, and strand ß32 of the Rpb1 funnel domain. The 
Bye1 loop α2-α3 contacts the N-terminus of Rpb5 (Figure A.2B-D).  
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Bye1 Does Not Change RNAPII Conformation 
TFIIS binding to RNAPII induces three major conformational changes. It 
repositions the large jaw-lobe module, traps the trigger loop in a locked conformation 
(Kettenberger et al. 2003), and realigns the RNA in the active site (Kettenberger et al. 
2004). Although Bye1 resembles part of TFIIS and binds to a similar position on 
RNAPII, it does not induce conformational changes (Figure A.2E). These observations 
predicted that Bye1 does not impair nucleoside triphosphate (NTP) binding to RNAPII, 
which requires closure of the trigger loop. Indeed, an additional structure of Bye1 bound 
to the RNAPII elongation complex with an NTP substrate revealed a closed trigger loop 
(Figure A.1F, A.4A). Bye1 binding also did not prevent backtracking of RNA into the 
RNAPII pore, as revealed by another structure of Bye1 bound to arrested RNAPII with 
backtracked RNA (Figure A.4B).  
 
Bye1 Does Not Influence Basic RNAPII Functions 
These observations suggested that Bye1 had no functional influence on basal 
transcription. Indeed nuclear extracts prepared from yeast cells lacking the gene 
encoding Bye1 were active in promoter-dependent in vitro transcription assays, and 
addition of purified Bye1 to WT nuclear extracts did not alter their activity (Figure A.5, 
(Ranish et al. 1999; Seizl et al. 2011a; Seizl et al. 2011b)). In contrast to TFIIS, Bye1 did 
not induce RNAPII backtracking and RNA cleavage on DNA-RNA scaffolds, but allowed 
for unperturbed elongation activity in RNA extension assays (Figure A.6, (Damsma et al. 
2007)). In addition, overall mRNA levels did not change upon Bye1 depletion, as shown 
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by comparative dynamic transcriptome analysis (Sun et al. 2012) (not shown). All these 
data indicate that Bye1 does neither induce structural changes in RNAPII functional 
complexes nor influence their function in vitro. 
 
Bye1 Associates with Chromatin via its TLD Domain 
The above results suggested that Bye1 functions in a chromatin context. To investigate 
whether Bye1 associates with chromatin in vivo and whether its RNAPII-binding TLD is 
required for this, we fractionated cell extracts into an insoluble, chromatin-containing 
fraction and a soluble, non-chromatin associated fraction as described (Donovan et al. 
1997; Keogh et al. 2006). We used strains harboring plasmids containing HA-tagged, 
full-length Bye1 (WT) or variants lacking either the PHD domain (∆PHD) or the TLD 
domain (∆TLD) (Wu et al. 2003). All variants of Bye1 were present at the same level in 
unfractionated whole cell extract (Figure A.7, lanes 1-4). WT Bye1 was present in the 
chromatin fraction. The ∆PHD variant was also present in the chromatin fraction, but the 
∆TLD variant associated with chromatin only weakly (Figure A.7, lanes 9-12). These 
results demonstrate that the TLD of Bye1 is important for the association of Bye1 with 
chromatin, but regions outside the TLD contributes to chromatin association. 
 
Bye1 Binds Active Histone Marks via its PHD Domain 
These results suggested that the PHD domain of Bye1 contributes to chromatin 
association, consistent with a report that this domain can bind trimethylated H3K4 
peptides (Shi et al. 2007a). We therefore investigated binding of the Bye1 PHD domain 
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to about 200 different histone peptides on a microarray (Rothbart et al. 2012b). 
Microarrays were spotted at high density (~4,000 individual features) with unique 
histone peptides that encompass known single and combinatorial post-translational 
modifications on the core and tail domains of the four histone proteins H3, H4, H2A, and 
H2B, and their variants. The Bye1 PHD domain as well as full-length Bye1 bound 
specifically to H3K4me3 peptides (Figure A.8A). The high correlation between arrays 
probed with full length Bye1 and the isolated PHD domain indicated that the histone 
binding potential of Bye1 is harbored solely within its PHD domain (Figure A.8B). The 
interaction of Bye1 with H3K4me3 was strongly influenced by neighboring modifications 
(Figure A.8C). In particular, marks of active transcription (H3K9ac, H3K14ac, H3K18ac, 
and H3S10p) enhanced Bye1 affinity to H3K4me3, whereas marks of transcription 
repression (H3R2 and H3R8 methylation, Cit2, T3 and T6 phosphorylation, and 
H3K9me3) impaired the interaction (Figure A.8D). 
 
Bye1 Occupies the 5’-Region of Active Genes 
These results suggested that Bye1 is recruited to actively transcribed genes in 
vivo. To test this, we carried out genomic occupancy profiling with the use of chromatin 
immunoprecipitation (ChIP) as described (Mayer et al. 2012). Metagene analysis by 
averaging occupancy profiles of genes of similar length revealed a Bye1 occupancy 
peak 110 nucleotides downstream of the transcription start site (TSS). No significant 
signals were observed in promoter regions or downstream of the polyadenylation (pA) 
site (Figure A.9A). Bye1 was found on all active genes and its occupancy level 
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correlated with those for bona fide RNAPII elongation factors such as Spt5 (Figure 
A.10A). Published ChIP data for active histone H3 marks show a peak at a similar 
location downstream of the TSS (Figure A.10B, (Schulze et al. 2011)). These results 
indicated that Bye1 is recruited to the 5’-region of active genes in vivo, and that active 
histone marks contribute to Bye1 recruitment. 
In order to interpret the ChIP data, we generated a three-dimensional topological 
model of the Bye1-bound RNAPII elongation complex approaching the +2 nucleosome 
of an active yeast gene (Figure A.9C). For the modeling we assumed that Bye1 
crosslinks to DNA via RNAPII in ChIP experiments, and set the RNAPII active center to 
nucleotide position +110 downstream of the TSS. We positioned the +2 nucleosome 
based on its experimentally defined average position. We also included models of the 
flexible Bye1 SPOC and PHD domains, with the latter bound to the H3 tail emerging 
from the core nucleosome particle (Figure A.9C). The resulting model explained the 
position of the ChIP peak with high H3K4me3 occupancy, and shows that it is 
structurally possible that Bye1 interacts simultaneously with the RNAPII core and the 
trimethylated H3 tail in the 5’ region of active genes. 
 
Bye1 Genetically Interacts with Paf1 and Tho2 
In order to identify genes that interact functionally with the gene encoding Bye1 
and thereby further elucidate Bye1 function, we screened a yeast deletion strain 
collection (Tong et al. 2001; Tong et al. 2004) for synthetic growth defects with bye1∆, 
which does not show any obvious phenotype (Wu et al. 2003). This screen revealed two 
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candidate genes, paf1 and tho2. Generating bye1∆paf1∆ and bye1∆tho2∆ double 
mutants in a different genetic background confirmed the synthetic interaction between 
these genes (Figure A.9D). The genes paf1 and tho2 encode for subunits of two bona 
fide elongation factor complexes. Paf1 belongs to the 5-subunit Paf1 complex that 
recruits the histone methyltransferase Set1 to transcribed genes (Krogan et al. 2003b; 
Wood et al. 2003b; Dehe and Geli 2006; Shilatifard 2008; Jaehning 2010). Set1 in turn 
is responsible for H3K4 trimethylation during transcription (Roguev et al. 2001). The 
interaction of Bye1 with H3K4me3 hence closes the link between Paf1 and Bye1. Tho2 
resides in the 4-subunit THO complex that is required for efficient transcription 
elongation (Rondon et al. 2003). These results strongly support an involvement of Bye1 
in transcription elongation through chromatin. 
 
PHF3 and DIDO1 are Human Homologues of Bye1 
No homologues in higher eukaryotes have been reported for Bye1. We 
performed a bioinformatics search based on the Pfam database (Punta et al. 2012) to 
identify potential homologues based on domain organization. We found two human 
proteins, PHD finger protein 3 (PHF3) and Death-inducer obliterator 1 (DIDO1), which 
show the same domain organization as Bye1. Both proteins contain an N-terminal PHD 
domain, a central TLD domain, and a C-terminal SPOC domain, with linkers of varying 
lengths in between these domains. PHF3 has been associated with glioma development 
as its expression is significantly reduced or lost in glioblastomas (Fischer et al. 2001). 
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DIDO1 is a potential tumor suppressor showing abnormal expression patterns in 
patients with myelodysplastic and myeloproliferative diseases (Futterer et al. 2005).  
To corroborate the homology of PHF3 and DIDO1 with Bye1, we analyzed the 
conservation of the RNAPII-TLD interface. Both yeast RNAPII and Bye1 surfaces 
forming the interface are well conserved in human RNAPII and PHF3/DIDO1, 
respectively (Figure A.11, A.12). In particular, a salt bridge between Bye1 residue K314 
and E1168 in the largest RNAPII subunit Rpb1 is conserved in the predicted human 
PHF3/DIDO1-RNAPII complexes. Similarly, many hydrogen bonds observed between 
the Bye1 TLD and Rpb1 (Bye1 residues N292, S311, D315, R355, N362, F363) are 
predicted to be conserved in the homologous human complexes. These results predict 
that PHF3 and DIDO1 contain RNAPII-binding TLD domains and are human 
homologues of yeast Bye1, and indicate that our structures and results are relevant for 
understanding the human proteins. 
 
Discussion 
Here we show that the nuclear protein Bye1 binds to RNAPII, and report crystal 
structures of the central TLD domain of Bye1 bound to free RNAPII, a RNAPII 
elongation complex with DNA template and RNA transcript, an elongation complex with 
an NTP analogue, and an arrested elongation complex with backtracked RNA. These 
studies represent only the third high-resolution structural analysis of a transcription 
factor complex with the polymerase core. Whereas the previously studied factors TFIIB 
and TFIIS alter RNAPII function by directly affecting catalytic events, Bye1 does not 
alter basic RNAPII functions in vitro. Consistent with this, Bye1 binding to RNAPII does 
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not alter RNAPII conformation in the structures. Additional functional data in vitro and in 
vivo indicate that Bye1 occupies active genes in their 5’-region and can bind to histone 
H3 tails with active marks using its PHD domain. 
What could be the function of Bye1 in chromatin transcription? We show that the 
TLD of Bye1 is required for chromatin association of Bye1. It is thus unlikely that Bye1 
would recognize active chromatin marks, and then recruit RNAPII to active chromatin 
regions. In contrast, our data indicate that Bye1 binds RNAPII during early elongation 
and tethers surrounding H3 histones containing active marks to RNAPII, maybe to 
cooperate with other chromatin elongation factors such as Spt6 and FACT and prevent 
loss of histones during polymerase passage through chromatin. This model is 
consistent with the observation that PHF3 and DIDO1, the putative homologues of Bye1 
in human cells that we detected here, both may prevent deregulated transcription that 
may arise from histone loss, thus suppressing cancer development. 
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9.95 (1.57) 14.66 (1.52) 
CC(1/2) 98.5 
(60.8) 
99.8 (63.2) 99.6 (56.3) 99.8 (67.1) 
Refinement 
Non-H atoms 31510 33234 33026 32753 
B-factor 
(mean) 
199.00 109.12 125.34 120.59 
Rmsd bonds 0.010 0.010 0.010 0.010 
Rmsd angles 1.33 1.27 1.29 1.29 
Rcryst (%) 19.06 18.92 17.49 18.03 
Rfree (%) 25.27 20.70 20.62 20.68 
 
Values in parenthesis are for the highest resolution shell. All data were collected with a 
radiation wavelength of 0.9188 Å.  





Figure A.1 Structure of the RNAPII-Bye1 Elongation Complex 
 
(A) Bye1 domain organization. PHD: Plant Homeodomain, TLD: TFIIS-like domain, 
SPOC: Spen paralogue and orthologue C-terminal domain. Bordering residue numbers 
are indicated. (B) SDS–PAGE analysis (Coomassie staining) of endogenous yeast Pol II 
(left), recombinant Bye1 (center), and the Pol II-Bye1 complex after size exclusion 
chromatography (right). (C) Ribbon model of the Pol II-Bye1 elongation complex crystal 
structure. The views correspond to the side and front views of Pol II used before 
(Cramer et al. 2001) and are related by a 90° rotation around a vertical axis. (D) 
Unbiased difference electron density (blue mesh, contoured at 2.6 σ) for Bye1 TLD after 
phasing with the Pol II structure. (E) Close-up view of the Pol II-Bye1 interaction. Mobile 
loops are indicated by dashed lines. (F) Contacts of AMPCPP with the closed trigger 
loop in the AMPCPP-containing Pol II-Bye1 elongation complex structure. Residues 
involved in hydrogen bond formation are shown as sticks, hydrogen bonds are indicated 
by dashed lines. 
 












Figure A.2 RNAPII-Bye1 Interaction and Comparison with TFIIS 
 
(A) Side view of the Bye1 TLD bound to Pol II (top), TFIIS (middle) in its Pol II-bound 
state (Cheung and Cramer 2011) with its central domain II (green), linker helix (yellow), 
and the C-terminal zinc ribbon domain III (orange), and superposition of the two 
structures (bottom). (B) Details of the interaction of the Bye1 TLD with the Pol II Rpb1 
jaw domain (blue). The view is from the side. (C) Side view of the Pol II Rpb1 funnel and 
jaw domain-Bye1 TLD interaction. Residues involved in hydrogen bond formation or salt 
bridges (dashed lines) are shown as sticks. (D) Details of the interaction of the Bye1 
TLD with the Pol II Rpb5 jaw domain (magenta). (E) In the Pol II-TFIIS complex 
structure, conformational changes in Pol II are induced by movements of the Pol II Rpb1 
loop α20-α21, which results in opening of a crevice in the polymerase funnel. Loop 
movements are observed for TFIIS-bound Pol II (yellow) (Cheung and Cramer 2011), 














Figure A.3 Structure of RNAPII-TFIIS Complex 
 
Adapted from (Kettenberger et al. 2004). 
 
  








Figure A.4 Structures of Additional RNAPII-Bye1 Complexes 
 
(A) Ribbon model of the Pol2-Bye1 complex containing an additional nucleotide. (B) 























Figure A.5 Transcriptional Activity of Bye1-Depleted Nuclear Extracts 
 
Transcriptional activities of wild type (WT) and Bye1-depleted (bye1∆) nuclear extracts 
(NE) in an in vitro transcription assay using a nucleosome-free DNA template. 
 
  










Figure A.6 Effect of Bye1 on RNAPII Elongation in Vitro 
 
(A) Nucleic acid scaffold for reconstitution of Pol II-EC. (B) Gel electrophoresis 









Figure A.7 Bye1 Associates with Chromatin via its TLD Domain 
 
Immunoblot of whole-cell extract (WCE), chromatin-bound and soluble cell fraction to 
hemagglutinin tag (HA), histone H4 (H4) and glucose-6-phosphate-1-dehydrogenase 
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Figure A.8 Bye1 Preferentially Binds Histone Peptides Carrying Active 
Modifications 
 
(A) Peptide array binding analysis reveals that Bye1 preferentially binds a H3K4me3 
peptide and its PHD domain is sufficient for this interaction. (B) Scatter plot showing the 
correlation of two arrays probed with full-length Bye1 and the Bye1 PHD domain for 
H3K4me3 binding (green dots). All other peptides are shown as black dots. (C) Heat 
map depicting the effects of combinatorial modifications on the binding of Bye1 to 
H3K4me3-containing peptides. Binding intensities are represented relative to H3K4me3 
(0, white). Enhanced (1, red) and occluded (− 1, blue) interactions are depicted. (D) 
Summary of modifications enhancing (blue) and impairing (red) Bye1 affinity to 
H3K4me3. 
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Figure A.9 Bye1 Associates with Active Genes in Front of the +2 Nucleosome 
 
(A) Gene-averaged Bye1 ChIP occupancy profile for the median gene length class 
(1,238 ± 300 nt, 339 genes). TSS, transcription start site; pA, polyadenylation site. (B) 
Scheme showing occupancies of Bye1 and H3K4me4 derived from ChIP data and 
nucleosome position derived from the model in C. (C) Model of a Pol II-nucleosome-
Bye1 complex based on crystal structures and ChIP occupancy peak positions. 
Distances in base pairs (bp) are indicated between the Pol II active center and the 
nucleosome as well as for the nucleosomal DNA. The model is based on the structure 
of the nucleosome core particle by Luger et al. (1997). Modeling was performed with 
Coot (Emsley et al. 2010). Bye1 PHD and SPOC domain were modeled using Modeller 
(Sanchez and Sali 1997). The PHD domain model is based on structures 3kqi, 1wem, 
1wew, 2lv9 and 1wep, which were identified by HHpred (Soding et al. 2005) to be most 
similar to Bye1 PHD. Binding of the PHD domain to H3K4me3 was modeled based on 
structure 2jmj. The SPOC domain model is based on structure 1ow1. (D) Bye1 
genetically interacts with Paf1 and Tho2. Serial dilutions of strains bye1∆, paf1∆, 
bye1∆paf1∆, tho2∆, bye1∆tho2∆, and an isogenic wild-type (WT) control strain were 
placed on YPD plates and incubated at 30°C for 3 days. 
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Figure A.10 ChIP-chip Analysis of Bye1 
 















Figure A.11 Conservation of RNAPII-Binding Residues in Bye1 Human 
Homologues 
 
Amino-acid sequence alignments of S. cerevisiae Bye1, H. sapiens PHF3, H. sapiens 
DIDO1, H. sapiens TFIIS and S. cerevisiae TFIIS. Secondary structure elements are 
indicated as arrows (ß-strands) or rods (α-helices). Loops are indicated with solid lines. 
Residues that are part of the Pol II-Bye1 interface are marked with black triangles. 
















Figure A.12 Conservation of RNAPII-Bye1 Interface in Human Homologues 
 
Amino-acid sequence alignments of S. cerevisiae Rpb1 and H. sapiens 
Rpb1.Secondary structure elements are indicated as arrows (ß-strands) or rods (α-
helices). Loops are indicated with solid lines. Residues that are part of the Pol II-Bye1 
interface are marked with black triangles. 
  126 
REFERENCES   
Aasland R, Gibson TJ, Stewart AF. 1995. The PHD finger: implications for chromatin-
mediated transcriptional regulation. Trends Biochem Sci 20: 56-59. 
Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging 
roles in metazoans. Nat Rev Genet 13: 720-731. 
Ahn SH, Cheung WL, Hsu JY, Diaz RL, Smith MM, Allis CD. 2005. Sterile 20 kinase 
phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced 
apoptosis in S. cerevisiae. Cell 120: 25-36. 
Altaf M, Utley RT, Lacoste N, Tan S, Briggs SD, Cote J. 2007. Interplay of chromatin 
modifiers on a short basic patch of histone H4 tail defines the boundary of 
telomeric heterochromatin. Molecular cell 28: 1002-1014. 
Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M. 2008. Recognition of hemi-
methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. 
Nature 455: 818-821. 
Ariyoshi M, Schwabe JW. 2003. A conserved structural motif reveals the essential 
transcriptional repression function of Spen proteins and their role in 
developmental signaling. Genes Dev 17: 1909-1920. 
Armache KJ, Mitterweger S, Meinhart A, Cramer P. 2005. Structures of complete RNA 
polymerase II and its subcomplex, Rpb4/7. J Biol Chem 280: 7131-7134. 
Avvakumov N, Nourani A, Cote J. 2011. Histone chaperones: modulators of chromatin 
marks. Molecular cell 41: 502-514. 
Awrey DE, Shimasaki N, Koth C, Weilbaecher R, Olmsted V, Kazanis S, Shan X, 
Arellano J, Arrowsmith CH, Kane CM et al. 1998. Yeast transcript elongation 
factor (TFIIS), structure and function. II: RNA polymerase binding, transcript 
cleavage, and read-through. J Biol Chem 273: 22595-22605. 
Bannister AJ, Kouzarides T. 2011. Regulation of chromatin by histone modifications. 
Cell research 21: 381-395. 
Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, Kouzarides T. 2010. 
Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 
143: 470-484. 
Berger SL. 2007. The complex language of chromatin regulation during transcription. 
Nature 447: 407-412. 
Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, 
McMahon S, Karlsson EK, Kulbokas EJ, 3rd, Gingeras TR et al. 2005. Genomic 
  127 
maps and comparative analysis of histone modifications in human and mouse. 
Cell 120: 169-181. 
Black BE, Cleveland DW. 2011. Epigenetic centromere propagation and the nature of 
CENP-a nucleosomes. Cell 144: 471-479. 
Black JC, Van Rechem C, Whetstine JR. 2012. Histone lysine methylation dynamics: 
establishment, regulation, and biological impact. Molecular cell 48: 491-507. 
Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE. 2012. A tumor 
suppressor function of Smurf2 associated with controlling chromatin landscape 
and genome stability through RNF20. Nat Med 18: 227-234. 
Brachmann CB, Sherman JM, Devine SE, Cameron EE, Pillus L, Boeke JD. 1995. The 
SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell 
cycle progression, and chromosome stability. Genes Dev 9: 2888-2902. 
Brickner DG, Cajigas I, Fondufe-Mittendorf Y, Ahmed S, Lee PC, Widom J, Brickner JH. 
2007. H2A.Z-mediated localization of genes at the nuclear periphery confers 
epigenetic memory of previous transcriptional state. PLoS biology 5: e81. 
Bricogne G, Blanc E, Brandl M, Flensburg C, Keller P, Paciorek P, Roversi P, Sharff A, 
Smart O, Vonrhein C et al. 2012. BUSTER Version 2.11.5. 
Briggs SD, Xiao T, Sun ZW, Caldwell JA, Shabanowitz J, Hunt DF, Allis CD, Strahl BD. 
2002. Gene silencing: trans-histone regulatory pathway in chromatin. Nature 418: 
498. 
Burgess RJ, Zhang Z. 2013. Histone chaperones in nucleosome assembly and human 
disease. Nature structural & molecular biology 20: 14-22. 
Bushnell DA, Westover KD, Davis RE, Kornberg RD. 2004. Structural basis of 
transcription: an RNA polymerase II-TFIIB cocrystal at 4.5 Angstroms. Science 
303: 983-988. 
Calo E, Wysocka J. 2013. Modification of enhancer chromatin: what, how, and why? 
Molecular cell 49: 825-837. 
Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, Anderson 
S, Yates J, Washburn MP et al. 2005. Histone H3 methylation by Set2 directs 
deacetylation of coding regions by Rpd3S to suppress spurious intragenic 
transcription. Cell 123: 581-592. 
Chandrasekharan MB, Huang F, Chen YC, Sun ZW. 2010a. Histone H2B C-terminal 
helix mediates trans-histone H3K4 methylation independent of H2B 
ubiquitination. Molecular and cellular biology 30: 3216-3232. 
  128 
Chandrasekharan MB, Huang F, Sun ZW. 2009. Ubiquitination of histone H2B regulates 
chromatin dynamics by enhancing nucleosome stability. Proceedings of the 
National Academy of Sciences of the United States of America 106: 16686-
16691. 
Chandrasekharan MB, Huang F, Sun ZW. 2010b. Histone H2B ubiquitination and 
beyond: Regulation of nucleosome stability, chromatin dynamics and the trans-
histone H3 methylation. Epigenetics : official journal of the DNA Methylation 
Society 5: 460-468. 
Chernikova SB, Razorenova OV, Higgins JP, Sishc BJ, Nicolau M, Dorth JA, 
Chernikova DA, Kwok S, Brooks JD, Bailey SM et al. 2012. Deficiency in 
mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication 
stress and chromosomal instability. Cancer Res 72: 2111-2119. 
Cheung AC, Cramer P. 2011. Structural basis of RNA polymerase II backtracking, arrest 
and reactivation. Nature 471: 249-253. 
Cheung AC, Sainsbury S, Cramer P. 2011. Structural basis of initial RNA polymerase II 
transcription. The EMBO journal 30: 4755-4763. 
Cheung V, Chua G, Batada NN, Landry CR, Michnick SW, Hughes TR, Winston F. 
2008. Chromatin- and transcription-related factors repress transcription from 
within coding regions throughout the Saccharomyces cerevisiae genome. PLoS 
biology 6: e277. 
Clapier CR, Cairns BR. 2009. The biology of chromatin remodeling complexes. Annual 
review of biochemistry 78: 273-304. 
Cramer P, Bushnell DA, Kornberg RD. 2001. Structural basis of transcription: RNA 
polymerase II at 2.8 angstrom resolution. Science 292: 1863-1876. 
Damsma GE, Alt A, Brueckner F, Carell T, Cramer P. 2007. Mechanism of 
transcriptional stalling at cisplatin-damaged DNA. Nature structural & molecular 
biology 14: 1127-1133. 
Dantuma NP, Groothuis TA, Salomons FA, Neefjes J. 2006. A dynamic ubiquitin 
equilibrium couples proteasomal activity to chromatin remodeling. J Cell Biol 173: 
19-26. 
Dehe PM, Geli V. 2006. The multiple faces of Set1. Biochem Cell Biol 84: 536-548. 
Donovan S, Harwood J, Drury LS, Diffley JF. 1997. Cdc6p-dependent loading of Mcm 
proteins onto pre-replicative chromatin in budding yeast. Proceedings of the 
National Academy of Sciences of the United States of America 94: 5611-5616. 
  129 
Dover J, Schneider J, Tawiah-Boateng MA, Wood A, Dean K, Johnston M, Shilatifard A. 
2002. Methylation of histone H3 by COMPASS requires ubiquitination of histone 
H2B by Rad6. J Biol Chem 277: 28368-28371. 
Dronamraju R, Strahl BD. 2014. A feed forward circuit comprising Spt6, Ctk1 and PAF 
regulates Pol II CTD phosphorylation and transcription elongation. Nucleic acids 
research 42: 870-881. 
Du HN, Briggs SD. 2010. A nucleosome surface formed by histone H4, H2A, and H3 
residues is needed for proper histone H3 Lys36 methylation, histone acetylation, 
and repression of cryptic transcription. J Biol Chem 285: 11704-11713. 
Eberl HC, Spruijt CG, Kelstrup CD, Vermeulen M, Mann M. 2013. A map of general and 
specialized chromatin readers in mouse tissues generated by label-free 
interaction proteomics. Molecular cell 49: 368-378. 
Elsaesser SJ, Allis CD. 2010. HIRA and Daxx constitute two independent histone H3.3-
containing predeposition complexes. Cold Spring Harb Symp Quant Biol 75: 27-
34. 
Emre NC, Ingvarsdottir K, Wyce A, Wood A, Krogan NJ, Henry KW, Li K, Marmorstein 
R, Greenblatt JF, Shilatifard A et al. 2005. Maintenance of low histone 
ubiquitylation by Ubp10 correlates with telomere-proximal Sir2 association and 
gene silencing. Molecular cell 17: 585-594. 
Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. 
Acta Crystallogr D Biol Crystallogr 66: 486-501. 
Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K, Zhang Y. 2002. 
Methylation of H3-lysine 79 is mediated by a new family of HMTases without a 
SET domain. Current biology : CB 12: 1052-1058. 
Ferreira H, Flaus A, Owen-Hughes T. 2007. Histone modifications influence the action 
of Snf2 family remodelling enzymes by different mechanisms. J Mol Biol 374: 
563-579. 
Fierz B, Chatterjee C, McGinty RK, Bar-Dagan M, Raleigh DP, Muir TW. 2011. Histone 
H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nature 
chemical biology 7: 113-119. 
Fingerman IM, Li HC, Briggs SD. 2007. A charge-based interaction between histone H4 
and Dot1 is required for H3K79 methylation and telomere silencing: identification 
of a new trans-histone pathway. Genes Dev 21: 2018-2029. 
  130 
Fischer U, Struss AK, Hemmer D, Michel A, Henn W, Steudel WI, Meese E. 2001. 
PHF3 expression is frequently reduced in glioma. Cytogenet Cell Genet 94: 131-
136. 
Flanagan JF, Mi LZ, Chruszcz M, Cymborowski M, Clines KL, Kim Y, Minor W, 
Rastinejad F, Khorasanizadeh S. 2005. Double chromodomains cooperate to 
recognize the methylated histone H3 tail. Nature 438: 1181-1185. 
Fleming AB, Kao CF, Hillyer C, Pikaart M, Osley MA. 2008. H2B ubiquitylation plays a 
role in nucleosome dynamics during transcription elongation. Molecular cell 31: 
57-66. 
Fuchs SM, Kizer KO, Braberg H, Krogan NJ, Strahl BD. 2012. RNA polymerase II 
carboxyl-terminal domain phosphorylation regulates protein stability of the Set2 
methyltransferase and histone H3 di- and trimethylation at lysine 36. J Biol Chem 
287: 3249-3256. 
Fuchs SM, Laribee RN, Strahl BD. 2009. Protein modifications in transcription 
elongation. Biochim Biophys Acta 1789: 26-36. 
Futterer A, Campanero MR, Leonardo E, Criado LM, Flores JM, Hernandez JM, San 
Miguel JF, Martinez AC. 2005. Dido gene expression alterations are implicated in 
the induction of hematological myeloid neoplasms. J Clin Invest 115: 2351-2362. 
Game JC, Chernikova SB. 2009. The role of RAD6 in recombinational repair, 
checkpoints and meiosis via histone modification. DNA Repair (Amst) 8: 470-
482. 
Game JC, Williamson MS, Spicakova T, Brown JM. 2006. The RAD6/BRE1 histone 
modification pathway in Saccharomyces confers radiation resistance through a 
RAD51-dependent process that is independent of RAD18. Genetics 173: 1951-
1968. 
Gardner KE, Allis CD, Strahl BD. 2011. Operating on chromatin, a colorful language 
where context matters. J Mol Biol 409: 36-46. 
Gardner RG, Nelson ZW, Gottschling DE. 2005. Ubp10/Dot4p regulates the persistence 
of ubiquitinated histone H2B: distinct roles in telomeric silencing and general 
chromatin. Molecular and cellular biology 25: 6123-6139. 
Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S, Lucau-Danila A, 
Anderson K, Andre B et al. 2002. Functional profiling of the Saccharomyces 
cerevisiae genome. Nature 418: 387-391. 
  131 
Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, 
Law M, Guo X, Li X et al. 2010. Distinct factors control histone variant H3.3 
localization at specific genomic regions. Cell 140: 678-691. 
Grant PA, Duggan L, Cote J, Roberts SM, Brownell JE, Candau R, Ohba R, Owen-
Hughes T, Allis CD, Winston F et al. 1997. Yeast Gcn5 functions in two 
multisubunit complexes to acetylate nucleosomal histones: characterization of an 
Ada complex and the SAGA (Spt/Ada) complex. Genes Dev 11: 1640-1650. 
Gunesdogan U, Jackle H, Herzig A. 2010. A genetic system to assess in vivo the 
functions of histones and histone modifications in higher eukaryotes. EMBO 
reports 11: 772-776. 
Hagstrom KA, Meyer BJ. 2003. Condensin and cohesin: more than chromosome 
compactor and glue. Nat Rev Genet 4: 520-534. 
Hahn S, Young ET. 2011. Transcriptional regulation in Saccharomyces cerevisiae: 
transcription factor regulation and function, mechanisms of initiation, and roles of 
activators and coactivators. Genetics 189: 705-736. 
Hani J, Stumpf G, Domdey H. 1995. PTF1 encodes an essential protein in 
Saccharomyces cerevisiae, which shows strong homology with a new putative 
family of PPIases. FEBS Lett 365: 198-202. 
Hartzog GA, Wada T, Handa H, Winston F. 1998. Evidence that Spt4, Spt5, and Spt6 
control transcription elongation by RNA polymerase II in Saccharomyces 
cerevisiae. Genes Dev 12: 357-369. 
Heidemann M, Hintermair C, Voss K, Eick D. 2013. Dynamic phosphorylation patterns 
of RNA polymerase II CTD during transcription. Biochim Biophys Acta 1829: 55-
62. 
Henry KW, Wyce A, Lo WS, Duggan LJ, Emre NC, Kao CF, Pillus L, Shilatifard A, Osley 
MA, Berger SL. 2003. Transcriptional activation via sequential histone H2B 
ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes 
Dev 17: 2648-2663. 
Hirschhorn JN, Bortvin AL, Ricupero-Hovasse SL, Winston F. 1995. A new class of 
histone H2A mutations in Saccharomyces cerevisiae causes specific 
transcriptional defects in vivo. Molecular and cellular biology 15: 1999-2009. 
Horn PJ, Peterson CL. 2002. Molecular biology. Chromatin higher order folding--
wrapping up transcription. Science 297: 1824-1827. 
Hsin JP, Manley JL. 2012. The RNA polymerase II CTD coordinates transcription and 
RNA processing. Genes Dev 26: 2119-2137. 
  132 
Huibregtse JM, Yang JC, Beaudenon SL. 1997. The large subunit of RNA polymerase II 
is a substrate of the Rsp5 ubiquitin-protein ligase. Proceedings of the National 
Academy of Sciences of the United States of America 94: 3656-3661. 
Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C, Madhani HD. 
2003. A conserved RING finger protein required for histone H2B 
monoubiquitination and cell size control. Molecular cell 11: 261-266. 
Jacobson RH, Ladurner AG, King DS, Tjian R. 2000. Structure and function of a human 
TAFII250 double bromodomain module. Science 288: 1422-1425. 
Jaehning JA. 2010. The Paf1 complex: platform or player in RNA polymerase II 
transcription? Biochim Biophys Acta 1799: 379-388. 
Janke C, Magiera MM, Rathfelder N, Taxis C, Reber S, Maekawa H, Moreno-Borchart 
A, Doenges G, Schwob E, Schiebel E et al. 2004. A versatile toolbox for PCR-
based tagging of yeast genes: new fluorescent proteins, more markers and 
promoter substitution cassettes. Yeast 21: 947-962. 
Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293: 1074-1080. 
Jha DK, Strahl BD. 2014. An RNA polymerase II-coupled function for histone H3K36 
methylation in checkpoint activation and DSB repair. Nat Commun 5: 3965. 
Johnsson B, Lofas S, Lindquist G. 1991. Immobilization of proteins to a 
carboxymethyldextran-modified gold surface for biospecific interaction analysis in 
surface plasmon resonance sensors. Anal Biochem 198: 268-277. 
Jones PA. 2012. Functions of DNA methylation: islands, start sites, gene bodies and 
beyond. Nat Rev Genet 13: 484-492. 
Kaiser SE, Riley BE, Shaler TA, Trevino RS, Becker CH, Schulman H, Kopito RR. 2011. 
Protein standard absolute quantification (PSAQ) method for the measurement of 
cellular ubiquitin pools. Nat Methods 8: 691-696. 
Kao CF, Hillyer C, Tsukuda T, Henry K, Berger S, Osley MA. 2004. Rad6 plays a role in 
transcriptional activation through ubiquitylation of histone H2B. Genes Dev 18: 
184-195. 
Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Tillo D, Field Y, LeProust EM, 
Hughes TR, Lieb JD, Widom J et al. 2009. The DNA-encoded nucleosome 
organization of a eukaryotic genome. Nature 458: 362-366. 
Kasten M, Szerlong H, Erdjument-Bromage H, Tempst P, Werner M, Cairns BR. 2004. 
Tandem bromodomains in the chromatin remodeler RSC recognize acetylated 
histone H3 Lys14. The EMBO journal 23: 1348-1359. 
  133 
Katan-Khaykovich Y, Struhl K. 2002. Dynamics of global histone acetylation and 
deacetylation in vivo: rapid restoration of normal histone acetylation status upon 
removal of activators and repressors. Genes Dev 16: 743-752. 
Keogh MC, Kim JA, Downey M, Fillingham J, Chowdhury D, Harrison JC, Onishi M, 
Datta N, Galicia S, Emili A et al. 2006. A phosphatase complex that 
dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. 
Nature 439: 497-501. 
Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, Schuldiner M, 
Chin K, Punna T, Thompson NJ et al. 2005. Cotranscriptional set2 methylation of 
histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123: 593-605. 
Kettenberger H, Armache KJ, Cramer P. 2003. Architecture of the RNA polymerase II-
TFIIS complex and implications for mRNA cleavage. Cell 114: 347-357. 
Kettenberger H, Armache KJ, Cramer P. 2004. Complete RNA polymerase II elongation 
complex structure and its interactions with NTP and TFIIS. Molecular cell 16: 
955-965. 
Kim J, Kim JA, McGinty RK, Nguyen UT, Muir TW, Allis CD, Roeder RG. 2013. The n-
SET domain of Set1 regulates H2B ubiquitylation-dependent H3K4 methylation. 
Molecular cell 49: 1121-1133. 
Kim J, Roeder RG. 2009. Direct Bre1-Paf1 complex interactions and RING finger-
independent Bre1-Rad6 interactions mediate histone H2B ubiquitylation in yeast. 
J Biol Chem 284: 20582-20592. 
Kizer KO, Phatnani HP, Shibata Y, Hall H, Greenleaf AL, Strahl BD. 2005. A novel 
domain in Set2 mediates RNA polymerase II interaction and couples histone H3 
K36 methylation with transcript elongation. Molecular and cellular biology 25: 
3305-3316. 
Komander D, Rape M. 2012. The ubiquitin code. Annual review of biochemistry 81: 203-
229. 
Kornberg RD, Lorch Y. 1999. Twenty-five years of the nucleosome, fundamental particle 
of the eukaryote chromosome. Cell 98: 285-294. 
Kostrewa D, Zeller ME, Armache KJ, Seizl M, Leike K, Thomm M, Cramer P. 2009. 
RNA polymerase II-TFIIB structure and mechanism of transcription initiation. 
Nature 462: 323-330. 
Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705. 
  134 
Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, 
Golshani A, Johnston M et al. 2003a. The Paf1 complex is required for histone 
H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to 
histone methylation. Molecular cell 11: 721-729. 
Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, 
Golshani A, Johnston M et al. 2003b. The Paf1 complex is required for histone 
H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to 
histone methylation. Molecular cell 11: 721-729. 
Kumar A, Cheung KH, Ross-Macdonald P, Coelho PS, Miller P, Snyder M. 2000. 
TRIPLES: a database of gene function in Saccharomyces cerevisiae. Nucleic 
acids research 28: 81-84. 
Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG, Roth SY, Allis 
CD. 1996. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at 
specific lysines. Nature 383: 269-272. 
Kwak H, Lis JT. 2013. Control of transcriptional elongation. Annu Rev Genet 47: 483-
508. 
Lacoste N, Utley RT, Hunter JM, Poirier GG, Cote J. 2002. Disruptor of telomeric 
silencing-1 is a chromatin-specific histone H3 methyltransferase. The Journal of 
biological chemistry 277: 30421-30424. 
Lan F, Collins RE, De Cegli R, Alpatov R, Horton JR, Shi X, Gozani O, Cheng X, Shi Y. 
2007. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-
mediated gene repression. Nature 448: 718-722. 
Laribee RN, Krogan NJ, Xiao T, Shibata Y, Hughes TR, Greenblatt JF, Strahl BD. 2005. 
BUR kinase selectively regulates H3 K4 trimethylation and H2B ubiquitylation 
through recruitment of the PAF elongation complex. Current biology : CB 15: 
1487-1493. 
Latham JA, Chosed RJ, Wang S, Dent SY. 2011. Chromatin signaling to kinetochores: 
transregulation of Dam1 methylation by histone H2B ubiquitination. Cell 146: 
709-719. 
Lee JS, Shukla A, Schneider J, Swanson SK, Washburn MP, Florens L, Bhaumik SR, 
Shilatifard A. 2007. Histone crosstalk between H2B monoubiquitination and H3 
methylation mediated by COMPASS. Cell 131: 1084-1096. 
Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128: 
707-719. 
  135 
Li B, Howe L, Anderson S, Yates JR, 3rd, Workman JL. 2003. The Set2 histone 
methyltransferase functions through the phosphorylated carboxyl-terminal 
domain of RNA polymerase II. The Journal of biological chemistry 278: 8897-
8903. 
Li B, Jackson J, Simon MD, Fleharty B, Gogol M, Seidel C, Workman JL, Shilatifard A. 
2009. Histone H3 lysine 36 dimethylation (H3K36me2) is sufficient to recruit the 
Rpd3s histone deacetylase complex and to repress spurious transcription. The 
Journal of biological chemistry 284: 7970-7976. 
Li G, Reinberg D. 2011. Chromatin higher-order structures and gene regulation. Current 
opinion in genetics & development 21: 175-186. 
Liu C, Apodaca J, Davis LE, Rao H. 2007. Proteasome inhibition in wild-type yeast 
Saccharomyces cerevisiae cells. Biotechniques 42: 158, 160, 162. 
Liu X, Bushnell DA, Wang D, Calero G, Kornberg RD. 2010. Structure of an RNA 
polymerase II-TFIIB complex and the transcription initiation mechanism. Science 
327: 206-209. 
Löfås SaJ, Bo. 1990. A Novel Hydrogel Matrix on Gold Surfaces in Surface Plasmon 
Resonance Sensors for Fast and Efficient Covalent Immobilization of Ligands 
Journal of The Chemical Society, Chemical Communications. 
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure 
of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260. 
Luk E, Vu ND, Patteson K, Mizuguchi G, Wu WH, Ranjan A, Backus J, Sen S, Lewis M, 
Bai Y et al. 2007. Chz1, a nuclear chaperone for histone H2AZ. Molecular cell 25: 
357-368. 
Maltby VE, Martin BJ, Schulze JM, Johnson I, Hentrich T, Sharma A, Kobor MS, Howe 
L. 2012. Histone H3 lysine 36 methylation targets the Isw1b remodeling complex 
to chromatin. Molecular and cellular biology 32: 3479-3485. 
Mayer A, Heidemann M, Lidschreiber M, Schreieck A, Sun M, Hintermair C, Kremmer E, 
Eick D, Cramer P. 2012. CTD tyrosine phosphorylation impairs termination factor 
recruitment to RNA polymerase II. Science 336: 1723-1725. 
Maze I, Noh KM, Soshnev AA, Allis CD. 2014. Every amino acid matters: essential 
contributions of histone variants to mammalian development and disease. Nat 
Rev Genet 15: 259-271. 
McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW. 2008. Chemically ubiquitylated 
histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature 
453: 812-816. 
  136 
Mehta M, Braberg H, Wang S, Lozsa A, Shales M, Solache A, Krogan NJ, Keogh MC. 
2010. Individual lysine acetylations on the N terminus of Saccharomyces 
cerevisiae H2A.Z are highly but not differentially regulated. J Biol Chem 285: 
39855-39865. 
Milne TA, Kim J, Wang GG, Stadler SC, Basrur V, Whitcomb SJ, Wang Z, Ruthenburg 
AJ, Elenitoba-Johnson KS, Roeder RG et al. 2010. Multiple interactions recruit 
MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis. 
Molecular cell 38: 853-863. 
Mimnaugh EG, Chen HY, Davie JR, Celis JE, Neckers L. 1997. Rapid deubiquitination 
of nucleosomal histones in human tumor cells caused by proteasome inhibitors 
and stress response inducers: effects on replication, transcription, translation, 
and the cellular stress response. Biochemistry 36: 14418-14429. 
Mischo HE, Proudfoot NJ. 2013. Disengaging polymerase: terminating RNA polymerase 
II transcription in budding yeast. Biochim Biophys Acta 1829: 174-185. 
Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C. 2004. ATP-driven exchange of 
histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. 
Science 303: 343-348. 
Moehle EA, Ryan CJ, Krogan NJ, Kress TL, Guthrie C. 2012. The yeast SR-like protein 
Npl3 links chromatin modification to mRNA processing. PLoS genetics 8: 
e1003101. 
Morris DP, Phatnani HP, Greenleaf AL. 1999. Phospho-carboxyl-terminal domain 
binding and the role of a prolyl isomerase in pre-mRNA 3'-End formation. J Biol 
Chem 274: 31583-31587. 
Musselman CA, Lalonde ME, Cote J, Kutateladze TG. 2012. Perceiving the epigenetic 
landscape through histone readers. Nature structural & molecular biology 19: 
1218-1227. 
Nakanishi S, Lee JS, Gardner KE, Gardner JM, Takahashi YH, Chandrasekharan MB, 
Sun ZW, Osley MA, Strahl BD, Jaspersen SL et al. 2009. Histone H2BK123 
monoubiquitination is the critical determinant for H3K4 and H3K79 trimethylation 
by COMPASS and Dot1. J Cell Biol 186: 371-377. 
Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. 2013. Mechanisms and functions of 
ATP-dependent chromatin-remodeling enzymes. Cell 154: 490-503. 
Ng HH, Dole S, Struhl K. 2003a. The Rtf1 component of the Paf1 transcriptional 
elongation complex is required for ubiquitination of histone H2B. J Biol Chem 
278: 33625-33628. 
  137 
Ng HH, Feng Q, Wang H, Erdjument-Bromage H, Tempst P, Zhang Y, Struhl K. 2002a. 
Lysine methylation within the globular domain of histone H3 by Dot1 is important 
for telomeric silencing and Sir protein association. Genes & development 16: 
1518-1527. 
Ng HH, Robert F, Young RA, Struhl K. 2003b. Targeted recruitment of Set1 histone 
methylase by elongating Pol II provides a localized mark and memory of recent 
transcriptional activity. Molecular cell 11: 709-719. 
Ng HH, Xu RM, Zhang Y, Struhl K. 2002b. Ubiquitination of histone H2B by Rad6 is 
required for efficient Dot1-mediated methylation of histone H3 lysine 79. J Biol 
Chem 277: 34655-34657. 
Nikolov DB, Burley SK. 1997. RNA polymerase II transcription initiation: a structural 
view. Proceedings of the National Academy of Sciences of the United States of 
America 94: 15-22. 
Nordick K, Hoffman MG, Betz JL, Jaehning JA. 2008. Direct interactions between the 
Paf1 complex and a cleavage and polyadenylation factor are revealed by 
dissociation of Paf1 from RNA polymerase II. Eukaryot Cell 7: 1158-1167. 
Norris A, Boeke JD. 2010. Silent information regulator 3: the Goldilocks of the silencing 
complex. Genes & development 24: 115-122. 
Oh S, Jeong K, Kim H, Kwon CS, Lee D. 2010. A lysine-rich region in Dot1p is crucial 
for direct interaction with H2B ubiquitylation and high level methylation of H3K79. 
Biochem Biophys Res Commun 399: 512-517. 
Onishi M, Liou GG, Buchberger JR, Walz T, Moazed D. 2007. Role of the conserved 
Sir3-BAH domain in nucleosome binding and silent chromatin assembly. 
Molecular cell 28: 1015-1028. 
Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin 
SP, Allis CD et al. 2007. DNMT3L connects unmethylated lysine 4 of histone H3 
to de novo methylation of DNA. Nature 448: 714-717. 
Orphanides G, Wu WH, Lane WS, Hampsey M, Reinberg D. 1999. The chromatin-
specific transcription elongation factor FACT comprises human SPT16 and 
SSRP1 proteins. Nature 400: 284-288. 
Parra MA, Kerr D, Fahy D, Pouchnik DJ, Wyrick JJ. 2006. Deciphering the roles of the 
histone H2B N-terminal domain in genome-wide transcription. Molecular and 
cellular biology 26: 3842-3852. 
Parra MA, Wyrick JJ. 2007. Regulation of gene transcription by the histone H2A N-
terminal domain. Molecular and cellular biology 27: 7641-7648. 
  138 
Pavri R, Zhu B, Li G, Trojer P, Mandal S, Shilatifard A, Reinberg D. 2006. Histone H2B 
monoubiquitination functions cooperatively with FACT to regulate elongation by 
RNA polymerase II. Cell 125: 703-717. 
Pengelly AR, Copur O, Jackle H, Herzig A, Muller J. 2013. A histone mutant reproduces 
the phenotype caused by loss of histone-modifying factor Polycomb. Science 
339: 698-699. 
Perales R, Bentley D. 2009. "Cotranscriptionality": the transcription elongation complex 
as a nexus for nuclear transactions. Molecular cell 36: 178-191. 
Pesavento JJ, Kim YB, Taylor GK, Kelleher NL. 2004. Shotgun annotation of histone 
modifications: a new approach for streamlined characterization of proteins by top 
down mass spectrometry. Journal of the American Chemical Society 126: 3386-
3387. 
Peterson CL, Laniel MA. 2004. Histones and histone modifications. Current biology : CB 
14: R546-551. 
Piro AS, Mayekar MK, Warner MH, Davis CP, Arndt KM. 2012. Small region of Rtf1 
protein can substitute for complete Paf1 complex in facilitating global histone 
H2B ubiquitylation in yeast. Proceedings of the National Academy of Sciences of 
the United States of America 109: 10837-10842. 
Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW, Walker K, 
Rolfe PA, Herbolsheimer E et al. 2005. Genome-wide map of nucleosome 
acetylation and methylation in yeast. Cell 122: 517-527. 
Psathas JN, Zheng S, Tan S, Reese JC. 2009. Set2-dependent K36 methylation is 
regulated by novel intratail interactions within H3. Molecular and cellular biology 
29: 6413-6426. 
Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, 
Ceric G, Clements J et al. 2012. The Pfam protein families database. Nucleic 
acids research 40: D290-301. 
Rando OJ, Winston F. 2012. Chromatin and transcription in yeast. Genetics 190: 351-
387. 
Ranish JA, Yudkovsky N, Hahn S. 1999. Intermediates in formation and activity of the 
RNA polymerase II preinitiation complex: holoenzyme recruitment and a 
postrecruitment role for the TATA box and TFIIB. Genes Dev 13: 49-63. 
Rao B, Shibata Y, Strahl BD, Lieb JD. 2005. Dimethylation of histone H3 at lysine 36 
demarcates regulatory and nonregulatory chromatin genome-wide. Molecular 
and cellular biology 25: 9447-9459. 
  139 
Rizzardi LF, Dorn ES, Strahl BD, Cook JG. 2012. DNA replication origin function is 
promoted by H3K4 di-methylation in Saccharomyces cerevisiae. Genetics 192: 
371-384. 
Robzyk K, Recht J, Osley MA. 2000. Rad6-dependent ubiquitination of histone H2B in 
yeast. Science 287: 501-504. 
Roguev A, Schaft D, Shevchenko A, Pijnappel WW, Wilm M, Aasland R, Stewart AF. 
2001. The Saccharomyces cerevisiae Set1 complex includes an Ash2 
homologue and methylates histone 3 lysine 4. The EMBO journal 20: 7137-7148. 
Rondon AG, Jimeno S, Garcia-Rubio M, Aguilera A. 2003. Molecular evidence that the 
eukaryotic THO/TREX complex is required for efficient transcription elongation. J 
Biol Chem 278: 39037-39043. 
Rothbart SB, Krajewski K, Nady N, Tempel W, Xue S, Badeaux AI, Barsyte-Lovejoy D, 
Martinez JY, Bedford MT, Fuchs SM et al. 2012a. Association of UHRF1 with 
methylated H3K9 directs the maintenance of DNA methylation. Nature structural 
& molecular biology 19: 1155-1160. 
Rothbart SB, Krajewski K, Strahl BD, Fuchs SM. 2012b. Peptide microarrays to 
interrogate the "histone code". Methods Enzymol 512: 107-135. 
Rothbart SB, Strahl BD. 2014. Interpreting the language of histone and DNA 
modifications. Biochim Biophys Acta 1839: 627-643. 
Ruthenburg AJ, Li H, Milne TA, Dewell S, McGinty RK, Yuen M, Ueberheide B, Dou Y, 
Muir TW, Patel DJ et al. 2011. Recognition of a mononucleosomal histone 
modification pattern by BPTF via multivalent interactions. Cell 145: 692-706. 
Ruthenburg AJ, Li H, Patel DJ, Allis CD. 2007. Multivalent engagement of chromatin 
modifications by linked binding modules. Nature reviews Molecular cell biology 8: 
983-994. 
Sainsbury S, Niesser J, Cramer P. 2013. Structure and function of the initially 
transcribing RNA polymerase II-TFIIB complex. Nature 493: 437-440. 
Sanchez R, Sali A. 1997. Evaluation of comparative protein structure modeling by 
MODELLER-3. Proteins Suppl 1: 50-58. 
Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, 
Schreiber SL, Mellor J, Kouzarides T. 2002. Active genes are tri-methylated at K4 
of histone H3. Nature 419: 407-411. 
Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, 
Gottschling DE, O'Neill LP, Turner BM, Delrow J et al. 2004. The histone 
  140 
modification pattern of active genes revealed through genome-wide chromatin 
analysis of a higher eukaryote. Genes & development 18: 1263-1271. 
Schulze JM, Hentrich T, Nakanishi S, Gupta A, Emberly E, Shilatifard A, Kobor MS. 
2011. Splitting the task: Ubp8 and Ubp10 deubiquitinate different cellular pools of 
H2BK123. Genes Dev 25: 2242-2247. 
Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, Moore IK, Wang JP, 
Widom J. 2006. A genomic code for nucleosome positioning. Nature 442: 772-
778. 
Seizl M, Hartmann H, Hoeg F, Kurth F, Martin DE, Soding J, Cramer P. 2011a. A 
conserved GA element in TATA-less RNA polymerase II promoters. PloS one 6: 
e27595. 
Seizl M, Lariviere L, Pfaffeneder T, Wenzeck L, Cramer P. 2011b. Mediator head 
subcomplex Med11/22 contains a common helix bundle building block with a 
specific function in transcription initiation complex stabilization. Nucleic acids 
research 39: 6291-6304. 
Shandilya J, Roberts SG. 2012. The transcription cycle in eukaryotes: from productive 
initiation to RNA polymerase II recycling. Biochim Biophys Acta 1819: 391-400. 
Sharma S, Kelly TK, Jones PA. 2010. Epigenetics in cancer. Carcinogenesis 31: 27-36. 
Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N, Raver-Shapira N, Minsky N, 
Pirngruber J, Tarcic G et al. 2008. The histone H2B-specific ubiquitin ligase 
RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation 
of gene expression. Genes Dev 22: 2664-2676. 
Shema-Yaacoby E, Nikolov M, Haj-Yahya M, Siman P, Allemand E, Yamaguchi Y, 
Muchardt C, Urlaub H, Brik A, Oren M et al. 2013. Systematic identification of 
proteins binding to chromatin-embedded ubiquitylated H2B reveals recruitment of 
SWI/SNF to regulate transcription. Cell reports 4: 601-608. 
Shi X, Chang M, Wolf AJ, Chang CH, Frazer-Abel AA, Wade PA, Burton ZF, Jaehning 
JA. 1997. Cdc73p and Paf1p are found in a novel RNA polymerase II-containing 
complex distinct from the Srbp-containing holoenzyme. Molecular and cellular 
biology 17: 1160-1169. 
Shi X, Finkelstein A, Wolf AJ, Wade PA, Burton ZF, Jaehning JA. 1996. Paf1p, an RNA 
polymerase II-associated factor in Saccharomyces cerevisiae, may have both 
positive and negative roles in transcription. Molecular and cellular biology 16: 
669-676. 
  141 
Shi X, Kachirskaia I, Walter KL, Kuo JH, Lake A, Davrazou F, Chan SM, Martin DG, 
Fingerman IM, Briggs SD et al. 2007a. Proteome-wide analysis in 
Saccharomyces cerevisiae identifies several PHD fingers as novel direct and 
selective binding modules of histone H3 methylated at either lysine 4 or lysine 36. 
J Biol Chem 282: 2450-2455. 
Shi X, Kachirskaia I, Walter KL, Kuo JH, Lake A, Davrazou F, Chan SM, Martin DG, 
Fingerman IM, Briggs SD et al. 2007b. Proteome-wide analysis in 
Saccharomyces cerevisiae identifies several PHD fingers as novel direct and 
selective binding modules of histone H3 methylated at either lysine 4 or lysine 36. 
The Journal of biological chemistry 282: 2450-2455. 
Shilatifard A. 2008. Molecular implementation and physiological roles for histone H3 
lysine 4 (H3K4) methylation. Curr Opin Cell Biol 20: 341-348. 
Shilatifard A. 2012. The COMPASS family of histone H3K4 methylases: mechanisms of 
regulation in development and disease pathogenesis. Annual review of 
biochemistry 81: 65-95. 
Simic R, Lindstrom DL, Tran HG, Roinick KL, Costa PJ, Johnson AD, Hartzog GA, Arndt 
KM. 2003. Chromatin remodeling protein Chd1 interacts with transcription 
elongation factors and localizes to transcribed genes. The EMBO journal 22: 
1846-1856. 
Sims RJ, 3rd, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS, Reinberg D. 2005. 
Human but not yeast CHD1 binds directly and selectively to histone H3 
methylated at lysine 4 via its tandem chromodomains. The Journal of biological 
chemistry 280: 41789-41792. 
Smith E, Shilatifard A. 2010. The chromatin signaling pathway: diverse mechanisms of 
recruitment of histone-modifying enzymes and varied biological outcomes. 
Molecular cell 40: 689-701. 
Smolle M, Venkatesh S, Gogol MM, Li H, Zhang Y, Florens L, Washburn MP, Workman 
JL. 2012. Chromatin remodelers Isw1 and Chd1 maintain chromatin structure 
during transcription by preventing histone exchange. Nature structural & 
molecular biology 19: 884-892. 
Soding J, Biegert A, Lupas AN. 2005. The HHpred interactive server for protein 
homology detection and structure prediction. Nucleic acids research 33: W244-
248. 
Somesh BP, Reid J, Liu WF, Sogaard TM, Erdjument-Bromage H, Tempst P, Svejstrup 
JQ. 2005. Multiple mechanisms confining RNA polymerase II ubiquitylation to 
polymerases undergoing transcriptional arrest. Cell 121: 913-923. 
  142 
Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PW, Bauer C, Munzel M, 
Wagner M, Muller M, Khan F et al. 2013. Dynamic readers for 5-
(hydroxy)methylcytosine and its oxidized derivatives. Cell 152: 1146-1159. 
Squazzo SL, Costa PJ, Lindstrom DL, Kumer KE, Simic R, Jennings JL, Link AJ, Arndt 
KM, Hartzog GA. 2002. The Paf1 complex physically and functionally associates 
with transcription elongation factors in vivo. The EMBO journal 21: 1764-1774. 
Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403: 
41-45. 
Strahl BD, Grant PA, Briggs SD, Sun ZW, Bone JR, Caldwell JA, Mollah S, Cook RG, 
Shabanowitz J, Hunt DF et al. 2002. Set2 is a nucleosomal histone H3-selective 
methyltransferase that mediates transcriptional repression. Molecular and cellular 
biology 22: 1298-1306. 
Strahl BD, Ohba R, Cook RG, Allis CD. 1999. Methylation of histone H3 at lysine 4 is 
highly conserved and correlates with transcriptionally active nuclei in 
Tetrahymena. Proceedings of the National Academy of Sciences of the United 
States of America 96: 14967-14972. 
Sun M, Schwalb B, Schulz D, Pirkl N, Etzold S, Lariviere L, Maier KC, Seizl M, Tresch 
A, Cramer P. 2012. Comparative dynamic transcriptome analysis (cDTA) reveals 
mutual feedback between mRNA synthesis and degradation. Genome Res 22: 
1350-1359. 
Sun ZW, Allis CD. 2002. Ubiquitination of histone H2B regulates H3 methylation and 
gene silencing in yeast. Nature 418: 104-108. 
Sydow JF, Brueckner F, Cheung AC, Damsma GE, Dengl S, Lehmann E, Vassylyev D, 
Cramer P. 2009. Structural basis of transcription: mismatch-specific fidelity 
mechanisms and paused RNA polymerase II with frayed RNA. Molecular cell 34: 
710-721. 
Tada K, Susumu H, Sakuno T, Watanabe Y. 2011. Condensin association with histone 
H2A shapes mitotic chromosomes. Nature 474: 477-483. 
Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, Rousseaux S, 
Rajagopal N et al. 2011. Identification of 67 histone marks and histone lysine 
crotonylation as a new type of histone modification. Cell 146: 1016-1028. 
Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. 2007. How chromatin-binding 
modules interpret histone modifications: lessons from professional pocket 
pickers. Nature structural & molecular biology 14: 1025-1040. 
  143 
Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Page N, Robinson M, 
Raghibizadeh S, Hogue CW, Bussey H et al. 2001. Systematic genetic analysis 
with ordered arrays of yeast deletion mutants. Science 294: 2364-2368. 
Tong AH, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost RL, 
Chang M et al. 2004. Global mapping of the yeast genetic interaction network. 
Science 303: 808-813. 
Trojer P, Reinberg D. 2007. Facultative heterochromatin: is there a distinctive molecular 
signature? Molecular cell 28: 1-13. 
Trujillo KM, Osley MA. 2012. A role for H2B ubiquitylation in DNA replication. Molecular 
cell 48: 734-746. 
van Leeuwen F, Gafken PR, Gottschling DE. 2002. Dot1p modulates silencing in yeast 
by methylation of the nucleosome core. Cell 109: 745-756. 
van Nuland R, Schram AW, van Schaik FM, Jansen PW, Vermeulen M, Marc Timmers 
HT. 2013. Multivalent Engagement of TFIID to Nucleosomes. PloS one 8: 
e73495. 
Vermeulen M, Mulder KW, Denissov S, Pijnappel WW, van Schaik FM, Varier RA, 
Baltissen MP, Stunnenberg HG, Mann M, Timmers HT. 2007. Selective 
anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 
131: 58-69. 
Vethantham V, Yang Y, Bowman C, Asp P, Lee JH, Skalnik DG, Dynlacht BD. 2012. 
Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 
trimethylation during myogenic differentiation. Molecular and cellular biology 32: 
1044-1055. 
Vezzoli A, Bonadies N, Allen MD, Freund SM, Santiveri CM, Kvinlaug BT, Huntly BJ, 
Gottgens B, Bycroft M. 2010. Molecular basis of histone H3K36me3 recognition 
by the PWWP domain of Brpf1. Nature structural & molecular biology 17: 617-
619. 
Vitaliano-Prunier A, Menant A, Hobeika M, Geli V, Gwizdek C, Dargemont C. 2008. 
Ubiquitylation of the COMPASS component Swd2 links H2B ubiquitylation to 
H3K4 trimethylation. Nature cell biology 10: 1365-1371. 
Voss TC, Hager GL. 2014. Dynamic regulation of transcriptional states by chromatin 
and transcription factors. Nat Rev Genet 15: 69-81. 
Wade PA, Werel W, Fentzke RC, Thompson NE, Leykam JF, Burgess RR, Jaehning 
JA, Burton ZF. 1996. A novel collection of accessory factors associated with 
yeast RNA polymerase II. Protein Expr Purif 8: 85-90. 
  144 
Wagner EJ, Carpenter PB. 2012. Understanding the language of Lys36 methylation at 
histone H3. Nature reviews Molecular cell biology 13: 115-126. 
Wang D, Bushnell DA, Huang X, Westover KD, Levitt M, Kornberg RD. 2009. Structural 
basis of transcription: backtracked RNA polymerase II at 3.4 angstrom resolution. 
Science 324: 1203-1206. 
Wang E, Kawaoka S, Yu M, Shi J, Ni T, Yang W, Zhu J, Roeder RG, Vakoc CR. 2013. 
Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia. 
Proceedings of the National Academy of Sciences of the United States of 
America 110: 3901-3906. 
Weake VM, Workman JL. 2008. Histone ubiquitination: triggering gene activity. 
Molecular cell 29: 653-663. 
Wind M, Reines D. 2000. Transcription elongation factor SII. Bioessays 22: 327-336. 
Wood A, Krogan NJ, Dover J, Schneider J, Heidt J, Boateng MA, Dean K, Golshani A, 
Zhang Y, Greenblatt JF et al. 2003a. Bre1, an E3 ubiquitin ligase required for 
recruitment and substrate selection of Rad6 at a promoter. Molecular cell 11: 
267-274. 
Wood A, Schneider J, Dover J, Johnston M, Shilatifard A. 2003b. The Paf1 complex is 
essential for histone monoubiquitination by the Rad6-Bre1 complex, which 
signals for histone methylation by COMPASS and Dot1p. J Biol Chem 278: 
34739-34742. 
Wozniak GG, Strahl BD. 2014. Hitting the 'Mark': Interpreting Lysine Methylation in the 
Context of Active Transcription. Biochim Biophys Acta. 
Wu X, Rossettini A, Hanes SD. 2003. The ESS1 prolyl isomerase and its suppressor 
BYE1 interact with RNA pol II to inhibit transcription elongation in 
Saccharomyces cerevisiae. Genetics 165: 1687-1702. 
Wu X, Wilcox CB, Devasahayam G, Hackett RL, Arevalo-Rodriguez M, Cardenas ME, 
Heitman J, Hanes SD. 2000. The Ess1 prolyl isomerase is linked to chromatin 
remodeling complexes and the general transcription machinery. The EMBO 
journal 19: 3727-3738. 
Xiao T, Kao CF, Krogan NJ, Sun ZW, Greenblatt JF, Osley MA, Strahl BD. 2005. 
Histone H2B ubiquitylation is associated with elongating RNA polymerase II. 
Molecular and cellular biology 25: 637-651. 
Young NL, Plazas-Mayorca MD, Garcia BA. 2010. Systems-wide proteomic 
characterization of combinatorial post-translational modification patterns. Expert 
review of proteomics 7: 79-92. 
  145 
Yudkovsky N, Logie C, Hahn S, Peterson CL. 1999. Recruitment of the SWI/SNF 
chromatin remodeling complex by transcriptional activators. Genes Dev 13: 
2369-2374. 
Zentner GE, Henikoff S. 2013. Regulation of nucleosome dynamics by histone 
modifications. Nature structural & molecular biology 20: 259-266. 
Zhang Y, Jurkowska R, Soeroes S, Rajavelu A, Dhayalan A, Bock I, Rathert P, Brandt 
O, Reinhardt R, Fischle W et al. 2010. Chromatin methylation activity of Dnmt3a 
and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 
tail. Nucleic acids research 38: 4246-4253. 
Zheng S, Wyrick JJ, Reese JC. 2010. Novel trans-tail regulation of H2B ubiquitylation 
and H3K4 methylation by the N terminus of histone H2A. Molecular and cellular 
biology 30: 3635-3645. 
Zhu B, Mandal SS, Pham AD, Zheng Y, Erdjument-Bromage H, Batra SK, Tempst P, 
Reinberg D. 2005. The human PAF complex coordinates transcription with 
events downstream of RNA synthesis. Genes Dev 19: 1668-1673. 
Zhuang M, Guan S, Wang H, Burlingame AL, Wells JA. 2013. Substrates of IAP 
ubiquitin ligases identified with a designed orthogonal E3 ligase, the NEDDylator. 
Molecular cell 49: 273-282. 
Zlatanova J, Thakar A. 2008. H2A.Z: view from the top. Structure 16: 166-179. 
 
